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ABSTRACT
The transfer of farming practices from low intensity farming systems for livestock
production to commercial enterprises which employ intensive practices has resulted
in the use of veterinary drugs becoming a critical component of food production.
Resulting residues of veterinary drugs occurring in food of animal origin may give
rise to potential health risks to consumers. The aim of this research is the
development of analytical methods capable of screening and confirming increased
number of these residues in more target matrices by Liquid Chromatography Tandem
Mass Spectrometry (LC-MS/MS). Its focus is the analysis of nitroimidazole residues
in food of animal origin and authorised and prohibited medicinal additives in animal
feed.
This research resulted in the development and validation of methods for analysis of
nitroimidazoles (NMZs) in plasma, eggs, milk and honey and prohibited and
authorised medicinal additives in animal feed. The analytical technique used in all
methods was the highly selective and sensitive LC-MS/MS. This technique allowed
for multi-analyte methods to be developed for different matrices. NMZ residues
examined were metronidazole, dimetridazole, ronidazole, ipronidazole, ternidazole,
ornidazole, carnidazole and tinidazole along with three metabolite, hydroxymetronidazole,

2-Hydroxymethyl-1-methyl-5-nitroimidazole

(HMMNI)

and

hydroxy-ipronidazole. Chloramphenicol was included with the analysis of NMZs in
the matrices of milk and honey. Fourteen medicinal additives; metronidazole,
dimetridazole,

ronidazole,

ipronidazole,

clopidol,

carbadox,

sulfadiazine,

sulfamethazine, dinitolimide, chloramphenicol, ethopabate, avilamycin, tylosin and
virginiamycin were analysed for in animal feed. The final method developed allowed
for coccidiostats; halofuginone, robenidine, nicarbazin, diclazuril, decoquinate,
ii

semduramicin, lasalocid, salinomycin, monensin, narasin and maduramicin to be
analysed for at levels related to unavoidable carryover in feed.
All veterinary residue methods used were validated in accordance with EU
legislation; Commission Decision 2002/657/EC. This legislation is concerned with
the performance of analytical methods and the interpretation of results. Validation
criteria were examined using protocols set out in this legislation and these included
specificity, accuracy, precision, repeatability, reproducibility, decision limits (CCα),
detection capabilities (CCβ) along with measurement uncertainty (MU). In the four
methods developed for the analysis of NMZ residues in plasma, egg, milk and honey
the accuracy and precision for all analytes ranged from 87.2% to 108.9% and 3.7%
to 11.3% respectively in all matrices. CCα and CCβ for all nitroimidazole residues
ranged from 0.33 to 1.60 g L-1 / g kg-1 and 0.56 to 2.64 g L-1 / g kg-1
respectively with MUs ranging from 18 to 90% for all compounds in the various
matrices. Chloramphenicol CCα and CCβ values were below its minimum required
performance level (MRPL) of 0.3 g L-1 / g kg-1.
At present there is no legislation in place describing validation approaches for
methods used for the analysis of medicinal additives in animal feed. Therefore for
the validation of the two feed methods developed as part of this research the
veterinary residue legislation was used as a basis. In the case of the analysis of
coccidiostats at unavoidable carry over levels; the method was validated entirely in
accordance with veterinary residue legislation, Commission Decision 2002/657/EC.
However the method for the analysis of 14 prohibited medicinal additives in feed
was validated with some adaptations to this legislation. To ensure that the method
was fit for purpose a wide variety of feed was used in validation and a wider
concentration range was examined. Parameters of specificity, accuracy, precision,
iii

repeatability, reproducibility were all examined and deemed to be acceptable along
with measurement uncertainty.
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The production of food from animal origin in the form of meat, milk, eggs and honey
is necessary in maintaining a sustainable food supply. Due to an increasing
worldwide population there is a greater demand on food production but there is less
space available to allow for it. In order to facilitate increased production, intensive
farming practices have been implemented into the production of food from animal
origins. To help aid these practices both authorised and prohibited veterinary drugs
are either administered routinely as part of the feeding process or non-routinely in the
form of injections, pour-ons or implants. This process of animal medication has
become an integral part of animal husbandry. While this process leads to increased
food production and less stock loss due to disease; it can result in the occurrence of
veterinary residues in the food we eat. As a result of health risks, the issue of
veterinary drug residues in foods of animal origin has become increasingly important
throughout the European Union.
The main human health risks associated with the occurrence of veterinary residues in
food are related firstly to the safety of food and secondly to the production of
pathogens in humans with antibiotic immunity due to the continuous intake of
residues from food. Therefore the European Union has acted in order to reduce the
occurrence of residues in food by bringing into force a number of pieces of
legislation such as Council Directives 96/22/EC, 96/23/EC and Commission
Recommendation 2005/925/EC to set limits for and in some cases prohibit the use of
veterinary drugs in food producing animals. These legislative acts have resulted in
the need for countries to improve their farming practices by meeting set limits for
veterinary residues by following withdrawal times and recommendations for
veterinary products. Failure to meet requirements in relation to levels of residues in
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food can have serious economic consequences for the country involved as heavy
fines and exclusion from trading are associated with breaches. Despite this increase
in legislation there is still growing public concern over drug residues in food due to
the improper use of veterinary drugs in intense farming practices.
Due to an increasing population and a changing diet there has been an increase in the
consumption of meat and dairy products, in particular poultry products [Abele et al.,
2004]. As a result, more intensive farming methods have evolved in order to meet
this demand. Instead of mixed agricultural systems focusing on a number of areas on
a small scale, current food production practices are commonly focused of one area of
agriculture in the form of large commercial businesses with intensive farming
systems in place for continuous production. This has resulted in a significant increase
in the use of veterinary products such as coccidiostats and antibiotics to ensure stock
is not lost to disease and growth promoting agents to ensure the largest profit can be
made from the stock [Chevance et al., 2009; Raloff, 2002; VMD, 2008]. Also in
addition to this there is an increased percentage of food imported into Europe from
third countries. Legislation in place in these countries may not be in line with
European requirements which may result in the occurrence of residues in our food at
possibly harmful levels.
Veterinary medicinal products used in animal production can be divided into a two
main groups as set out in Council Directive 96/23/EC. These are Group A
compounds which are unauthorized for use in food producing animals and Group B
compounds which are authorized for use. Each group in divided into a number of
classes of compounds and these classifications are seen in Table 1-1.

3

Chapter 1

Introduction

Table 1-1. Two Main Groups of Veterinary Medicinal Product

Group A
Prohibited Substances
A1
STILBENES

Group B
Veterinary drugs and contaminants
B1
ANTIMICROBRIALS

A2
THYROSTATS
A3
STEROIDS
A4
ZERANOL
A5
BETA-AGONIST
A6 (Nitroimidazoles,
Chloramphenicol)
Prohibited compounds
listed in Table 2 of
Regulation 37/2010/EC

B2a
ANTHELMINTICS
B2b
COCCIDIOSTATS
B2c
CARBAMATES/
PYRETHROIDS
B2d
SEDATIVES
B2e
Non Steroidal AntiInflammatory Drugs

B3a
ORGANOCHLORINES
including PCBs,
B3b
ORGANOPHOSPHATES
B3c
HEAVY METALS
B3d
MYCOTOXINS
B3e
DYES

B2f
OTHERS e.g.
corticoids

The occurrences of residues in food that are in breach of levels stated in legislation
can arise in a variety of different ways. These include either the improper use of
licensed products or the illegal use of unlicensed and prohibited substances [Kennedy
et al., 2000]. In relation to licensed products, there are numerous factors that can
result in residues being present in food above authorised levels; some of these are
listed in Table 1-2. If the user of the authorized substance (Group B) adheres to the
product license and provided that the drug withdrawal periods are respected, drug
residues should not occur in food at concentrations greater than the maximum
residue limits (MRLs). Prohibited veterinary products (Group A) are ones that are
not permitted for use in the production of food from animal origin. Some of the main
reasons for the occurrence of prohibited veterinary drug residues in the human food
chain can be seen in Table 1-2.
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Table 1-2. Reasons for drug residues from authorized and prohibited substances.

Authorized Substances
Prohibited Substances
1. Extended usage or excessive dosage of 1. The use of growth promoting
approved drugs
hormones in order to increase the
weight of animals and reduce amount
of feed needed by animals to gain
weight [Debackere et al., 1989]
2. Poor records of treatment leading to 2. The use of certain banned
problems identifying in Treated-animal compounds that can be very effective at
resulting in overdosing
controlling particular infections e.g.
nitrofurans [O’Keeffe et al., 2004]
3. Use of incorrect veterinary drug for 3. The use of prohibited compounds
particular species.
that are very cheap and readily
available.
4. Contaminated feed being used as
withdrawal feed for target animals as a result
of carry over issues in feed mills.
[Commission Directive 2009/8/EC].

Studies carried out on residues and metabolites of prohibited veterinary drugs (Group
A) have highlighted the possibility of their harmful health effects. Reports published
by both The European Agency for the Evaluation of Medicinal Products (EMEA)
and The International Agency for Research on Cancer (IARC) have both suggested
that nitroimidazoles and chloramphenicol are possible carcinogens and are therefore
are classed as A6 compounds and are prohibited for use in food producing animals.
Although Group A substances are considered more of a human health risk than
Group B substances; their use is not without there consequences. Apart from allergic
reaction one of the main reasons for the control of some group B substance is the
similarity between animal antibiotics and there human counterparts. It is feared that
the continuous use of these compounds in animals may result in the increase of
antibiotic immune bacteria that could transferred to humans. Immunity such as this
has been seen for tetracycline [Smith et al., 1957] and vancomycin in the late 1980s
[Bates et al., 1993].
5

Chapter 1

Introduction

With this ever increasing list of risks to human health, the European Commission has
focused its attentions on consumer protection in relation to the use of veterinary
drugs in animal husbandry. Legislation is continuously being updated and amended
to assist with this. In order for each member state’s regulatory authority to enforce
this legislation and ensure ongoing consumer protection throughout Europe there is a
need for robust and sensitive analytical methods for the detection of these residues to
be developed.

1.2

Aims of the Study

The main aim of this research was to develop and validate reliable, robust and
suitably sensitive analytical methods for the analysis of veterinary drugs and their
residues in various biological and feed matrices. These methods were validated
taking into consideration all relevant European legislation, ensuring that all criteria
with regards to analytical methods, target analytes and suitable matrices were
satisfied.
The initial part of the research dealt specifically with the analysis of 5nitroimidazoles in biological matrices of food producing animals. Analysis of the
suspected carcinogenic 5-nitroimidazole compounds is limited and this was the case
in Ireland prior to this research as the analysis of these compounds was limited to
two hydroxy-metabolites in a single matrix. In addition studies have shown that
matrices such as muscle and liver don’t allow for the best possible identification of
abuse of these compounds. Prior to this research the analysis of these compounds
often involved the examination of these unsuitable matrices.
The focus of the research then moved to the analysis of animal feed for the presence
of medicinal feed additives. High levels of veterinary drug residues in food that can
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pose a risk to human health may be the result of animals being fed contaminated
feed. Therefore the development of analytical methods for the analysis of a wide
variety of these additives in animal feeds is an important part of the research.
There were a number of specific aims within the research as a whole and these
included:
I. To help improve the surveillance capabilities of The State Laboratory with regards
to the analysis of nitroimidazoles by the development of a number of novel, rapid,
confirmatory, multi residue methods using liquid chromatography tandem mass
spectrometry in a variety of biological matrices.
a) Nitroimidazoles in Plasma.
b) Nitroimidazoles in Eggs.
c) Nitroimidazoles and Chloramphenicol in Milk and Honey
II. In order to meet the requirements of EU legislation with regard to medicinal feed
additives new liquid chromatography tandem mass spectrometry methods were
developed. These included the analysis of:
a) Prohibited Medicinal feed additives in pig and poultry feed
b) Eleven Coccidiostats in animal feed at levels relating to unavoidable
carry over from feed mills.
III. To determine the potential misuse of nitroimidazole compounds in the Irish Egg
Industry by the analysis retail survey egg samples.
IV. Implementation of these methods into the National Reference Laboratory in Ireland
designated for the control of the particular substance groups in question.
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Introduction

This chapter will give an overview of the main issues regarding veterinary drug
analysis and the areas that should be taken into consideration when developing an
analytical method. These issues include;


Background information on nitroimidazoles, their metabolism, their stability
and their carcinogenicity.



Background information on chloramphenicol.



Background information on medicinal feed additives and their use in feed.



Review of the current legislation pertaining to veterinary drugs within the EU



Review of the current legislation pertaining to medicinal feed additives and
cross contamination issues.



Review of validation protocols within the EU



Review of extraction and purification procedures used in residue analysis for
the compounds of interest, highlighting the relevant matrices.



2.2

Review of LC-MS/MS and its uses in the field of veterinary residue analysis.

Overview of Veterinary Drugs Investigated

1.2.1. Nitroimidazoles
In the initial part of this research; the class of veterinary drugs of most interest was
nitroimidazoles. This was due to the fact that although they are prohibited for the use
in food producing animals, there remained a shortage of methods that could analyse
for these carcinogenic compounds in a wide variety of matrices to ensure that a
potential risk to human health was identified.
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Nitroimidazoles are imidazole heterocycles with nitrogen groups incorporated in the
structure. Examples of these compounds are metronidazole [1-(2-hydroxyethyl)-2methyl-5-nitroimidazole

(MNZ)],

dimetridazole

[1,2-dimethyl-5-nitroimidazole

(DMZ)], ronidazole [1-methyl-2-[(carbamoyloxy)-methyl]-5-nitroimidazole (RNZ)],
ipronidazole [2-isopropyl-1-methyl-5-nitroimidazole (IPZ)], carnidazole [1-(2ethylcarbamothioic
ornidazole

acid

O-methyl

ester)-2-methyl-5-nitroimidazole

[1-(3-chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole

(CNZ)],
(ONZ)],

ternidazole [1-propanol-2-Methyl-5-nitroimidazole (TRZ)] and tinidazole [1-(2ethylsulfonylethyl)-2-methyl-5-nitroimidazole (TNZ)]. These examples are known as
5-nitroimidazoles as they contain a NO2 group on the 5 ring position. This base
structure is seen in Figure 2-1 along with the different compounds investigated as
part of this research.
5-Nitroimidazoles are active against most obligate anaerobic bacteria and variety of
protozoa where organism resistance is rare but have limited activity against aerobic
bacteria [Bishop, 2005]. Nitroimidazole compounds that were licensed as veterinary
medicines include metronidazole, dimetridazole and ronidazole. Metronidazole was
the most commonly used 5-Nitroimidazole and can be used to treat a wide variety of
infection in animals. It is used in the treatment of humans and animals for infections
caused by Trichomonas, Histomonas and Clostridium. It can be used for treatment of
dysentery in pigs and in combination with neomycin can treat retentio secundinarum
in cows [EMEA Report, Metronidazole].
Dimetridazole is used mainly in the poultry industry in particular for the treatment of
histomoniasis in turkeys and trichomoniasis in pigeons. It has also been used in the
treatment of cattle for genital trichoniasis and pigs for haemorrhagic enteritis.
[EMEA Report, Dimetridazole]. The final nitroimidazole that was licensed for use in
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animal husbandry was ronidazole. This was used for the treatment of similar diseases
such as histomoniasis in turkeys, genital trichoniasis in cows and haemorrhagic
enteritis in pigs [EMEA Report, Ronidazole]. Articles published on nitroimidazoles
have also shown that dimetridazole [Griffin, 1972] and ronidazole [Taylor, 1974] are
effective in the treatment of swine dysentery. Another nitroimidazole, carnidazole,
can also be used for the treatment and prophylaxis of trichomoniasis in pigeons
[Bishop, 2005].
The antimicrobial effect of all 5-nitroimidazole derivatives is due to the same mode
of action as each other i.e. the metabolic reduction of the nitro group by susceptible
anaerobic microorganisms. The metabolic reduction of the nitro group is performed
by microbial ‘nitroreductases’ [Voogd, 1981; Johnson, 1993]. This allows
nitroimidazoles to be successful in the treatment of Trichomonas, Histomonas and
Clostridium, as they interact with DNA destroying its ability to act as a template for
DNA and RNA synthesis [Bishop, 2005].
Nitroimidazole compounds are believed to be carcinogenic and mutagenic to
humans. The majority of studies have been carried out on metronidazole. The results
of these studies show that it is believed to be a human carcinogen based on sufficient
evidence of carcinogenicity in experimental animals [IARC 1977, 1982, 1987].
Animal studies have shown that mice treated with metronidazole have shown
increased incidence of lung tumors for both sexes and lymphomas in female mice
[Rustia et al., 1972]. Oral administration of the compound also caused mammary
fibroadenomas and adenocarcinomas, and pituitary, testicular, and liver tumors in
rats [IARC 1977, 1982, 1987]. There is however inadequate evidence for the
carcinogenicity of metronidazole in humans [IARC 1982, 1987].
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Nitroimidazole Base Structure

Metronidazole

Ternidazole

Ronidazole

Ornidazole

Dimetridazole

Tinidazole

Ipronidazole

Carnidazole

Figure 2-1: Basic 5-Nitroimidazole Structure and various different compounds examined in this
research

The European Agency for the Evaluation of Veterinary Products (EMEA) has
published summary reports on three nitroimidazole compounds; metronidazole
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[EMEA Report, Metronidazole], dimetridazole [EMEA Report, Dimetridazole] and
ronidazole [EMEA Report, Ronidazole]. While the reports suggest the studies carried
out on humans are insufficient and inconclusive to prove or disprove carcinogenicity
of these compounds, results in animal studies are conclusive [Rustia et al., 1972;
IARC 1977, 1982, 1987]. This, in their opinion, is enough to consider these
compounds as carcinogenic and in the interest of human health they are prohibited
for use in food producing animals. The legislation covering this is discussed fully in
section 2.3.
A number of studies carried out on these compounds have shown that they are
rapidly metabolised in bovine, porcine and avian species [MacDonald et al., 1971;
Craine et al., 1974; Cala et al., 1976; Rosenblum et al., 1972]. The main metabolite
of DMZ, IPZ and MNZ results from the oxidation of the side chain in the C-2
position of the imidazole ring to form hydroxy metabolites [MacDonald et al., 1971;
Craine et al., 1974]. RNZ has a different degradation pathway but results in an
identical metabolite to that of DMZ [Cala et al., 1976; Rosenblum et al., 1972]. The
metabolite of DMZ and RNZ is HMMNI (2-hydroxymethyl-1-methyl-5nitroimidazole), of MNZ is MNZ-OH (1-(2-hydroxyethyl)-2-hydroxymethyl-5nitroimidazole) and of IPZ is IPZ-OH (1-methyl-2-(2′-hydroxyisopropyl)-5nitroimidazole). There structures can be seen in figure 2-2. As these compounds still
contain the imidazole ring their carcinogenicity cannot be overlooked [EMEA
Report, Metronidazole]. Also these metabolites can be an indication of potential
misuse of prohibited nitroimidazole compounds and therefore should also be
analysed for.
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Figure 2-2. Structure of the hydroxy-metabolites MNZ-OH, HMMNI and IPZ-OH

The most recent study carried out on nitroimidazole metabolism by Polzer et al.,
2004 examined the amount of parent drug and the corresponding main hydroxymetabolite in various matrices taken from treated turkeys and as a result a number of
conclusions were made. The study demonstrated that the metabolites of DMZ and
IPZ, HMMNI and IPZ-OH, should be chosen as target analytes to prove illegal
treatment whereas to check for a treatment with RNZ or MNZ, the measurement of
the parent drug is to be preferred. This is due to the fact that these are the most
abundant residues left after administering nitroimidazoles. However the study also
goes on to state that the ratio of parent drug to metabolite in the case of dimetridazole
was found to vary with the length of the withdrawal time. Therefore it might be
prudent to look for both the metabolite and parent residue for dimetridazole to ensure
non compliant samples are identified. In addition to this without respective data on
the behaviour of the other nitroimidazoles, a recommendation was made to monitor
both, the parent drug and the respective metabolite, whenever possible in order to
identify any possible abuse of these compounds. [Polzer et al., 2004]
Methods used to analyse nitroimidazoles in food producing animals will be discussed
fully in section 2.4.2. However studies on the stability and homogeneity of
nitroimidazoles have been carried out by the European Union Reference Laboratory
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(EURL) for nitroimidazoles in Berlin to identify suitable matrices and marker
analytes for their analysis [Polzer et al., 2004 and 2005]. These involved the analysis
of turkeys administered nitroimidazoles in controlled experiments. In several animal
studies turkeys were treated with different nitroimidazoles (DMZ, MNZ, RNZ, IPZ).
Apart from the identification of target analytes as mentioned previously the main
observations of their studies were; the repeatability of the analysis of muscle samples
was unacceptable due to the inhomogeneity of the matrix and a rapid degradation of
the analytes was observed during sampling and continues during storage in a nonfrozen state [Polzer et al., 2004 and 2005].
They showed clearly that in the stability studies they carried out, nitroimidazoles are
not stable in muscle and liver and suggested that care must be taken to ensure an
immediate and efficient cooling directly after sampling. The also showed that
inhomogeneity of the analytes in muscle and liver and recommended to thoroughly
homogenise sufficient quantities of these matrices in order to obtain representative
sample material, e.g. by lyophilisation [Polzer et al., 2004 and 2005].
Even with the implementation of these measures depletion studies of dimetridazole
show there is a rapid disappearance of analyte in liver and muscle. In contrast they
found that in plasma and eggs a longer detection period of the nitroimidazole
residues is possible. They also found that these residues are more stable and there is
no problem with inhomogeneity in the matrix of plasma and eggs. Furthermore, they
feel that the matrix is readily available and is therefore very well suited for residue
control purposes [Polzer et al., 2004 and 2005]. Finally, the study determined that the
same is true for retina. It stated that the highest concentrations of nitroimidazoles
were measured in this matrix.
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As these studies are carried out in turkeys the results could differ from poultry to
larger animals such as pigs. That said these studies have suggested that, in order to
accurately ensure that the misuse of nitroimidazoles is not taking place sampling,
matrix and marker analyte selection is crucial. Taking this into consideration
matrices that should be used for the analyses of nitroimidazoles are plasma, retina
and eggs and once sampled should be cooled immediately [Polzer et al., 2004 and
2005].

1.2.2. Chloramphenicol
Chloramphenicol (CAP) is a broad spectrum bacteriostatic antibacterial [Bishop,
2005] whose structure can be seen in figure 2-3. Like nitroimidazoles it is prohibited
for the use in food producing animals. Much of the same European legislation
governs both compounds. The analysis of CAP is often performed in single analyte
methods (section 2.4.3) and it was felt that to combine these into one method would
be beneficial.
Chloramphenicol is active against a wide range of illnesses and infections including
rickettsial and chlamydophilial infections, numerous obligate anaerobes, gram
positive aerobes, and non-enteric aerobes such as Bordetella and Haemophilus
[Burnham et al., 2000]. CAP is a simple lipid-soluble compound which readily
crosses the cellular barrier. For this reason it is a very effective medicinal product as
it diffuses throughout the body and reaches infection sites inaccessible to many other
antibacterial drugs which include areas such as cerebrospinal fluid and the internal
structures of the eye. The process by which CAP exerts its effect is by inhibiting
bacterial protein synthesis. [Bishop, 2005].
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Figure 2-3. Structure of Chloramphenicol

Studies on the carcinogenicity of CAP in humans suggest that it is believed to be a
human carcinogen. Case reports have shown leukemia to occur after medical
treatment for chloramphenicol-induced aplastic anemia [IARC 1990]. Three case
reports have also documented the occurrence of leukemia after chloramphenicol
therapy in the absence of intervening aplastic anemia. In a case-control study in
China, elevated risks of childhood leukemia were found, which increased
significantly with the number of days chloramphenicol was taken [Shu et al. 1987,
1988]. Two case-control studies [Issaragrisil et al. 1997; Laporte et al. 1998] found
high, but nonsignificant, increases in the risk of aplastic anemia associated with the
use of chloramphenicol in the six months before onset of aplastic anemia. However,
two case-control studies [Zheng et al., 1993; Doody et al., 1996] found no
association between the use of chloramphenicol and the risk of adult leukemia,
suggesting that children may be a particularly susceptible subgroup. One report by
Zahm et al., 1989 found an association between chloramphenicol use and increased
risk of soft-tissue sarcoma. When considered together, the many case reports
implicating chloramphenicol as a cause of aplastic anemia, the evidence of a link
between aplastic anemia and leukemia, and the increased risk of leukemia found in
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some case-control studies support the conclusion that chloramphenicol exposure is
associated with an increased cancer risk in humans.
Another issue with CAP is that it is metabolized more slowly in babies and infants
than in adults, which can result in gray baby syndrome. This syndrome is
characterized by cardiovascular collapse in infants, apparently caused by
accumulation of active, unconjugated chloramphenicol in the serum, resulting from
low inactivation through glucuronide conjugation in the liver [Burnham et al., 2000].
Taking this information into consideration, the European Union has prohibited the
use of CAP in animals used in food production. The legislation governing this is
discussed fully in section 2.3.

1.2.3. Veterinary Medicinal Additives
A major area of interest of this research was based on the development of methods
for the analysis of medicinal additives in animal feed. New legislation governing the
control of these additives is discussed in section 2.3.2. A wide range of compounds
are detailed in this legislation which are either prohibited for use as a feed additive or
are detailed specifically for certain species of animal. These medicinal additives
include; compounds prohibited for use in food producing animals such as
nitroimidazoles (section 2.2.1) and chloramphenicol (section 2.2.2); compounds
specifically allowed only in medicated feed such as sulphonamides and compounds
no longer allowed to be used as feed additives such as antibacterial growth promoters
(AGPs) e.g. tylosin and virginiamycin. The other list of compounds that is governed
by this new legislation are ionophore coccidiostats and histomonostats that are, as a
result of this legislation, the only medicinal products that are allowed to be used as
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feed additives but only for specific species. The two lists covered by the legislation
can be seen in Table 2-3.
Previously there were a wide variety of medicinal products that were added to feed to
help improve the general health of the livestock while also aiding in growth
promotion of the animals. The majority of these additives are now prohibited by the
new legislation. The history behind particular compounds investigated in this
research is as follows. Carbadox (CAR) and olaquindox (OLA) have been approved
for use as feed additives for pigs since 1974 and 1976 respectively. CAR and OLA
are antimicrobial growth promotants (AGPs) used mainly in swine feed for growth
promotion, to improve feed efficiency, increase the rate of weight gain, control swine
dysentery and bacterial enteritis in young swine [Boison et al., 2009]. These
compounds have been expressly prohibited from inclusion in animal feedingstuffs in
the EU since 1998 as they are believed to be carcinogenic and mutagenic [Regulation
2788/98/EC]. Other AGPs were also prohibited for use as feed additives around this
time. These included spiramycin, virginiamycin and tylosin phosphate which were
used for growth promotion as well as disease treatment and prophylaxis [Situ et al.,
2005] but were prohibited as they were believed to contribute to bacterial resistance
in humans. [Regulation 2821/98/EC].
The concerns over antibiotic immunity and bacterial resistance are the major driving
force behind prohibiting medicinal feed additives. The use of antimicrobial feed
additives can result in the development of antibiotic immunity which could be
transferred to humans. The first evidence of this occurring with antibiotics was
tetracycline [Smith et al., 1957] and later vancomycin in the late 1980s [Bates et al.,
1993] and most recently streptogramin resistances [Butaye et al., 2001]. This new
legislation prohibits the use of any medicinal feed additives except for the use of
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coccidiostats and histomonostats [Recommendation 2005/925/EC]. It is envisaged
that these will also be prohibited as feed additives before 2013 [Regulation
1831/2003/EC]. After this date, medical substances in animal feeds will be limited to
therapeutic use by veterinary prescription [Castanon, 2007].
Until then eleven coccidiostats including monensin, narasin and nicarbazin are the
only compounds permitted for use as feed additives. These compounds are only
licensed for use in particular animals and therefore they are only allowed for the use
as feed additives in feed intended for that specific target species [Recommendation
2005/925/EC]. Coccidiostats constitute the main choice to fight against coccidiosis.
Coccidiosis is an infectious disease caused by several species of Eimeria and
Isospora protozoa which results in significant loss of stock causing serious
economical consequences in farming industry. In the European Union, coccidiostats
are authorized mainly as feed additives, according to the Regulation 1831/2003/EC
for the prevention and treatment of coccidiosis in rabbits and chickens. As a result of
issues with carry over in feed mills the contamination of feed with coccidiostats
needs to be monitored. Levels are set out in legislation for sensitive and less sensitive
non-target animal species, withdrawal feed and non-target feed for ‘continuous foodproducing animals’, such as dairy cows or laying fowl [Regulation 2009/8/EC] in
order ensure animal and human welfare. This legislation is discussed fully in section
2.3.2.
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2.3. Outline of European Legislation
2.3.1. Legislation regarding Substances that are prohibited for the use in Food
Producing Animals
As a result of carcinogenic and other health risks some veterinary products
previously used for treatment in animal husbandry, such as nitroimidazoles and
chloramphenicol were prohibited firstly in Annex IV of Commission Regulation
2377/90 but are now included in table 2 of Council Regulation 37/2010/EC.
Regulation 2377/90 was one of the first substantial pieces of legislation published by
the European commission which tried to encompass the large amount of veterinary
drugs in use and as a result try to limit the residues resulting from them. This was
done by introducing maximum residue limits (MRLs) and this regulation defined
what MRLs are and described the procedure for the establishment of MRLs for
veterinary medicinal products in foodstuffs of animal origin. A definition of MRL is
the maximum concentration of residue resulting from the use of a veterinary
medicinal product (expressed in mg/kg on a fresh weight basis) which may be
accepted by the European Community to be legally permitted or recognized as
acceptable in or on a food. It is based on the type and amount of residue considered
to be without any toxicological hazard for human health as expressed by the
acceptable daily intake (ADI), or on the basis of a temporary ADI that utilizes an
additional safety factor. It also takes into account other relevant public health risks as
well as food technology aspects. When establishing a MRL, consideration is also
given to residues that occur in food of plant origin and/or come from the
environment. Furthermore, the MRL may be reduced to be consistent with good
practices in the use of veterinary drugs and to the extent that practical analytical
methods are available. It also gave a definition of what constitutes residues of
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veterinary medicinal products. They are all pharmacologically active substances,
whether active principles, excipients or degradation products and their metabolites
which remain in foodstuffs obtained from animals to which the veterinary medicinal
product in question has been administered.
Also included in this legislation were five annexes that cover the range of veterinary
products in use and the allowed or prohibited residues resulting from that use. These
annexes taken from Regulation 2377/90 are listed below.
Annex 1: List of pharmacologically active substances for which maximum residue
levels have been fixed.
Annex 2: List of substances not subject to maximum residue levels.
Annex 3: List of pharmacologically active substances used in veterinary medicinal
products for which maximum residue levels have provisionally been fixed.
Annex 4: Lists of pharmacologically active substances for which no maximum levels
can be fixed.
Annex 5: Information and particulars to be included in an application for the
establishment of a maximum residue limit for a pharmacologically active substance
used in veterinary medicinal products.
The compounds listed in Annex 4 include dimetridazole, ronidazole, metronidazole
and also chloramphenicol. As a result of their suspected negative human health
effects, no MRL could be established and therefore they are prohibited for use in
food producing animals. Other nitroimidazoles such as ipronidazole were never
issued a veterinary licence for the use in food producing animals and therefore are
also prohibited.
Regulation 2377/90 has recently been replaced by Council Regulation 470/2009/EC.
This new regulation allowed for the use of a maximum residue limit established in
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one species or foodstuff to be used for another species or another foodstuff. The new
legislation also allowed for the provision of reference points of action for prohibited
substances in order to harmonise trade between member states. These reference
points of action would also take into account what concentrations of residue it is
possible to measure in the laboratory. This regulation also refers to another new
regulation that would replace Annexes 1-4 of 2377/90. This new regulation 37/2010;
was brought in to simplify matters and only contains one Annex with two tables. The
first table lists all the authorised substances in alphabetical order and the second table
lists all the prohibited substances in alphabetical order.
As the compounds of interest in this study, nitroimidazoles and chloramphenicol, are
in table 2 of regulation 37/2010 i.e. compounds that are prohibited substances, there
is no maximum residue limit set for these and as such there is a zero tolerance policy
towards their use within the EU. In practice however it is not possible to measure
zero. In order to harmonise, to some extent, performance of laboratories from
different Member States the Minimum Required Performance Level (MRPL) concept
was devised, however legislative MRPLs have only been set for a small number of
prohibited substances including, medroxyprogesterone acetate, chloramphenicol,
malachite green and some nitrofuran metabolites (Table 2-1) [Commission Decision
2003/181/EC, Commission Decision 2004/25/EC]. These levels correspond to the
average limits above which the detection of a substance or its residues can be
construed as methodologically meaningful and therefore be used as the reference
point for action to ensure a harmonised approach throughout the EU. Therefore all
methods used to analyse for the compounds with MRPLs must be able to confirm
there presence at this level. As chloramphenicol has an MRPL of 0.3μg/kg all
methods developed for analysis of it in meat, eggs, urine, aquaculture products, milk
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and honey must have the capability to confirm its presence at this level and therefore
the method should be validated at this level.
Table 2-1: All Minimum required performance levels taken from legislation.

Substance and/or metabolite

Matrices

MRPL

Meat, Eggs, Milk, Urine,
Chloramphenicol

Aquaculture products,

0.3μg/kg

Honey

Medroxyprogesterone acetate

Pig kidney fat

1μg/kg

Poultry meat, Aquaculture

1μg/kg Total

products

combined residue

Nitrofuran metabolites:
furazolidone, furaltadone,
nitrofurantoin, nitrofurazone

Sum of malachite green and

Meat of aquaculture
2μg/kg

leucomalachite green

products

As there are very few legislative MRPLs, the European Union Reference
Laboratories (EURL) which are in charge of the control veterinary residues in
Europe went about producing a Guidance Document in 2007 [CRL Guidance 2007]
that outlined recommended concentration/levels (RC/RL) that laboratories should
aspire to measure for prohibited substances with no MRPL. The document also
specified which matrices should be sampled and also what marker residue should be
analysed for (parent drug or metabolite). The information given in this document in
relation to nitroimidazoles can be seen in Table 2-2.
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This document recommends that as a minimum, laboratories should analyse for
DMZ, MNZ, RNZ, IPZ and their hydroxy metabolites HMMNI, MNZ-OH and IPZOH at a RL of 3 μg/kg in matrices such as plasma, retina and eggs. Therefore any
methods that are developed for the analysis of NMZs must take these
recommendations into consideration when selecting matrix, target analytes and levels
at which to validate.
Table 2-2. EURL recommendations for nitroimidazoles adapted from CRL Guidance Document
2007.

Substances

Nitroimidazole:
Dimetridazole,
Ronidazole,
Metronidazole

hydroxy metabolites:
MNZ-OH,
HMMNI

Matrix

Recommended
Concentaration *

Poultry:
Plasma,
Serum,
Eggs
3ppb
Pigs (and others species):
Plasma,
Serum,
Muscle

* CCβ for screening methods or CCα for confirmatory methods should be lower than the value expressed
in this column

2.3.2. Legislation Relating to Veterinary Products which are used as Feed Additives
In the European Union the use of feed additives is authorised according to
Regulation No. 1831/2003 as long as various criteria are fulfilled including the need
to provide suitable methods of analysis for official control of these compounds in
feedingstuffs. Other requirements that need to be specified are the target animal, the
level of active substance in feed and in some cases, as with coccidiostats, the
withdrawal period before slaughter when the use of these substances are prohibited.
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More recent legislation published in the EU, has gone about prohibiting the use of
many veterinary products for use as feed additives. Commission Recommendation
2005/925/EC prohibits the use of many antibiotics, coccidiostats and antibacterial
growth promoters as feed additives. This recommendation lists medicinal substances
that should be monitored and the substances are divided into two groups; medicinal
substances authorised as feed additives for certain animal species or categories e.g.
ionophore coccidiostats and medicinal substances no longer authorised as feed
additives e.g. carbadox, nitroimidazoles, tetracyclines. The two lists can be seen in
Table 2-3.
Table 2-3: List of medicinal substances that should be monitored according to Commission
Recommendation 2005/925/EC.

1. Medicinal substances authorised as feed
additives for certain animal species or categories

2. Medicinal substances no longer
authorised as feed additives

decoquinate (Deccox)
diclazuril (Clinacox 0,2 %)
halofuginone hydrobromide (Stenorol)
lasalocid A sodium (Avatec 15 %)
maduramicin ammonium alpha (Cygro 1 %)
monensin sodium (Elancoban G100, 100, G200, 200)
narasin (Monteban)
narasin — nicarbazin (Maxiban G160)
robenidine hydrochloride (Cycostat 66 G)
salinomycin sodium (Sacox 120G, 120)
semduramicin sodium (Aviax 5 %)

Amprolium
amprolium/ethopabate
Arprinocid
Avilamycin
Avoparcin
Carbadox
Dimetridazole
Dinitolmid
Flavophospholipol
Ipronidazole
Meticlorpindol
meticlorpindol/methylbenzoquate
Nicarbazin
Nifursol
Olaquindox
Ronidazole
Spiramycin
Tetracyclines
tylosin phosphate
Virginiamycin
zinc bacitracin
other antimicrobial substances

This legislation went about harmonising the existing legislation on residues in
animals and the existing legislation governing feedingstuffs. Compounds that are
prohibited in food of animal origin are prohibited as feed additives e.g.
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nitroimidazoles and compounds with MRLs in food of animal origin are only
permitted in medicated feed e.g. tetracyclines. This has helped to reinforce the farm
to plate philosophy i.e. ensure control of harmful residues through every stage of
food production and as a result ensure consumer protection. Following the
publication of this legislation no antibiotics other than coccidiostats and
histomonostats can be marketed and used as feed additives within the European
Union. Coccidiostats constitute the main choice to fight against coccidiosis. This is a
major disease in poultry as well as in many other hosts [Matabudul et al., 1999].
Following on from this legislation a problem was identified with carryover of
coccidiostats from feed with additives added and non additive feed. This is due to the
fact that feed business operators may produce within one establishment a broad range
of feeds. Different types of products may have to be manufactured after each other in
the same production line. It may happen that unavoidable traces of a product remain
in the production line and end up in the beginning of the production of another feed
product. This transfer from one production lot to another is called ‘carry-over’ or
‘cross-contamination’ and may occur for instance when coccidiostats or
histomonostats are used as authorised feed additives. This may result in the
contamination of feed produced subsequently by the presence of technically
unavoidable traces of those substances in ‘non-target feed’, i.e. in feed for which the
use of coccidiostats or histomonostats are not authorised, such as feed intended for
animal species or categories not provided for in the additive authorisation. This
unavoidable cross-contamination may occur at all stages of production and
processing of feed but also during storage and transport of feed as cited in Regulation
2009/8/EC. This may lead to high concentrations of coccidiostats in non-target feed;
which could pose a health risk to both the species itself and to humans.
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As a result of concerns over the production of animal feed and in order to avoid
carry-over, the Feed Hygiene Regulation 2005/183/EC was published. This lays
down specific requirements for feed businesses using coccidiostats and
histomonostats in the production of feed. In particular, the operators concerned have
to take all appropriate measures concerning facilities and equipment, production,
storage and transport in order to avoid any cross-contamination [Regulation
2005/183/EC].
Taking into account the application of good manufacturing practices set out in the
feed hygiene regulation there are still levels of coccidiostat carryover that are
considered unavoidable. The European Commission published legislation in the form
of Regulation 2009/8/EC and this established maximum limits for unavoidable carry
over of coccidiostats and histomonostats. Using the ALARA (As Low As
Reasonably Achievable) principle the commission set maximum limits for
unavoidable carry over. As a result and for the purpose of enabling the feed
manufacturer to manage the unavoidable carry-over of coccidiostats, a carryover rate
of approximately 3% of the authorised maximum content is considered acceptable
with regard to feed for less sensitive non-target animal species, while a carry-over
rate of approximately 1% of the authorised maximum content should be retained for
feed intended for sensitive non-target animal species i.e. animals for which the
additive might be harmful and ‘withdrawal feed’, i.e. feed used for the period before
slaughter. The carry-over rate of 1% is also considered for allowed crosscontamination of other feed for target species to which no coccidiostats or
histomonostats are added, and as regards non-target feed for ‘continuous foodproducing animals’, such as dairy cows or laying hens, where there is evidence of
transfer from feed to food of animal origin. The levels related to 1% and 3% carry
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over of all the coccidiostats and histomonostats covered by this legislation are seen in
Table 2-4.
Table 2-4. 1% and 3% carry over of all the coccidiostats as stated in legislation 2009/8/EC.

Compound
Halofuginone
Robenidine
Nicarbazin
Diclazuril
Decoquinate
Semduramicin
Lasalocid
Salinomycin
Monensin
Narasin
Maduramicin

1% Carry Over
(mg/kg)
0.03
0.70
0.50
0.01
0.40
0.25
1.25
0.70
1.25
0.70
0.05

3% Carry Over
(mg/kg)
0.09
2.10
1.50
0.03
1.20
0.75
3.75
2.10
3.75
2.10
0.15

2.3.3. Legislation describing procedures for the control of residues
Monitoring of veterinary residues in food of animal origin is carried out according to
European legislation Council Directive 96/23/EC. This Directive lays down
measures to monitor substances and groups of residues listed and defines the role of
the national reference laboratories in monitoring. The main aims of this legislation is
to give direction on the approach to be taken in monitoring illegal substances and
incorrect use of authorised substances in food producing animals within the EU. As a
result it is hoped that monitoring throughout the EU will be firstly effective but also
consistent from one country to the next. In order to enable this harmonised approach
this legislation lays down measures to monitor the substances and groups of residues.
The legislation goes about setting up national reference laboratories in each member
state that will be responsible for analysis of veterinary residues. Approaches to
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sampling, frequency and numbers of samples taken and enforcement measures for
non compliant results are all outlined in this legislation. This legislation also breaks
up the different veterinary compounds into Group A and Group B. As mentioned
previously Group A substances are those whose use are prohibited in food producing
animals. The residues of compounds which were studied as part of this thesis i.e.
nitroimidazoles and chloramphenicol are both categorised as A6 compounds in
96/23/EC.

2.3.4. Guidelines concerning the analytical performance and interpretation of
results of residue methods.
As a result of legislation for the control of residues in food of animal origin,
analytical methods for the analysis of the controlled substances needed to be
developed. These methods needed to be sensitive, selective and fit for purpose. In
order to ensure this the European Commission initiated the production of a
legislation to ensure any method developed met certain quality criteria. This
legislation lays down performance criteria for the analytical methods to be used for
the analysis of certain substances and residues thereof in live animals and animal
products according to Council Directive 96/23/EC. The resulting piece of legislation
is Commission Decision 2002/657/EC and it is concerned with the performance of
analytical methods and the interpretation of results. The severe implications on
countries where abuse of prohibited compounds (Group A) is identified resulted in
the need for more rigorous criteria to be specified within 2002/657/EC for
confirmation of the presence of these substances.
According to Commission Decision 2002/657/EC validation; in the case where no
certified reference material is available; should be carried out as follows:
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 Prepare a set of samples of identical matrices, fortified with the analyte to
yield concentrations equivalent to 1, 1.5 and 2 times the MRPL/RL or 0.5, 1
and 1.5 times the MRL.
 At each level the analysis should be performed with at least six replicates.
 Analyse the samples and calculate the concentration present in each sample.
 Repeat these steps on at least two other occasions.
 Values for recovery, repeatability, within-laboratory reproducibility and the
analytical limits of Decision Limit (CCα), Detection capability (CCβ) are
calculated from the results obtained.
Technical guidelines and required performance criteria are detailed within
Commission Decision 2002/657/EC and specific ones relevant to this research in
terms of quantitative methods are as follows;
 Specificity: A method shall be able to distinguish between the analyte and the
other substances under the experimental conditions. An estimate to which extent
this is possible has to be provided. Strategies have to be employed in order to
overcome any foreseeable interference with substances when the described
measuring technique is used. These strategies include the use of internal
standards such as homologues, analogues, metabolic products of the residue of
interest used to correct for any interferences. It is of prime importance that
interference, which might arise from matrix components, is also investigated.
 Confirmatory Requirements: For a analytical instrument to be deemed
confirmatory, it must have a certain number of identification points while
meeting criteria for relative ion intensities and relative retention times.
 Identification Points: As the methods developed in this research concern
the analysis of prohibited compounds i.e. NMZs and CAP the method
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used for their analysis needs to achieve 4 identification points. The
number of identification points gained by a particular method depends on
the detector employed. Tandem mass spectrometry using a number of
different triple quadrupole mass spectrometers operated in multi reaction
monitoring mode was utilised as the determination step for all methods
developed within the research carried out as part of this thesis. This
technique is classified within 2002/657/EC as being low-resolution mass
spectrometry (LR-MS), when operated in multi reaction monitoring
mode; it gains one identification point for each precursor ion and 1.5
identification points for each product ion monitored. So if two product
ions are monitored, which result from one precursor ion, a total of 4
identification points is achieved. List of MS techniques and the
identification points associated as given in the directive are seen in Table
2-5.

Table 2-5. The relationship between a range of classes mass spectrometry detectors and
identification points earned (CD 2002/657)

Identificaton points
earned per ion
Low resolution mass spectrometry (LR)
1.0
n
LR-MS precusor ion
1.0
n
LR-MS transition products
1.5
HRMS
2.0
n
HR-MS precusor ion
2.0
n
HR-MS transition products
2.5
n: multiple mass spectrometers e.g tandem mass spectrometry (MS/MS)
MS Technique

 Ion Ratio: The relative intensities of the detected ions, expressed as a
percentage of the intensity of the most intense ion, shall correspond to
those of the calibration standard, either from calibration standard
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solutions or from spiked samples, at comparable concentrations,
measured under the same conditions, within the tolerances given in the
legislation seen in Table 2-6.

Table 2-6. Maximum permitted tolerances for relative ion intensities using a range of mass
spectrometric techniques (CD 2002/657)

Relative Intensity
(% of base peak)

EI- GC-MS
(relative)

CI-GC-MS, GCMSn,
LC-MS, LCMSn
(relative)

> 50%

± 10%

± 20%

> 20% to 50%
> 10% to 20%
≤ 10%

± 15%
± 20%
± 50%

± 25%
± 30%
± 50%

 Relative Retention Times: The ratio of the chromatographic retention time
of the analyte to that of the internal standard, i.e. the relative retention
time of the analyte, shall correspond to that of the calibration standards at
a tolerance of ± 0.5 % for GC and ± 2.5 % for LC.
 Calibration Curves: When calibration curves are used for quantification:
 at least five levels (including zero) should be used in the construction of
the curve,
 the working range of the curve should be described,
 the mathematical formula of the curve and the goodness-of-fit of the data
to the curve should be described,
 acceptability ranges for the parameters of the curve should be described.
 Recovery: During the analysis of samples the recovery shall be determined in
each batch of samples, if a fixed recovery correction factor is used. If the
recovery is within limits, the fixed correction factor may then be used. Otherwise
33

Chapter 2

Literature Review

the recovery factor obtained for that specific batch shall be used; unless the
specific recovery factor of the analyte in the sample is to be applied in which case
the standard addition procedure or an internal standard shall be used for the
quantitative determination of an analyte in a sample. % Recovery = 100 ×
measured content/fortification level
 Trueness/Accuracy: When no certified reference materials (CRMs) are available,
it is acceptable that trueness of measurements is assessed through recovery of
additions of known amounts of the analyte(s) to a blank matrix. The recovery can
be determined as described above. Data for recovery are only acceptable when
they fall within the ranges shown in Table 2-7.

Table 2-7. Minimum trueness of quantitative methods (CD 2002/657)

Mass Fraction

Range

≤ 1 µg/kg

-50% to 20%

> 1 µg/kg to 10µg/kg

-30% to 10%

≥10 µg/kg

-20% to 10%

 Precision: The inter-laboratory coefficient of variation (CV) for the repeated
analysis of a reference or fortified material, under reproducible conditions, shall
not exceed the level calculated by the Horwitz Equation.
(1 – 0.5 log C)

 The equation is: CV = 2

.

 Where C is the mass fraction expressed as a power (exponent) of 10 (e.g.
1 mg/g = 10-3).
 Examples are shown in the Table 2-8.
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Table 2-8. Examples for reproducibility CVs for quantitative methods at a range of analyte
mass fractions. (CD 2002/657)

Mass Fraction

Reproducibility CV (%)

1 µg/kg

(*)

10 µg/kg

(*)

100 µg/kg

23

1000 µg/kg (1 mg/kg)

16

(*) For mass fractions lower that 100 µg/kg the application of the Horwitz equation gives
unacceptably high values. Therefore, the CVs for concentrations lower than 100 µg/kg shall be
as low as possible

 Analytical Limits: decision limit, CCα, and detection capability, CCβ, are also
specified in this legislation and were intended in some way to take the place of
performance characteristics; limit of detection (LOD) and limit of quantification
(LOQ). CCα is defined as “the concentration at and above which it can be
concluded with an error probability of α that a sample is non-compliant
(contains the analyte)”. CCβ is defined as “the smallest content of the substance
that may be detected, identified and/or quantified in a sample with an error
probability of β”. In β% of the cases, a non-compliant sample will be classified
as compliant, and therefore reveals a false-negative result (Figure 2-4 gives a
graphical illustration of these concepts).
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Mean Response of the blank sample

B

SB

X

Standard deviation of the blank sample
Mean Response of contaminated sample

S

SS

Standard Deviation of the contaminated sample

α

Rate of false non-compliant results

β

Rate of false compliant results

CCα

Response with a given α -error and 50% β-error

CCβ

Response with a very small α-error and β-error

Figure 2-4: Adapted from 2002/657/EC illustrating CCα and CCβ

A variety of approaches on how these performance characteristics could be
determined are also set out in this document. The approach used in this research
is as follows;
 For the calculation of CCα blank material is used, which is fortified at
and above the MRPL/RL in equidistant steps. The samples are analysed
and after identification, a plot of the signal against the added
concentration is made. The corresponding concentration at the y36
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intercept plus 2.33 times the standard deviation of the within-laboratory
reproducibility of the intercept equals the decision limit. This is
applicable to quantitative assays only (α = 1 %).

 For the calculation of CCβ, the corresponding concentration at the
decision limit plus 1.64 times the standard deviation of the withinlaboratory reproducibility of the mean measured content at the decision
limit equals the detection capability (β = 5 %).
The document describes approaches on how all these parameters can be determined,
however it does not obligate laboratories to use these approaches; as stated in the
document “Other approaches to demonstrate that the analytical method complies
with performance criteria for the performance characteristics may be used, provided
that they achieve the same level and quality of information”.

2.4. Extraction and Purification Procedures

2.4.1. Introduction to Sample Preparation
Sample preparation is an essential stage in the analytical process. It takes place
between sampling and measuring the prepared sample by means of an instrumental
technique. It involves the extraction of the analyte of interest from either biological
or feed matrix followed by the purification of this extract to help remove matrix
components that may interfere with the instrument of detection. Although
advancements in technology in the form of Ultra high performance liquid
chromatography (UHPLC) and in tandem mass spectrometry (MS/MS) have reduced
the need for labour intensive extraction protocols, sample preparation still plays a
key role. However approaches and techniques used in sample extraction and
purification have changed dramatically.
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Historically analytical methods were performed on non specific instruments such as
HPLC-UV. As a result methods used in the analysis of veterinary residues were often
single analyte or at most single class methods which involved labour intensive
extraction and purification protocols. These techniques often struggled to reach
required sensitivity and therefore large sample sizes were necessary and large
amounts of solvent were required for extraction. Quite often these methods included
complex purification steps consisting of one or more solid phase extraction (SPE)
steps (Figure 2-5), in order to make extracts suitable for non-specific detection
techniques such as LC-UV [Sun et al., 2007; Civitareale et al., 2004; Dousa et al.,
2000].

Figure 2-5. Schematic of Solid Phase Extraction operation

Recently the advancements in mass spectrometry have allowed for the development
of methods for the analysis of potentially hundreds of compounds in a single
experiment [Peters et al., 2009; Kaufmann et al., 2011]. These advancements have
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resulted in a shift from complex labour intensive sample preparations to more
generic extraction protocols and purification techniques being utilised. Resulting
from this shift, a number of articles have been published involving generic sample
preparation protocols which allow for a number of classes of drugs to be analysed in
the same method [Boschera et al., 2010; Stubbings et al., 2009].
There are many benefits in using a generic extraction procedure for analysis of
veterinary residues. There are significant economic benefits to this approach due to
the fact that more analytes can be analysed in a single run with less solvent use and
in a shorter time. Another benefit is that different classes of compounds previously
analysed separately can now be analysed in a single run and as a result samples can
be analysed for more residues in the same time. This also allows for more samples to
be batched together allowing for reduced sample turnaround times. While the
advantages of generic sample preparations are beneficial there are drawbacks to this
approach when used with LC-MS in particular ion suppression which will be
discussed in detail in section 2.5.4.
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2.4.2. Extraction Methods and Purification Methodologies for Nitroimidazoles
Table 2-9: Overview of methods used for the analysis of nitroimidazoles as discussed in section
2.4.2
Reference

No. of
compounds
analysed

Matrix

Extraction Method

Measurement
Technique

LOD
(μg kg-1)

Egg Method
Daeseleire 2000

3

Egg

Extraction with ACN; Evaporated and filtered

LC-MS/MS

0.50

Mohamed 2008

7

Egg

Extraction with ACN and NaCl; Clean-up on MIPs
SPE

LC-MS/MS

1.00

Mottier 2006

7

Egg

Extraction with ACN and NaCl; Clean-up on Oasis
HLB SPE

LC-MS/MS

0.60

4

Egg,
Muscle

Extraction with ACN and NaCl; Evaporated and
filtered

LC-MS/MS

0.80

LC-MS/MS

32.00

Xia 2006

Carretero 2008

1

Muscle

Clare Ho 2005

2

Connolly 2007

5

Matusik 1992

4

Mottier 2006

7

Polzer 2001

7

Stubbings 2005

3

Sun 2007

7

Xia 2007

4

Liver

Xia 2008

6

Muscle

Xia 2009

7

Kidney

Aerts 1991

4

Plasma,
Egg,
Faeces

Fraselle 2007

7

Plasma

Tissue Methods
Extraction by ASE; Samples homogenised with
EDTA washed sand and extracted with water at
high temperature and pressure

Muscle,
Extraction with Toluene mixed with Hexane; CleanKidney,
GC-MS/MS
up on amine SPE cartridges
Liver
Extraction with Ethyl Acetate; Evaporated and reMuscle
Optical Biosensor
constituted in HBS-EP
IPZ and IPZ-OH extracted with Benzene; Purified on
Silica columns. DMZ and HMMNI extracted with
LC-MS/MS
Muscle
acidic buffer and then extracted into Methylene
Chloride
Muscle,
Fish

Extraction with Potassium Phosphate solution and
Ethyl Acetate; Upper layer defatted with Hexane

Extraction by enzymatic hydrolysis; Clean-up on
Kieselguhr SPE
Extraction with ACN; Extract dried with Sodium
Muscle,
Sulphate; Acidified with Acetic Acid before clean-up
Egg
on SCX SPE
Extraction with Ethyl Acetate; Clean-up on SCX
Muscle
SPE
Muscle

Extraction with Ethyl Acetate; Defatted with Hexane;
Clean-up on Oasis MCX SPE
Samples incubated overnight with HCl and 2nitrobenzaldehyde; Neutralised with di-potassium
hydrogen phosphate and NaOH; Clean-up on Oasis
HLB SPE
Extraction with Ethyl Acetate; Defatted with Hexane;
Clean-up on MCX SPE
Plasma Methods
Extraction with Aqueous Buffer; Clean-up on
Extrelute SPE followed by liquid-liquid partitioning
with Isooctane
NaCl/Potassium Phosphate buffer and Protease
solution added to samples; pH adjusted to 3 with
HCl and hydrolised overnight; Defatted with Hexane
and pH adjusted to 6 with NaOH; Clean-up on
Chromobond XTR SPE

1.90
2.00

10.00

LC-MS/MS

0.60

GC-MS

2.80

HPLC-UV

5.00

HPLC-UV

0.80

LC-MS/MS

0.50

LC-MS/MS

0.20

LC-MS/MS

0.50

HPLC-UV

10.00

LC-MS/MS

1.25

Plasma,
Kidney,
Liver, Extraction with ACN followed by ultra-centrifugation Optical Biosensor
Milk,
Egg
Other Matrices Methods

Thompson 2009

7

3.00

Capitan-Vallvey 2002

5

Water

Extraction with ACN; Clean-up on HLB SPE

LC-MS

0.20

Ding 2006

3

Royal
Jelly

Samples dissolved in NaOH solution; Liquid-liquid
extraction with Ethyl Acetate

LC-MS/MS

TBC

Stolker 2008

2

Milk

Extraction with ACN and dilution with water; Cleanup on Strata-X SPE

UPLC-TOF-MS

17.70

Zhou 2007

5

Honey

Extraction with Ethyl Acetate; Clean-up on amino
SPE

HPLC-UV

TBC
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The complexity of the matrices involved and also the high sensitivity that developed
methods should be capable of achieving in order to identify treated animals are two
main aspects that developed methods need to address. Nitroimidazole compounds
were permitted for use in the European Union until the mid 1990s. As a result this
research carried out on these compounds was limited until recently. Therefore
methods for the analysis of these compounds are still relatively undeveloped in
matrices recommended for analysis by EURL. Although in recent years more
methods have been developed, these are limited in the analytes that they analyse for
and in a lot of cases the sample matrix analysed is muscle and liver which as
discussed previously is not suitable.
As discussed previously the selection of a suitable matrix for the analysis of these
compounds is important to ensure abuse of these compounds is identified. Studies
carried out by the EURL on the stability and homogeneity of nitroimidazoles in
incurred muscle (i.e. in muscle of animals administered nitroimidazoles) [Polzer et

al., 2004; 2005] show that there is not a homogenous distribution of these analytes in
turkey muscle and they also observed a rapid degradation in analyte concentration
stored for prolonged periods above 4 °C. In contrast it was discovered that for
plasma, retina and egg samples the analytes were stable during storage under the
same conditions as the muscle samples which resulted in stable concentrations and
allowed detection of these compounds for longer periods after medication had been
halted. Therefore, it is advised that plasma, retina and eggs be used as target matrices
for the residue control of nitroimidazoles [Polzer et al., 2004; 2005]. The EURL has
also put forward RL of 3 µg kg-1 (or ng mL-1) for nitroimidazoles and therefore
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developed methods used in their analysis must be sensitive enough for analysis, to at
least this level.
Extraction methods largely depend on the matrix involved. Matrices differ greatly
from one to the next. Although the extraction solvent may be the same the presence
and absence of purification steps in the form of SPE is determined by the matrix in
question. For this reason this section is broken up into extraction methods for
specific matrices i.e. Egg, Tissue, and Plasma etc.

2.4.2.1.Egg Methods
There are a number of methods that exist for the determination of nitroimidazoles in
the matrix of egg. The majority of these methods involve extraction with acetonitrile
and the addition of NaCl. This is followed by either a purification step by SPE or by
filtering before analysis. Mottier et al., 2006 published a method for the detection of
4 nitroimidazoles and their three marker metabolites in eggs using detection by LCMS/MS. Acetonitrile and NaCl were added to egg samples and the mixture was
centrifuged. The resulting extracts were then purified on Oasis HLB SPE cartridges.
The method was capable of detecting all analytes to a concentration of at least 0.6 µg
kg-1. Mohamed et al., 2008 developed a method for the detection of 4
nitroimidazoles and their three marker metabolites in eggs using detection by LCMS/MS. Acetonitrile was again used to extract the compounds of interest from egg,
NaCl was then added to the resulting extract, the samples were centrifuged and the
upper layer removed. In this method Molecular Imprinted (MIPs) SPE cartridges
were then used for purification. The method was proficient in detecting each analyte
to a concentration of at least 1 µg kg-1. MIPs are cross-linked polymers with specific
binding sites for a particular analyte. They possess recognition sites that, in terms of
42

Chapter 2

Literature Review

size, shape and functionality, are complementary to the print molecule. MIPs provide
good selectivity as separation materials, which is their most widely investigated use,
their use as preconcentration and clean-up sorbents in MISPE (molecularly imprinted
SPE) has recently been used [Mohamed et al., 2008]. One limitation of MIPs is that,
depending on the synthetic procedure, there may be leaching of the template from the
polymer, even after extensive washing, and this contaminates the sample. Since
MIPs are made with large quantities of template, a small number of imprint
molecules may remain in the resulting polymer and these may leak later during SPE,
thus interfering with trace analysis.
The next two methods omit the use of an SPE step and replace it with a filtering step.
Xia et al., 2006 developed a method for the determination of 4 nitroimidazoles in
egg, poultry muscle and porcine muscle. Samples were again extracted with
acetonitrile and NaCl, samples were then concentrated by evaporation and filtered
with detection by LC-MS/MS. The method had the capability to detect all analytes to
0.8 µg kg-1.

Daeseleire et al., 2000 published work on a method for the

determination of RNZ, DMZ and MNZ in egg with detection by LC-MS/MS. This
time only acetonitrile was added to the egg samples to extract the analytes. The
samples were then concentrated and filtered. In this case no SPE purification was
employed. Compounds were detected to levels of 0.5 µg kg-1.
From examination of these published methods it is clear that extraction with
acetonitrile and the addition of NaCl is a popular and effective extraction technique
for the analysis of nitroimidazoles in egg matrices. This is often followed by
purification by SPE but methods have shown that this can be omitted but only for
less analytes as SPE methods which analyse for seven residues. Our research will
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attempt to adapt the rapid extraction protocols that omit SPE purification to allow for
the analysis of a greater number of analytes than previously seen.

2.4.2.2.Tissue Methods (Liver, Kidney and Muscle)
Many methods exist for the determination of nitroimidazoles in tissue samples even
though recent studies suggest that this may not be a suitable matrix for the detection
of nitroimidazoles due to problems with stability. Xia et al., 2007 developed a
method for the detection of 3 nitroimidazoles and one metabolite in porcine liver
with detection by LC-MS/MS. Liver samples were extracted with ethyl acetate, the
extract was then evaporated to dryness, reconstituted in 0.1 M HCl and defatted with
hexane. The extracts were further purified on Oasis MCX SPE cartridges. The
method was capable of detecting each analyte at 0.5 µg kg-1. Mottier et al., 2006
reported a method for the detection of 7 nitroimidazoles in poultry muscle and fish
using LC-MS/MS for determination. A potassium phosphate solution is added to the
samples followed by ethyl acetate; this solution is then mixed and the upper organic
layer removed. The extracts are then defatted with hexane; the method could detect
each analyte to concentrations of 0.6 µg kg-1. Matusik et al., 1992 developed a
method for the detection of 4 nitroimidazoles in turkey muscle with detection by LCMS/MS. DMZ and its metabolite and IPZ and its metabolite are extracted using two
different approaches. IPZ and IPZ-OH were extracted using benzene in the presence
of borax with purification on silica columns. DMZ and HMMNI were extracted with
an acidic buffer and then extracted into methylene chloride. Compounds could be
determined to levels of 10 µg kg-1. Clare Ho et al., 2005 developed a method for the
detection of 2 nitroimidazoles in poultry muscle and liver and porcine kidney and
liver. Samples were extracted with toluene mixed with hexane and purified on amine
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SPE cartridges. Residues are determined by GC-MS/MS, the method was capable of
detecting each analyte to a concentration of 1.9 µg kg-1.

Polzer et al., 2001

developed a method for the detection of 7 nitroimidazoles in poultry and porcine
muscle using detection by GC-MS. Samples underwent an enzymatic hydrolysis
followed by purification on kieselguhr SPE cartridges. The method was capable of
detecting residues to a concentration of 2.8 µg kg-1. Xia et al., 2008 developed a
multi-class, multi-residue method for the detection of 6 nitroimidazoles as well as a
number of nitrofurans in porcine muscle. Hydrochloric acid and 2-nitrobenzaldehyde
were added to the samples which were incubated overnight. Samples were then
neutralized to pH 7 with di-potassium hydrogen phosphate and sodium hydroxide
and purified on Oasis HLB SPE cartridges. The method was able to detect residues to
a level of 0.2 µg kg-1 by LC-MS/MS. Carretero et al., 2008 utilized accelerated
solvent extraction (ASE) for extraction of RNZ from muscle samples. Samples were
homogenized with EDTA washed sand and extracted with water at high temperature
and pressure. The method was only able to detect residues to a level of 32 µg kg-1 by
LC-MS/MS. Stubbings et al., 2005 developed a screening method for the analysis of
3 nitroimidazoles in poultry muscle and egg with detection by HPLC-UV. Samples
were extracted with acetonitrile then dried with sodium sulphate and acidified with
glacial acetic acid before being purified on Bond Elut strong cation exchange SPE
cartridges. The method was able to detect each analyte to a concentration of 5µg kg-1.
Sun et al., 2007 reported a screening method for the detection of 7 nitroimidazoles in
porcine and poultry muscle. Samples were extracted with ethyl acetate and purified
using SCX SPE cartridges; determination was carried out by LC-UV. The developed
method could detect each residue to a level of at least 0.8 µg kg-1. Xia et al., 2009
describes a method for the determination for 4 nitroimidazoles and 3 metabolites in
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porcine kidney by LC-MS/MS. The compounds of interest were extracted from
tissues with ethyl acetate. The crude extracts were subject to liquid–liquid partition
with hexane followed by solid-phase extraction using mixed-mode strong cationexchange column. The method could detect to levels of 0.5ug kg -1. Connolly et al.,
2007 developed a screening method for the detection of 5 nitroimidazoles in poultry
muscle with detection by optical biosensor. Samples were extracted with ethyl
acetate, evaporated to dryness and resuspended in 0.5 ml HBS-EP (0.01 M HEPES
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) [pH 7.4], 0.15 M NaCl, 3 mM
EDTA, 0.005% surfactant P20). The method could detect each of the residues to at
least 2 µg kg-1.
Taking into consideration studies on the homogeneity and stability of nitroimidazole
residues, it was decided that the extraction of muscle and liver samples do not ensure
that the possible abuse of these compounds is detected. Therefore it was felt that their
analysis should be from matrices such as plasma and eggs. Although the studies
carried out pertain specifically to avian matrices it was felt that in order to ensure the
methods developed were best suited for the routine analysis of nitroimidazoles in all
species that plasma is chosen for analysis; along with eggs, milk and honey for
specific species.

2.4.2.3.Plasma/Serum
Although plasma is one of the matrices recommended by the EURL for the analysis
of nitroimidazoles there are only a few methods published for this matrix. Aerts et

al., 1991 developed a screening method for the detection of 4 nitroimidazoles in
plasma, egg and faeces with LC-UV detection. The samples were extracted in an
aqueous buffer and purified on Extrelut SPE cartridges followed by liquid-liquid
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partitioning with isooctane. The method was able to detect all analytes to a level of
10 µg kg-1.
Fraselle et al., 2007 developed a method for the detection of 7 nitroimidazoles in
porcine plasma by LC-MS/MS. A NaCl/Potassium phosphate buffer as well as a
protease solution was added to the plasma. The pH was adjusted to 3 with HCl and
the mixture was allowed to hydrolyze overnight. The mixture was then defatted with
hexane adjusted to pH 6 with NaOH and purified on Chromabond XTR SPE
cartridges. The method could detect each residue to at least 1.25 µg kg-1. The method
by Fraselle includes a hydrolysis step to free bound residues, there is some debate on
whether this step is required for serum samples; Thompson et al., 2009 does not
include this step. Thompson et al., 2009 developed a screening method for 4
nitroimidazoles and their 3 marker metabolites in serum, kidney, liver, milk and
eggs. Acetonitrile was used for extraction followed by ultra centrifugation of the
extract. Detection was carried out using an optical biosensor technique and the
method was capable of detecting all residues to a level of 3 µg kg-1.
It is quite clear from examination of published articles that despite reports
recommending it, the analysis of nitroimidazoles in plasma is still not common
practice. No rapid extraction methods exist for the confirmatory analysis of
nitroimidazoles in plasma. By adapting the acetonitrile and NaCl method used in the
used the extraction of nitroimidazole residues in eggs; it is felt that a rapid method
could be developed to allow for an increased number of analytes to be analysed for.

2.4.2.4.Other
From investigation of literature only one method could be found that allows for the
analysis of NMZs in honey. Zhou et al., 2007, published a method for the analysis of
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5 NMZs in honey by HPLC-UV. Samples were extracted with ethyl acetate and
evaporated. The residue containing the NMZs was dissolved in ethyl acetate–hexane
and subjected to solid-phase extraction cleanup by amino extraction columns. The
eluent was evaporated, reconstituted and injected onto the column.
In relation to the analysis of nitroimidazoles in milk there are a limited number of
published methods available [Ortelli et al., 2009; Stolker et al., 2008; Thompson et

al., 2009]. These methods are all screening methods using either optical biosensor
[Thompson et al., 2009] or accurate mass instruments [Ortelli et al., 2009; Stolker et

al., 2008]. Stolker et al., 2008 developed a multi class, multi analyte method for the
detection of various groups of veterinary residues in milk using UPLC-TOF-MS. IPZ
and its hydroxy metabolite IPZ-OH were the only nitroimidazole compounds
included. Milk was mixed with acetonitrile to precipitate proteins and the supernatant
was diluted in water. This was then applied to Strata-X SPE columns and finally
determined by MS. The method could reach 17.7 µg kg-1for the detection of IPZ and
7.7 µg kg-1for IPZ-OH. From investigation of literature there are no methods for the
confirmatory analysis of NMZs in milk or honey at the levels desired.
Two other methods published for the analysis of nitroimidazoles are Ding et al.,
2006 who developed a method for the determination of 3 nitroimidazoles in royal
jelly by LC-MS/MS. Samples were dissolved in sodium hydroxide solution to
disassociate target analytes from the matrix. Liquid-liquid extraction methods using
ethyl acetate as solvent were utilised to clean up the sample. The other was published
by Capitan-Vallvey et al., 2002 on the analysis of 5 NMZs in water by LC-MS. The
extraction procedure was based on HLB (Hydrophilic-lipophilic balance) solid-phase
extraction with acetonitrile followed by an evaporation step. The method was
capable of identifying nitroimidazole residues at 0.2 µg L-1.
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It is quite clear that the matrices of milk and honey are not considered when methods
for the analysis of nitroimidazoles are developed. This is most likely due to the fact
that nitroimidazoles were previously not used routinely in honey and milk production
practices. That being said, nitroimidazoles can be used to treat genital tricchoniasis in
cattle and recently, reports from China suggest that the use of nitroimidazoles in
beekeeping is being practiced [Zhou et al., 2007]. Nitroimidazoles may be used to
prevent and control Nosema apis in hives [Official Method (2003)]. Taking this into
consideration the EURL for NMZs has suggested that honey be tested to ascertain
any possible misuse of nitroimidazoles and if non-compliant results are found then
this matrix should be included in monitoring plans. They also state that countries
with high milk production should also analyse for these analytes in milk as their
possible misuse in this matrix cannot be discounted. Therefore it was felt that the
development of methods for the analysis of nitroimidazole residues in these two
matrices should be developed. This would be performed by using previously
developed methods for the other matrices as a starting point for the analysis of milk
and honey.
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2.4.3. Extraction Methods and Purification Methodologies for Chloramphenicol
Table 2-10: Overview of methods used for the analysis of chloramphenicol as discussed in
section 2.4.3
Reference

No. of
compounds
analysed

Matrix

Extraction Method

Single Analyte Methods
Dissolution of samples in water before extraction
with DCM and Acetone mixture; Evaporated and
Honey
reconstituted in phosphate buffer; Clean-up on
C18 SPE cartridges
Dissolution of samples in 20mM phosphate
Honey, Milk,
solution at pH 4.0; Samples passed through
Egg
extraction tube containing a monolith
microextraction polymer

Measurement
Technique

LOD
(μg kg-1)

LC-MS/MS

0.07

LC-MS

0.02-0.04

Forti 2005

1

Huang 2006

1

Penney 2005

1

Milk, Eggs,
Muscle, Liver,
Kidney

Extraction with ACN and defatted with Hexane;
Evaporated and reconstituted in mobile phase;
Samples filtered prior to injection

LC-MS

0.20-0.60

Rejtharova 2009

1

Urine, Feed,
Water, Milk,
Honey

Extracion with ACN, Clean-up on MIP SPE
cartridges

GC-MS-NCI

<0.30

Rocha-Siqueira 2005

1

Shrimp, Fish,
Eggs; Poultry,
Porcine and
Bovine muscle

Extraction with phosphate solution followed by
LLE with Ethyl Acetate

LC-MS/MS

0.10

Rodziewicz 2008

1

Milk Powder

Extraction with Ethyl Acetate and de-fatted with
Hexane

LC-MS/MS

0.09

LC-MS/MS

0.02

Ronning 2006

1

Meat,
Seafood, Egg, Extracion with ACN; Chloroform added to remove
Plasma,
water; Evaproated and reconstitued in Methanol
Honey, Milk,
and water before injection
Urine

Shen 2005

1

Seafood,
Meat, Honey

Vinci 2005

1

?

Vivekanandan 2005

1

Hormazabal 2001

2

Shen 2009

4

Sheridan 2008

15

Wang 2007

3

Xie 2006

3

Zhang 2008

4

Honey

ELISA, HPLC-UV,
Extraction with phosphoric buffer solution (pH =
GC-ECD, GC-MS6.88)/ Ethyl Acetate; Samples de-fatted with
EI-SIM, GC-MSHexane and purifed by SPE
NCI-SIM

<0.30

Extraction with ACN and defatted with Hexane

LC-MS/MS

0.15

LC-MS/MS

0.05

?

1.00

GC-MS-NCI

0.10

LC-MS/MS

0.20

LC-MS/MS

0.10

LC-MS/MS

0.10

LC-MS/MS

0.10

Samples were diluted with water and purified
using diatomaceous-based LLE cartridges
Multi-Analyte Methods

Extraction with ACN; water removed by CHCl3;
Clean-up on Bond Elut SPE cartridges
Extraction with Ethyl Acetate; Extracts frozen to
Muscle, Liver
remove lipids; Further purified by LLE with
Hexane and SPE clean-up on HLB cartridges
Extraction by Acid Hydrolysis; Clean-up on HLB
Honey
SPE cartridges
Samples homogenised with water before
extraction with Ethyl Acetate; Evaporated and
Royal Jelly
reconstituted in phosphate buffer solution; Cleanup on C18 SPE cartridges
Extraction with Ethyl Acetate; Clean-up on C18
Feed
SPE cartridges
Meat, Milk

Chicken
Muscle

Extraction with Ethyl Acetate and defatted with
Hexane; Clean-up on MCX SPE cartridges

As discussed previously the use of CAP, due to health concerns, has been prohibited
in food producing species. In order to ensure this is enforced effectively a legislative
MRPL of 0.3 ng mL-1/µg kg-1 has been issued for CAP which means all methods
used in the analysis of this compound should be able to, at least, achieve this level. In
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order to achieve enough sensitivity a common trend in analysis of CAP is the use of
SPE as the sample purification technique. Common cartridge chemistries used in the
analysis of CAP are Oasis HLB [Shen et al., 2009], Oasis MCX [Zhang et al., 2008]
and the selective technique of Molecular Imprinted Polymers (MIPs) [Rejtharova et

al., 2009; Boyd et al., 2007]. The need for very sensitive methods and increased
sample purification in order to see down to the MRPL has resulted in CAP often
being analysed in single analyte methods although some multi amphenicol methods
do exist. An investigation into published literature found there are numerous methods
available for the analysis of CAP in all matrices but found that some were quite
labour intensive with use of SPE and resulted in the analysis of only one analyte
[Rejtharova et al., 2009; Ronning et al., 2006], although there are some multiamphenicol and multi-class methods available [Zhang et al., 2008; Shen et al., 2009].
Some of the more recently published methods are examined now under two headings
single analyte and multi-analyte.

2.4.3.1.Single Analyte Chloramphenicol Methods
The majority of methods for the analysis of CAP are single analyte methods utilising
SPE purification. Ronning et al., 2006 developed a method that analysed for CAP
residues in meat, seafood, egg, honey, milk, plasma and urine with liquid
chromatography–tandem mass spectrometry. Meat, seafood, egg, honey and milk
samples were extracted with acetonitrile. Chloroform was then added to remove
water. After evaporation, the residues were reconstituted in methanol/water before
injection. The urine and plasma were applied to a Chem Elut extraction cartridge,
eluted with ethyl acetate, and hexane washed. These samples were also reconstituted
in methanol/water after evaporation. CCα and CCβ for all matrices were 0.02 and
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0.04 μg kg-1. Rejtharova et al., 2009 described a method for the analysis of CAP in
urine, feed, water, milk and honey samples by GC-MS-NCI (Negative Chemical
Ionization) using molecular imprinted polymer clean-up. CAP could be detected well
below the MRPL in all matrices. Huang et al., 2006 presented a single analyte
method for the analysis of CAP in honey, milk, and eggs using polymer monolith
micro-extraction

followed

by

liquid

chromatography-mass

spectrometry

determination. A poly(methacrylic acid-ethylene glycol dimethacrylate) monolithic
capillary column was selected as the extraction medium. After dissolution in 20 mM
phosphate solution at pH 4.0 and centrifugation, honey, eggs, or milk samples were
directly passed through the extraction tube. The limits of detection for the method
were 0.02 μg kg-1, 0.04 μg L-1, and 0.04 μg kg-1 in honey, milk, and eggs,
respectively. Shen et al., 2005 developed a method for the screening, determination
and confirmation of chloramphenicol in seafood, meat and honey using ELISA,
HPLC-UVD, GC-ECD, GC-MS-EI-SIM and GCMS-NCI-SIM methods. Extraction
was with phosphoric buffer solution (pH = 6.88)/ethyl acetate, followed by defatting
with hexane. For confirmation on GC-MS the samples underwent purification with
SPE using LC-Si and LC-C18 cartridges. Forti et al., 2005 described the detection
and identification of CAP in honey. After a preliminary dissolution in water, samples
were extracted with a mixture of dichloromethane/acetone and evaporated to dryness
and reconstituted in a phosphate buffer solution. These were further cleaned up on an
octadecyl (C18) SPE cartridge. CAP was determined by LC-MS/MS, using
electrospray ionization in the negative ion mode with CCα of 0.07 μg kg-1 and CCβ
of 0.10 μg kg-1.
While the use of SPE is common there are published methods that omit this step.
Vivekanandan et al., 2005 published a method for the analysis of CAP in honey by
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LC-MS/MS. Samples were diluted with water and were purified using diatomaceousbased supported liquid-liquid extraction cartridges. The LOD and LOQ of the
method were 0.05 μg kg-1 and 0.1 μg kg-1 respectively. Rodziewicz et al., 2008
published a method for the analysis CAP in milk powder by LC-MS/MS with
negative electro-spray ionisation. Samples were extracted by using liquid-liquid
extraction steps with ethyl acetate and lipids were removed using hexane. The CCα
and CCβ of the method were 0.09 and 0.11 μg kg-1 respectively. Penney et al., 2005
published a liquid chromatography/mass spectrometry (LC/MS) method for the
determination of CAP residues in milk, eggs, chicken muscle and liver, and beef
muscle and kidney. CAP is extracted from the samples with acetonitrile and defatted
with numerous hexane washes. Samples are evaporated to dryness and reconstituted.
They are then filtered before injection. The method detection limits of CAP ranged
from 0.2 to 0.6 μg kg-1for the various matrices. Rocha Siqueira et al., 2005 developed
a LC-ESI-MS/MS method for determining chloramphenicol residues in fish, shrimp,
poultry, eggs, bovine and swine samples. The samples were extracted with a
phosphate extraction solution followed by liquid-liquid extraction with ethyl acetate.
The LOQ of the method was 0.1 μg kg-1. Finally a method was presented by Vinci et

al., 2005. CAP was extracted in acetonitrile and after liquid-liquid partitioning with
n-hexane is identified and quantitatively determined by ion trap liquid
chromatography/electrospray ionisation tandem mass spectrometry (LC/ESIMS/MS) analysis in the negative ionisation mode. The CCα and CCβ of the method
were 0.15 and 0.22 μg kg-1 respectively.
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2.4.3.2.Multi-Analyte Methods including Chloramphenicol Analysis
While the majority of methods published on the analysis of CAP are single analyte
methods there are a number of multi-amphenicol methods published. Xie et al., 2006
published a method for the determination of chloramphenicol, thiamphenicol and
florfenicol residues in original animal food by HPLC-ESI-MS/MS. The samples
were extracted with basified ethyl acetate and cleaned up with C18 column. The
detection limit of the method was 0.1 μg/kg. Shen et al., 2009 developed a method
capable of analysing for CAP, thiamphenicol (TAP), florfenicol (FF), and florfenicol
amine (FFA) in poultry and porcine muscle and liver. Extraction was with ethyl
acetate. The organic extracts were frozen to remove lipid and further purified by
liquid-liquid extraction (LLE) with hexane and SPE using Oasis HLB cartridges. The
target compounds were derivatized with BSTFA + 1% TMCS prior to GC-NCI/MS
determination. A LOD of 0.1 μg/kg for CAP was obtained. Zhang et al., 2008
published a LC-ESI-MS/MS method for the determination of CAP, TAP, FF and
FFA in chicken muscle. Samples were extracted with basified ethyl acetate, defatted
with hexane, and cleaned up on Oasis MCX cartridges. LOD was 0.1 μg/kg for CAP.
Wang et al., 2007 presented a method for simultaneous determination of residues of
CAP, TAP and FF in royal jelly by using LC-MS/MS. After a preliminary
homogenization of honey with water, samples were extracted with ethyl acetate, and
evaporated to dryness, reconstituted in phosphate buffer solution followed by clean
up on a C18 SPE cartridge. The method was capable of analysing for CAP at 0.1 μg
kg-1.
Apart from these multi-amphenicol methods there are a few multi-class methods
which include the analysis of CAP. Sheridan et al., 2008 developed a method for the
analysis of 14 sulfonamide antibiotics and chloramphenicol in honey by liquid
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chromatography-electrospray ionization-tandem mass spectrometry in negative mode
for all 15 analytes. The method describes the use of an acid hydrolysis step to
liberate the sugar-bound sulphonamides followed by a SPE method using Oasis HLB
to remove potential interferences. The method had a limit of detection of 0.2 µg kg-1
for CAP. Hormazabal et al., 2001 developed a method for determination of
chloramphenicol and ketoprofen in meat and milk. The samples were extracted with
acetonitrile, the organic layer was separated from water with CHCl3, evaporated to
dryness and then purified using Bond Elut SPE columns. The limit of detection for
CAP was 1 μg L-1.
Upon examining these published articles it was felt that incorporating the analysis of
CAP with the analysis of nitroimidazoles would be beneficial. As CAP is often
analysed on its own with the use of intensive extraction protocols the economic
impact on the laboratory is significant. Therefore it’s incorporation with
nitroimidazole analysis greatly reduces labour hours, solvent usage and increases
instrument capabilities, which greatly benefits the monitoring laboratory. Taking this
into consideration methods were developed to allow for the analysis of both
nitroimidazole and chloramphenicol residues in milk and honey.

2.4.4. Extraction Methods and Purification Methodologies for Veterinary Medicinal
Additives in Animal Feed
An overall search of published literature on the analysis of veterinary products as
feed additives shows that there are a limited number of methods available to analyse
for them. In many cases there is only single analyte or at best single class methods
available. Investigation into these methods shows that there is a wide variety of
extraction and purification methods involved in their analysis. As the legislation is
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divided into two lists, the published methods will be discussed under these two sets
of compounds. The first will be methods for the analysis of prohibited medicinal
additives and the second will be methods for the analysis of coccidiostats which are
still permitted for use as feed additives.

2.4.4.1.Prohibited Medicinal Feed Additives
Table 2-11: Overview of methods used for the analysis of prohibited feed additives as discussed
in section 2.4.4.1
Reference

Class of
Compounds
Analysed

Matrix

Extraction Method

Measurement
Technique

LOD
-1
(mg kg )

Barbosa 2007;
Vinas 2007;
Wang 2006

Nitrofurans

Feed

Organic solvent extraction followed by SPE
clean-up

LC-MS, HPLC-DAD

<0.01

Caballero 2002;
Houglum 1997

Tetracyclines

Feed

Organic solvent extraction followed by SPE
clean-up

HPLC-UV

<0.10

Capitan-Vallvey 2007

Nitromidizoles

Feed

Extraction with phosphate buffer solution (pH =
2); Clean-up on HLB SPE cartridges

LC-MS

0.05

Civitareale 2004

Antibacterial
Growth Promoters

Feed

Extraction with methanol; Clean-up on CN SPE
cartridges

HPLC-UV/DAD

<1.00

Dousa 2000;
Tollomelli 1992;
Ramos 1991

Nitromidizoles

Feed

Organic solvent extraction followed by SPE
clean-up

HPLC-UV

1.00

Dusi 2000

Nicarbazine and
Clopidol

Feed

Extraction with DMF; Clean-up on Aluminabasic SPE cartridge

HPLC-UV

1.00-2.50

Gramse 2004

Tylosin

Feed

Extraction with methanol; Clean-up on C18
SPE cartridges

HPLC-UV

0.22

Hajee 2001

Virginiamycin

Feed

Extraction with Ethyl Acetate; Clean-up on SepPak Silica Gel and HLB SPE cartridges

LC-UV, LC-MS

2.70

Higgins 2002

Tylosin and
Virginiamycin

Feed

Extraction by ASE using 65% aqueous acetone
(pH = 2)

ELISA

10.00

Hormazabal 2002

AGPs and
Ionophore
Coccidiostats

Feed

Samples homogenised with
methanol/acetone/THF; Samples mixed with
water and centrifuged; Supernatant diluted and
filtered through Spin-X microcentrifuge tube

LC-MS

1.50-2.50

Kesiunaite 2008

Antibacterial
Growth Promoters

Feed

Extraction using matrix solid phase dispersion
HILIC-UHPLC-DAD
(MSPD)

Qin 2005

Sulphonamides

Feed

Organic solvent extraction followed by SPE
clean-up; Dilution before injection

LC-MS/MS

<0.02

Situ 2006

Antibacterial
Growth Promoters

Feed

Analysis using Enzyme-linked Immuno-sorbant
Assay (ELISA) Kit

ELISA

1.00-4.00

Squadrone 2008

Amprolium

Feed

Extraction with methanol/water (80:20 v/v);
2
Extract filtered (filter paper 90g/m ); Filtrate
diluted with mobile phase before injection

LC-MS

0.20

Van Poucke 2003;
2005; 2006

Antibacterial
Growth Promoters

Feed

Extraction with methanol/water (7:3 v/v);
Extract diluted before clean-up on HLB SPE
cartridges

LC-MS

<1.00

Vinas 2006

Chloramphenicol

Feed

Samples mixed with water; 2 LLE with Ethyl
Acetate; Clean-up on SPE cartridge

LC-DAD

0.70

Wu 2009

Antibacterial
Growth Promoters

Feed

Extraction with ACN/water (60:40 v/v); Cleanup on HLB SPE cartridges

LC-MS/MS

<0.02

0.10
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As discussed previously NMZs and CAP are banned for use in food producing
animals and therefore are also prohibited for use as feed additives. While there are
numerous methods for the analysis of these compounds in biological matrices there
are only a few methods developed which allow for their analysis in animal feed. The
majority of methods that are used for the analysis of nitroimidazoles in feed are
HPLC-UV methods with the use of SPE purification for the analysis of, at most,
three analytes [Dousa, 2000; Tollomelli et al., 1992; Ramos et al., 1991]. Although
one method is published which includes the analysis of six analytes by LC-MS,
Capitan-Vallvey et al., 2007 presented a method that allowed for the analysis of
metronidazole, ronidazole, dimetridazole, secnidazole, tinidazole and ipronidazole in
feedstuff. The 5-nitroimidazoles were extracted from animal feed with a pH 2
phosphate buffer solution followed by a SPE based on HLB cartridges. The method
was applied successfully to determine 5-nitroimidazoles in feedstuff at level of 0.05
mg kg−1. For analysis of CAP only two methods could be found in feed. One of these
methods published by Vinas et al., 2006 allows for the determination of CAP
residues in animal feeds by liquid chromatography with photo-diode array detection.
Feed was mixed with water and then underwent two liquid-liquid extractions (LLE)
with ethyl acetate. Purification was performed using a Discovery DSC-18Lt SPE
cartridge. LOD using the proposed procedure was 0.7 μg kg−1.
Another set of antibiotic compounds prohibited for use in food producing animals are
nitrofurans and in turn are banned for use as feed additives. From examination of
literature there are three papers published for their analysis in feed. These methods
analyse for a number of nitrofuran analytes by either LC-MS or HPLC-DAD with
purification usually in the form of SPE [Barbosa et al., 2007; Vinas et al., 2007;
Wang et al., 2006].
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Compounds such as sulphonamides and tetracyclines are now prohibited for use as
feed additives although they are still permitted for use in medicated feed. While there
are numerous methods for the analysis of both of these class of compounds in
biological matrices [Shen et al., 2010; Carretero et al., 2008; Soto-Chinchilla et al.,
2007; Sergi et al., 2007 Shao et al., 2007] there are very few methods for their
analysis in animal feed. Qin et al., 2005 developed a method for the qualification and
quantification of 10 sulfonamides in animal feedstuff by LC-MS/MS. Samples were
solvent extracted, purified using SPE and diluted before injection. The LOQs for the
10 sulphonamides ranged from 0.5 - 2.0 μg/kg. In the case of tetracyclines there are
no MS methods published that are capable of analysing animal feed although some
chromatography methods are available [Caballero et al., 2002; Houglum et al.,
1997].
The rest of the compounds in the prohibited feed additives list could be classified
under the broad title of antibacterial growth promoters (AGPs). This list includes
compounds such as tylosin, virginiamycin, avilamycin, spiramycin, zinc bacitracin,
olaquindox,

carbadox,

aprinocid,

methyclorpindol

(Clopidol),

dinitolimide

amprolium and ethopabate. The analysis of some of these compounds in feed has in
some cases not been published before whereas some analytes have been investigated
as part of collaborative European wide studies.
A number of journal papers have been published as a result of the EC funded
Feedstuffs-RADIUS project. This was a study in particular into the analysis of AGPs
in animal feed. Situ et al., 2006 published a method for the screening of zinc
bacitracin, spiramycin, tylosin, virginiamycin and olaquindox in animal feedstuffs by
the use of an enzyme-linked immuno-sorbent assay (ELISA) kit. The detection limits
for the developed immunoassays were to detect concentrations of 4 mg kg-1, or more,
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of olaquindox and 1 mg kg-1 or more of the other compounds. A number of papers
have been published by van Poucke et al., 2003, 2005, 2006 on the area of AGPs
analysis in animal feed by LC-MS. Some of these research papers were also funded
by the Feedstuffs-RADIUS project. The three papers use the same method as a
starting point with small alterations and are for the analysis of zinc bacitracin,
spiramycin, tylosin, virginiamycin and olaquindox. Feed was extracted with 10 ml of
methanol/water (7:3 v/v), and 3 ml of this extract was purified on an OASIS HLB
column after dilution with 27 ml of water. The detection capability of the method for
all compounds was <1 mg kg-1.
Apart from van Pouke et al., there are very few confirmatory methods for the
analysis of AGPs in feed. Some of these methods are capable of seeing low levels of
analyte but some are in the ppm range. Wu et al., 2009 developed a method by LCMS/MS for the simultaneous determination of carbadox, olaquindox, mequindox and
quinocetone in swine feed. The analytes were extracted from the feed with
acetonitrile/water (60:40, v/v), and then further purified by solid-phase extraction
using Oasis HLB cartridges. The LOQs for the four compounds were <20 μg kg−1.
Squadrone et al., 2008 published a LC-MS method which was able to detect
amprolium in chicken feed. The samples were extracted with 100 mL
methanol/water 80/20 (v/v) and blended for 60 min. An aliquot of these extracts was
filtered on paper filter (90 g m−2, 250 mm) and collected into a 50 mL flask. These
filtrates were diluted 1:10 with initial mobile phase and filtered before injection.
LOQ of the method was 0.2 mg kg−1. Hormazabal et al., 2002 developed a method
for the determination of amprolium (AMP), ethopabate (ETB), lasalocid (LAS),
monensin (MON), narasin (NAR) and salinomycin (SAL) in feed by LC-MS. Feed
samples were homogenized with methanol-acetone-tetrahydrofuran. After addition of
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water, the samples were mixed and centrifuged. The compact bottom layer was reextracted with methanol-water. After centrifugation, the combined supernatants were
diluted and filtered through a Spin-X micro-centrifuge tube. Three separate LC
method were needed using three different columns in order to analyse for all
analytes. The limits of detection were close to 2 mg kg−1 for AMP, LAS, MON, and
NAR, 1.5 mg kg−1 for ETB, and 2.5 mg kg−1 for SAL in chicken feed. Hajee et al.,
2001 published a method for the detection of virginiamycin at sub-additive level in
pig, calf, piglet, sow, poultry, cattle and laying hen feeds by LC-UV/LC-MS.
Virginiamycin was extracted from animal feeds with ethyl acetate after wetting of
the feed with water followed by clean-up on Sep-Pak silica gel and OASIS HLB
cartridges. The LOQ of the method was 2.7 mg kg−1.
The rest of the published methods dealing with the analysis of AGPs in animal feed
are screening methods using chromatography or immunoassay techniques. Dusi et

al., 2000 described a method for the determination of nicarbazin and clopidol in
poultry feeds by LC. Ground feed samples were extracted using aqueous
dimethylformamide (DMF) after mixing with water. Co-extracted feed constituents
were removed with a solid-phase extraction on alumina-basic columns and the
eluates were directly analysed. LOD for nicarbazin and clopidol were 1 mg kg−1 and
2.5 mg kg−1 respectively. Kesiunaite et al., 2008 developed a method involving
matrix solid-phase dispersion (MSPD) extraction and hydrophilic interaction ultrahigh-pressure liquid chromatography (HILIC-UHPLC) with photodiode array
detection for the determination of carbadox and olaquindox in feed. Feed sample and
0.5 g of C18 sorbent were placed into an agate mortar and gently blended for about 2
min using a pestle and mortar to obtain a homogeneous mixture. The blend was then
transferred into a 15 mL syringe with a frit on the bottom and a second frit was
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placed over the dispersed sample with slight compression. The analytes were eluted
from the cartridge with 10 mL of acetonitrile–methanol mixture (8:2, v/v) applying
slight vacuum. This was then evaporated, reconstituted and filtered before injection.
The method could analyse levels of 0.1 mg kg-1for olaquindox and carbadox.
Civitareale et al., 2004 developed a method for the analysis of tylosin and spiramycin
by HPLC-UV/DAD. After methanolic extraction, samples were cleaned up on SPE
CN columns before analysis. Detection limits for the method were 176 and 118 μg
kg-1 for spiramycin and tylosin respectively. Gramse et al., 2004 published a method
for the determination of tylosin in feeds. The method involves extraction of tylosin
with methanol, concentration under a stream of nitrogen, and cleanup using C18 SPE
cartridge followed by analysis using HPLC-UV. The limit of detection and
quantitation of the method was 0.216 and 0.720 mg kg-1 respectively. Higgins et al.,
2002 developed a method for the screening of avoparcin, bacitracin zinc, spiramycin,
tylosin and virginiamycin by immunoassay. Extraction of analytes from 5g portions
of test samples was performed by use of a Dionex ASE200 accelerated solvent
extraction system with use of 65% aqueous acetone (adjusted to pH 2 by addition of
12 ml of 1M-HCl per litre of solvent). All compounds could be screened at levels
less than 10mg/kg.
It is quite clear from the published articles that there is no single method available to
analyse for a broad range of these prohibited medicinal additives in animal feed. This
is probably because legislation pertaining to these compounds in feed is relatively
new and the range of compounds incorporated is quite diverse. Therefore it is
anticipated the application of a generic extraction and purification protocol will allow
an increased amount of analytes to be analysed in a single run, therefore increasing
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the analytical capabilities of the laboratory and in doing so increase the likelihood of
finding possible breaches of this legislation.

2.4.4.2.Coccidiostats
Table 2-9: Overview of methods used for the analysis of coccidiostats in feed as discussed in
section 2.4.4.2
Reference

No. of
compounds
analysed

Matrix

Extraction Method

Measurement
Technique

LOD
(mg kg-1)

Campbell 2006

3

Feed

Extraction with methanol and water (9:1 v/v); Samples
shaken and diluted before injection

LC-UV

1.00

Extraction with 10% Na2CO3solution and ACN; Samples
agitated before centrifugation; Samples extracted a
second time with ACN; Both organic extracts combined;
An aliquot of extract evaportated and reconstituted before
injection

LC-MS/MS

1%
unavoidable
carryover

LC-MS

<1.00

LC-FD

1.00

LC-MS

0.20-0.60

Delahaut 2010

11

Feed

Ebel 2004

2

Feed

Focht 2008

1

Feed

Hormazabal 2005

4

Extraction with methanol; Samples filtered and de-fatted
with hexane; Samples concentrated by evaporation
before injection
Extraction with 0.5% HCl acidified methanol; Samples
sonicated and shaken; Samples diluted amd filtered
before injection

Feed

Samples homogenised with methanol/acetone/DHF;
Samples mixed and centrifuged; After centrifugation
supernatant was extracted with hexane; Evaporated to
dryness and re-constituted in ACN and water; Filtered
through Spin-X microcentrifuge tube before injection

Jong 2004 (a)

1

Feed

Extraction with ACN and methanol (1:1)

LC-UV

<20.00

Jong 2004 (b)

1

Feed

Extraction with methanol

LC-UV

2.00

Kot-Wasik 2005

1

Feed

Krabel 2000

1

Feed

Mortier 2005 (a)

1

Feed

Mortier 2005 (b)

6

Feed

Sanchez 2008

1

Feed

Thalmann 2004

1

Feed

Extraction with acidified methanol by ASE; Clean-up on
HPLC-UV / LC-MS
Aluminium Oxide cartridges
Extraction with ACN and water (4:1 v/v); Filtered before
LC-UV
injection
Extraction with methanol
LC-MS/MS

0.02
0.25
<0.01

Extraction with methanol
Extraction with 1% Calcium Chloride in methanol solution
using mechanical agitation; Samples centrifused and
diluted; Filtered before injection

LC-MS/MS

<0.01

LC-FD

1.00

Extraction with methanol and phosphate solution (9:1 v/v)

LC-UV

<20.00

LC-MS

1.00-50.00

LC-MS/MS

0.01

Extraction with hexane and ethyl acetate; Clean-up on
silica SPE cartridge
Extraction with methanol and water (9:1 v/v); Aliquot of
extract cleaned-up on IST Isolute SPE cartridge before
analysis

Turnipseed 2001

4

Feed

Vincent 2008

6

Feed

Vincent 2011

6

Feed

Extraction with ACN; Samples sonicated and agitated
before centrifugation; Quantification by Standard Addition

LC-MS/MS

1%
unavoidable
carryover

Wang 2000

2

Feed

Extraction with ACN; mixed for 1hr and then filtered;
Clean-up on C18 SPE cartridge; Eluate diluted before
analysis

MALDI-TOF-MS

2.40

The majority of methods published for the analysis of coccidiostats in animal feed
are for the analysis of single analytes by LC-UV. These include a number of papers
that validate LC methods as part of collaborative studies. These collaborative studies
include the following methods. Sanchez et al., 2008 developed a method for the
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analysis of decoquinate in supplements, premixes, and complete animal feeds (i.e
feed ready for use) at medicating and trace levels. Decoquinate was extracted from
feed previously ground to homongeniety with 1% calcium chloride-methanol
solution using mechanical agitation for 90 min. After centrifugation for 5 min and
dilution of medicated levels (if necessary) into an acceptable analytical range. The
diluted extracts are filtered and analyzed by reversed-phase LC with fluorescence
detection and is capable of analysing to levels of 1 mg kg−1. Focht, 2008 developed a
LC method for the analysis of lasalocid in medicated premixes and complete animal
feeds and at trace-level in feeds. The method employs a 0.5% HCl acidified methanol
extraction followed by 20 min sonication in a water bath heated to 40°C. Samples are
then shaken on a mechanical shaker for 1 h and stored overnight, followed by an
additional 10 min shaking the following morning. Sample extracts are diluted if
necessary with extractant, filtered, and injected onto an LC with fluorescence
detection and is capable of analysing to levels of 1 mg kg−1..
Other single analyte LC methods include two methods published by de Jong et al.,
2004 (a); Jong et al., 2004 (b) describing the analysis of nicarbazin in broiler feeds
and premixtures and maduramicin in feedingstuffs and premixtures at medicated
levels. The extraction solvent was an acetonitrile-methanol (1:1) mixture for
nicarbazin and was just methanol for maduramicin. Analysis was performed on LCUV instrument and the LOD was <20 mg kg−1 for nicarbazin and 2 mg kg−1 for
maduramicin. Kot-Wasik et al., 2005 published an analytical procedure for the
determination of robenidine in animal feeds. Robenidine was extracted from samples
with acidified methanol using ASE. Extracts were dried and subjected to clean-up
with aluminium oxide cartridges. Analysis was performed by HPLC coupled to DAD
UV and MS. LOQ was determined to me 0.1 and 0.02 mg kg−1 for DAD-UV and MS
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detection, respectively. Thalmann et al., 2004 developed a reversed-phase LC
method for the analysis of narasin in feedingstuffs and premixtures. The extraction
solvent was methanol-K2HPO4 solution (9:1, v/v). Narasin was detected at 600 nm
after post column derivatization with dimethylamino-benzaldehyde. The LOD was
found to be <20 mg kg−1. Krabel et al., 2000 developed a method for the analysis of
nicarbazin in animal feed. Feed is extracted with 200 ml acetonitrile/H2O (4:1, v/v).
An aliquot of the extract is filtered before analysis by LC-UV. The method has a
LOD of 250 μg kg-1 and a LOQ of 500 μg kg-1.
Some LC-UV methods are capable of analysing for more analytes. Campbell et al.,
2006 published a method for the analysis of monensin, narasin, and salinomycin in
mineral premixes, supplements, and complete animal feeds at medicating and trace
levels. The method uses methanol-water (9:1, v/v) extraction with mechanical
shaking for 1 h, filtration, and dilution if necessary. Determination of the 3
ionophores is by reversed-phase LC using post-column derivatization with vanillin
and detection at 520 nm. That said, the majority of multi analyte methods use LCMS as the instrument of analysis. Hormazabal et al., 2005 described a LC-MS
method for the determination of lasalocid, monensin, narasin and salinomycin in
feed. Samples were homogenized with methanol-acetone-tetrahydrofuran. The
samples were mixed and centrifuged. After centrifugation, 100 μL supernatant was
extracted with hexane, evaporated to dryness, diluted with acetonitrile-water, filtered
through a Spin-X micro-centrifuge tube, and injected into the LC/MS. The LOQ of
the method for all the analytes ranged from 0.2 to 0.6 mg kg−1. Turnipseed et al.,
2001 published a LC-MS method for the analysis of monensin, lasalocid,
salinomycin, and narasin. The drugs were extracted from the feed matrix using
hexane-ethyl acetate and isolated using a silica solid-phase extraction cartridge.
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These ionophores were confirmed in both medicated feeds and non medicated feeds
fortified with these drugs at the 1-50 mg kg−1 level. Ebel et al., 2004 published a
method on the LC-MS analysis of monensin and lasalocid in feed samples. The
samples were extracted with methanol. The extracts were filtered and then defatted
with hexane. These were concentrated up by evaporation before injection. The
method was capable of detecting compounds below 1 mg kg−1. While Wang et al.,
2000 published a method for the analysis of salinomycin and narasin in poultry feed
using MALDI-TOF MS. Ground feed samples were extracted with 10 ml acetonitrile
for 1 h and the mixture was filtered. The filtrate was applied to a C18 SPE cartridge.
The eluate was diluted before analysis. The LOD for both analytes was 2.4 mg kg−1.
With the publication of European legislation Regulation 2009/8/EC laying down
levels of unavoidable carry over for eleven coccidiostats in non target feed there is a
need for confirmatory methods for the quantitation of these analytes at various levels
in feed. LC-MS/MS offers a useful tool in the effort to ensure this legislation is
enforced. Previous methods for the analysis of some of these compounds in feed
show that LC-MS/MS is capable of confirming analytes at levels related to
unavoidable carry over. Mortier et al., 2005 (a) published a LC-MS/MS method for
the detection of the coccidiostat diclazuril in poultry meat and feed. Feed samples are
extracted with methanol. A portion of the extract is evaporated to dryness and then
reconstituted in mobile phase. The samples are then filtered before injection onto the
LC-MS/MS. Mortier et al., 2005 (b) published another method using the same
extraction protocol for the quantitative detection of the chemical coccidiostats
halofuginone, robenidine, diclazuril, nicarbazin and dimetridazole and its main
metabolite 2-hydroxydimetridazole in poultry eggs and feed. CCα and CCβ of the
method were no higher than 10.7 and 14.5 μg kg-1 respectively for all analytes in
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feed. While Vincent et al., 2008 developed a LC-MS/MS method for the analysis of
monensin, salinomycin, narasin, lasalocid, semduramicin and maduramicin in animal
feed. Samples were extracted with 100 ml of a MeOH: H2O mixture (90:10, v: v) for
60 min by agitation. 5ml of the extract was purified on IST Isolute cartridge before
analysis. The LOD and LOQ of the method were different for various analyte/matrix
combinations but were in all cases below 0.014 and 0.046 mg kg−1.
More recently two papers have been published with the objective of analysing feed at
levels relating to unavoidable carryover as stated in Regulation 2009/8/EC (Table
2.4). One of these methods published by Vincent et al., 2011 was capabable of
analysing for the six ionophore coccidiostats listed in the legislation. 5g of feed is
extracted with 40ml of ACN. The mixture was then placed in an ultrasonic bath for
30 mins and this was followed by a head to head agitation for 60mins. The sample is
centrifuged and seven 2ml aliquots are taken and used for analysis by utilising a
standard addition approach. The method was validated and is capable of analysing
the six compounds at levels relating to 1% and 3% unavoidable carry over values as
stated in legislation.
The only method to include the analysis of feed for all 11 coccidiostats in a single
method is one published by Delahaut et al., 2010. Feed samples were extracted with
a 10% Na2CO3 solution (w/v) and acetonitrile. The samples were shaken for 30 min
on a mechanical agitator and then centrifuged. The supernatant was transferred into a
tube and extraction with acetonitrile was repeated a second time and both organic
extracts were combined. Finally, 1ml of acetonitrile extract was transferred into a
tube and evaporated to dryness under nitrogen in a heated water bath. The sample
was re-dissolved in 1ml acetonitrile/water mixture (80:20, v/v) before analysis by
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LC-MS/MS. The method was validated using the levels permitted in feed of non
target animals as stated in 2009/8/EC.
After investigation of the published literature it is apparent that there are very few
methods available that can be applied in order to enforce Commission Regulation
2009/8/EC. To date only two methods have been published with the specific aim to
analyse for these compounds at levels related to unavoidable carryover into non
target feed. The similarities between the methods are that both use acetonitrile as the
extraction solution because its polarity is the most suitable for the extraction of these
compounds. It is also clear that dilution of sample extract rather that concentration
results in improved repeatability of the methods due to the fact that the
concentrations of the ionophore coccidiostats is above the analytical range of many
mass spectrometers and also the matrix of feed is complex and dilution results in
reduced interference from the matrix. Using these two papers as a starting point it is
hoped that a method for the analysis of all eleven coccidiostat compounds can be
developed for use in the analysis of the different feeds that are encountered in the
laboratory on a routine basis.

2.5. LC-MS/MS

2.5.1. Introduction to Mass Spectrometry
After World War II, mass spectrometry began to have a broad application in
chemistry and in particular organic chemistry. By the early 1950’s there were a
number of US companies building magnetic sector mass spectrometers. However it
wasn’t until the mid 1960’s and the combination of gas chromatography with mass
spectrometry did the use of mass spectrometry in the analysis of compounds become
more prominent. The further development of GC-MS resulted in it becoming an
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indispensable tool in a number of areas such as environmental, medical, food and
flavour industries and also in forensics [Watson et al. 2009]. Its development
continued from these early instruments into the extremely sensitive and selective
instruments that are available today.
A definition of a mass spectrometer published by Price, 1991 is an instrument in
which ions are analyzed according to their mass-to-charge ratio, and in which the
number of ions is determined electrically. For the most part, there are four basic
components that are standard in all mass spectrometers (Figure 2-6). These are; a
sample inlet, an ionization source, a mass analyzer and an ion detector. Although
there are many variation of mass spectrometers the process by which all sample
molecules are analysed is similar regardless of instrument configuration. Sample
molecules are introduced into the instrument through a sample inlet. Once inside the
instrument, the sample molecules are converted to ions in the ionization source,
before being electrostatically propelled into the mass analyzer. Ions are then
separated according to their m/z within the mass analyzer. The detector converts the
ion energy into electrical signals, which are then transmitted to a computer.

Figure 2-6: Basis components of a mass spectrometer
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2.5.2. Instrument Selection LC-MS versus GC-MS
Upon commencing this research a decision needed to be made on what instrumental
technique would result in improved methods for the analysis of pharmaceutical
compounds in a variety of animal and feed matrices. According to CD 2002/657/EC
there are only a number of instruments that can be used for the confirmatory analysis
of veterinary residues in food matrices. The most commonly available of these is
mass spectrometry. Therefore the majority of methods published in this area either
use GC-MSn or LC-MSn for confirmatory analysis. Historically GC-MS was the
most commonly used analytical instrument. This was as a result of GC-MS being a
more mature technology, being less expensive and having an extensive list of
established and approved operational protocols. However with improvements in the
manufacture of LC-MS systems and increased research on there use, LC-MS is fast
becoming the instrument of choice for analysis of veterinary residues in food
matrices. The main reason for this is that liquid chromatography offers tremendous
potential for analyzing non-volatile, polarized and ionized materials with reduced
sample purification, extraction and more importantly there is no need for
derivatisation.
For analysis by GC-MS, compounds need to be both volatile at the temperature
needed for separation and also thermally stable. As a result, analysis by GC–MS, in
many cases requires derivatization of the analytes in veterinary residue analysis. This
is carried out by a number of processes such as silylation, acylation or
oxime/silylation depending on the individual properties of the compounds to be
analysed. However this can cause problems and this is seen in the case of
nitroimidazoles where derivatisation results in the same trimethylsilylether product
formed from the derivatisation of RNZ and HMMNI with BSA [Polzer et al., 2001].
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This is as a result of the breaking up of carbamoyloxymethyl group of RNZ during
derivatisation. For this reason, a distinction between RNZ and HMMNI, which is the
metabolite of DMZ and RNZ, cannot be made with the use of GC-MS. In addition to
this a number of nitroimidazoles such as IPZ are not derivatisable with BSA [Polzer

et al., 2001].
The derivatisation process increases sample preparation times and in the case of
nitroimidazoles does not allow for the analysis of all compounds. However in some
cases GC-MS is a more specific and sensitive technique. This is due to the fact that
gas chromatography and mass spectrometry are compatible because analytes need to
be in the gas phase in order to be analysed by mass spectrometry. This gives GC-MS
an advantage in terms of sensitivity over LC-MS in the analysis of some veterinary
residues. The majority of the analyte which passes through the GC column will enter
the mass spectrometer and be analysed. This is not the case with LC-MS as the
combination of liquid chromatography and mass spectrometry is not as compatible as
with GC which results in the large amount of analyte being lost when the sample is
converted from liquid to gas phase ions. To allow for the use of this hyphenated
technique the use of an interface is required. The primary purpose of this interface is
the removal of the mobile phase and this results in the loss of analyte and a reduced
amount ionised analyte reaching the mass analyzer. The types of interfaces and
ionisation utilised in LC-MS are discussed further in the next section 2.5.3.
Taking this information into consideration, the most suitable instrument for use in
multi residue methods is LC-MS. The reason for this is that unlike GC-MS it can be
used for the analysis of all non volatile compounds without the need for
derivatisation. This results in increased analytical capability as more analytes can be
analysed for in single runs. Any problems with derivatisation are overcome by its
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omission and as a result would allow all nitroimidazole residues to be analysed and
distinguishable from each other. In the case of the feed methods it was felt that the
only option for analysis was by LC-MS as the number and diversity of the
compounds that needed to be incorporated into the method would not be achievable
using GC-MS due to problems with derivatising all analytes with a single
derivatising agent.

2.5.3. Liquid Chromatography to Mass Spectrometry: Interfaces and Ionisation
Techniques
As mentioned previously the main obstacle in the development of the hyphenated
technique LC-MS was the converting the analyte in the mobile phase to gas phase
ions in order for them to be analysed by the MS. This resulted in the need for an
interface linking the two techniques. This interface works at atmospheric pressure
and allows for the liquid to be changed into gas phase and also ionises the analyte.
This interface type is known as atmospheric pressure ionisation (API) interface.
There are many different designs of this interface but an example of one can be seen
in Figure 2-7.
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Figure 2-7. Diagram of API interface

Although ionisation is carried out at atmospheric pressure there are numerous
different ionisation techniques that may be used with LC-MS. The most common
ones used in veterinary residue analysis are electrospray ionization (ESI),
atmospheric pressure chemical ionization (APCI) and atmospheric pressure photo
ionization (APPI). From examination of Figure 2-8 it is clear that ESI works best
over a broader range of different analytes. Compounds with higher polarity and
molecular weights can only be analysed by ESI. Therefore it was decided that ESI
was the best ionisation technique in this research as it was applicable to all the
compounds that were to be analysed.

Figure 2-8. Portrayal of various ionization techniques such as ESI, APCI, and APPI as a
function of compound polarity and molecular weight.

ESI is generally accomplished by forcing the LC mobile phase containing the analyte
through a small capillary into an electric field of high positive or negative electrical
potential typically of the order of 3-5 kV depending on whether positive ionization
(higher voltages) or negative ionization (lower voltages) is required. (Figure 2-9).
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Analyser
(10-4/10-5 mbar)

(Source http://www.astbury.leeds.ac.uk/facil/MStut/mstutorial.htm)
Figure 2-9. Components of an ESI interface

When the solution reaches the end of the tube the strong electric field forces it to be
nebulized into a spray of small highly charged droplets of solution in solvent vapour.
Before entering the mass spectrometer the spray passes through a heated chamber,
through which a flow of drying gas, typically air or nitrogen, is continually passed at
high flow rates evaporating the solvent rapidly. Thus as the charged droplets get
smaller, the electrical surface charge density increases until it reaches a point where
the repulsive forces between charges of the same polarity at the surface of the droplet
are greater than the cohesive forces of surface tension which hold the droplet
together. This results in a “Coulombic explosion” (Figure 2-10), which produces a
number of smaller droplets and this continues until charged analyte ions are formed
which can be analysed by the mass spectrometer.
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(Source http://www.bris.ac.uk/nerclsmsf/techniques/hplcms.html)
Figure 2-10. A simplified mechanism of ion formation in the electrospray ionization process.

2.5.4. LC-MS and Ion Suppression
While the advantages of LC-MS are in its capability to analyse for a very broad
range of analytes with reduced sample purification and without the need for
derivatisation, it is not without its own adverse aspects and limitations. Its main
pitfall is a phenomenon known as ion suppression which occurs as a result of the
presence of high concentrations of background matrix components. These
components are primarily made up of endogenous substances for example organic or
inorganic molecules present in the sample and that remain in the final extract; while
other causes may be exogenous substances, i.e. molecules not present in the sample
but may enter from various external sources during the sample preparation [Antignac

et al., 2005].
These matrix components can result in ion suppression by a number of mechanisms
[Antignac et al., 2005]. These mechanisms include;
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Decrease in evaporation efficiency due to the presence of matrix which results
in increased viscosity and surface tension of droplets produced by ESI or APCI



Co-precipitation of analytes with non volatile material such as macromolecules
can also reduce their transfer into gas phase.



Competition between analytes and interfering components for ionization



Matrix can cause analytes to be basic in the gas phase and result in instability of
analyte ions produced. This can result in neutralization processes which can
affect analyte response.

These processes can all contribute to the occurrence of ion suppression which have
consequences for results acquired in LC-MS. These consequences are;


The detection capability is reduced due to the decrease of the analyte signal.



The repeatability is also affected, because the degree of suppression may vary
greatly from one sample to another.



Ion ratio, linearity, and quantification, are also affected due to the variability of
this unpredictable phenomenon.



Ion suppression may lead to existing analytes to go undetected, to the
underestimation of its real concentration or to the unsatisfactory results for
identification criteria, with immediate consequences in terms of false negative
(compliant) results.



Finally if affecting the internal standard rather than the analyte, ion suppression
may also lead sometimes to an overestimation of the analyte concentration with
increased risk of false positive (non-compliant) results for maximum residue
limit (MRL) compounds.
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Therefore to avoid these consequences it is critical to always take ion suppression
into consideration when developing a LC-MS method. There are a number of
approaches that can be looked at in order to overcome these possible pitfalls
[Antignac et al., 2005]. These include;


Modifying the mass spectrometric conditions if possible. This can be done by
altering ionization technique as (ESI, APCI, APPI) as ion suppression may
differ between different ionization techniques. Alternatively different ionization
modes (positive or negative), or equipments with different source design can
also reduce affect of ion suppression. Finding this type of solution is
advantageous because it does not require any change in the rest of the developed
analytical procedure (sample preparation and chromatographic condition)



Another solution to overcome this problem is to use adequate internal standard,
in order to balance the disturbance of the analyte signal by an equivalent
disturbance on the internal standard. The best way to achieve this is to use a
compound with a chemical structure and a retention time as close as possible to
those of the analyte. For this purpose, C13-labelled or deuterated analogues of
the analytes being tested significantly reduce signal variability observed for the
analyte and consequently improve the repeatability of the measurement.



Another way to reduce ion suppression is to adjust the LC conditions in order to
shift the analyte of interest away from the matrix components.



The previously described approaches only allow for the balancing of matrix
effects or minimizing the consequences of ion suppression, but they do not
eliminate it as the cause is not treated. The only way to definitively circumvent
this problem remains to improve the sample preparation and purification, in
order to limit the presence of interfering compounds in the final extract.
76

Chapter 2

Literature Review

The conclusion of the article published by Antignac et al., 2005 on ion suppression
in LC-MS is that only a combination of sufficient sample purification and practical
internal standard choice may ensure optimum performance in terms of repeatability
and quantification. Therefore throughout this research ion suppression was always
taken into consideration by the sourcing of suitable internal standards and by
examining a variety of matrices in development and validation of methods to ensure
that no effects were observed.

2.5.5. Types of Mass Analyzers
 Quadrupole: The quadrupole is the most widely used analyser due to its ease of
use, mass range covered, good linearity for quantitative work, resolution and
quality of mass spectra. The quadrupole is composed of two pairs of metallic
rods. One set of rod is at a positive electrical potential, and the other one at a
negative potential. A combination of DC and Rf (radio frequency) voltages is
applied on each set. The positive pair of rods is acting as a high mass filter; the
other pair is acting as a low mass filter. The resolution depends on the dc value
in relationship to the Rf value. The quadrupoles are operated at constant
resolution, which means that the Rf to DC ratio is maintained constant. For a
given amplitude of the dc and Rf voltages, only the ions of a given m/z (mass
to charge) ratio will resonate and have a stable trajectory to pass through the
quadrupole and be detected. Other ions will be de-stabilized and hit the rods.
As seen in figure 2-11.
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Figure 2-11. Quadropole Mass Analyzer

 Ion Trap: The principle of the trap is to store the ions in a device consisting of
a ring electrode and two end cap electrodes. The ions are stabilized in the trap
by applying a Rf voltage on the ring electrode. For maximum efficiency, the
ions must be focussed near the centre where the trapping fields are closest to
the ideal and the least distorted - maximizing resolution and sensitivity. This is
achieved by introducing a damping gas (99.998% helium) that collisionally
cools injected ions, damping down their oscillations until they stabilize. By
ramping the Rf voltage, or by applying supplementary voltages on the end cap
electrodes, or by combination of both, it is possible to: destabilise the ions, and
eject them progressively from the trap or keep only one ion of a given m/z
value in the trap, and then eject it to observe it specifically. The ion trap
analyzer can be seen in figure 2-12.
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Figure 2-12. Ion Trap Mass Analyzer

 Time of Flight: In a Time–Of–Flight (TOF) mass spectrometer, ions formed in
an ion source are extracted and accelerated to a high velocity by an electric
field into an analyser consisting of a long straight ‘drift tube’. The ions pass
along the tube until they reach a detector. After the initial acceleration phase,
the velocity reached by an ion is inversely proportional to its mass (strictly,
inversely proportional to the square root of its m/z value). Since the distance
from the ion origin to the detector is fixed, the time taken for an ion to traverse
the analyser in a straight line is inversely proportional to its velocity and hence
proportional to its mass (strictly, proportional to the square root of its m/z
value). Thus, each m/z value has its characteristic time–of–flight from the
source to the detector. In order to increase the resolution, the ion trajectory is
bent by an electronic mirror, the reflectron. When going through the reflectron,
the dispersion of ions of the same m/z value is minimized, leading to a great
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improvement in resolution. The TOF instrument with and without the
reflectron is seen in figure 2-13.

Figure 2-13. TOF Instrument with and without Reflectron .

2.5.6. Tandem Mass Spectrometry and Confirmatory Criteria
While the use of single mass analyzers is quite common, it is possible for ions to
undergo separation by two different mass analysers in the same experiment. This is
known as tandem mass spectrometry and it is a popular technique used in the
analysis of veterinary residues in biological and feed matrices. This technique is
concerned with the analysis of product ions formed from precursor ions as a result of
their fragmentation due to collision induced dissociation. The most commonly used
mode in tandem mass spectrometry for this purpose is “selected reaction monitoring”
(SRM) usually carried out on a triple quadrupole instrument (Figure 2-14) [Le Bizec

et al., 2009]. As suggested previously quadrupoles have become the most widely
used mass analysers in mass spectrometry [Dawson 1995]. In SRM mode, the
molecular ion of the target compound is isolated in the first mass analyser, it
subsequently undergoes fragmentation and only specific product ions are monitored
in the second mass analyser. Le Bizec et al., 2009 states that this technique offers
many advantages for the analysis of trace levels of substances in complex matrices.
The main advantage this technique gives is a significant decrease in noise observed
in the signal of target analytes as a result of the small probability that interferences

80

Chapter 2

Literature Review

from other compounds present in the final extract will have the same or very close
molecular weights and product fragments as the analyte of interest.

Figure 2-14. Diagram of triple quadrupole mass spectrometer (MS/MS)

The production of a precursor and two product ions in tandem mass spectrometry as
discussed previously in section 2.3.4 yields four identification points (IPs). As a
result this approach is classified as a confirmatory technique. The relative response
of the two product ions (ion ratio) acts as a confirmatory criterion. Ion ratios for non
compliant samples can be compared to the ion ratio of the analyte of interest which is
usually determined from matrix matched calibration standards. This approach is
similar to approaches for confirmation adopted by other regulatory bodies such as the
Association of Official Racing Chemists (AORC), the US Food and Drug
Administration (FDA), the International Olympic Committee (IOC) and the World
Anti-Doping Agency (WADA) [Van Eenoo, 2004]. Triple quadrupole LC-MS/MS in
SRM mode with 1 precursor and two product ions was the analytical technique
utilised in all methods developed as part of this research.
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research and are input into this thesis the same as they appear in the
respective journals in which they are published or accepted for publication.
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Abstract

A rapid LC-MS/MS method has been developed and validated for the simultaneous
identification, confirmation and quantitation of ten nitroimidazoles in plasma. The
method validated in accordance with Commission Decision (CD) 2002/657/EC and
is capable of analysing for Metronidazole (MNZ), Dimetridazole (DMZ), Ronidazole
(RNZ), Ipronidazole (IPZ) and their hydroxy metabolites MNZ-OH, HMMNI
(Hydroxymethyl, Methyl Nitroimidazole), IPZ-OH. The method is also capable of
analysing Carnidazole (CRZ), Ornidazole (ORZ) and Ternidazole (TRZ) which are
rarely analysed by modern methods. MNZ, DMZ and RNZ have a Recommended
Level (RL) of 3 ng mL-1 which this method is easily able to detect for all the
nitroimidazole compounds. Plasma samples are extracted with acetonitrile, and NaCl
is added to help remove matrix contaminants. The acetonitrile extract undergoes a
liquid-liquid wash step with hexane; it is then evaporated and reconstituted in mobile
phase. The reconstituted samples are analysed by liquid chromatography tandem
mass spectrometry (LC-MS/MS). The decision limits (CC range from 0.5-1.6 ng
mL-1 and the detection capabilities (CC, range from 0.8-2.6ng mL-1. The results of
the inter-assay study, which was performed by fortifying bovine plasma samples (n =
18) on three separate days, show the accuracy calculated for the various analytes
range between 101-108%. The precision of the method, expressed as CV% values for
the inter-assay variation of each analyte at the three levels of fortification (3, 4.5 and
6.0 ng mL-1), ranged between 4.9-15.2%. A Day 4 analysis was carried out to
examine species variances in animals such as avian, ovine, porcine and equine.
Keywords: Nitroimidazoles; Method Validation; Liquid Chromatography- tandem
Mass Spectrometry; Plasma
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Introduction

Nitroimidazoles are imidazole heterocycles with a nitrogen group incorporated in the
structure. Examples of these compounds are metronidazole (1-(2-hydroxyethyl)-2methyl-5-nitroimidazole, MNZ), dimetridazole (1, 2-dimethyl-5-nitroimidazole
DMZ), ronidazole (1-methyl-2-[(carbamoyloxy) methyl]-5-nitroimidazole, RNZ),
ipronidazole

(2-isopropyl-1-methyl-5-nitroimidazole,

ethylcarbamothioic

acid

O-methyl

IPZ),

carnidazole

ester)-2-methyl-5-nitroimidazole,

(1-(2CNZ),

ornidazole (1-(3-chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole, ONZ) and
ternidazole (2-Methyl-5-nitroimidazole-1-propanol; 3-(2-Methyl-5-nitroimidazol-1yl)propan-1-ol, TRZ). These examples are known as 5-nitroimidazoles as they
contain a NO 2 group on the 5th position on its ring which is seen in Figure 3-1 and
Figure 3-2.
These compounds are metabolised in bovine, porcine and avian species [Mottier et

al., 2006]. The main metabolite of DMZ, IPZ and MNZ results from the oxidation of
the side chain in the C-2 position of the imidazole ring to form hydroxy metabolites.
RNZ has a different degradation pathway but results in an identical metabolite to that
of DMZ [Mottier et al., 2006]. These metabolites are HMMNI (2-hydroxymethyl-1methyl-5-nitroimidazole),

MNZ-OH

(1-(2-hydroxyethyl)-2-hydroxymethyl-5-

nitroimidazole) and IPZ-OH (1-methyl-2-(2′-hydroxyisopropyl)-5-nitroimidazole).
Structures of the nitroimidazole compounds and their metabolites are shown in
Figure 3-1.
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5-Nitroimidazole Compounds

Metabolites

Dimetridazole
HMMNI

Ronidazole

Metronidazole

Ipronidazole

MNZ-OH

IPZ-OH

Figure 3-1: Chemical Structures of CRL Suggested Compounds and Metabolites
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Carnidazole

Ornidazole

Ternidazole

Figure 3-2: Chemical Structures of Three other 5-nitroimidazoles that the method can analyze
for.

These compounds can be used for the prophylactic and therapeutic treatments of
diseases such as histominiasis and coccidiosis in poultry, genital tricchoniasis in
cattle and hemorrhagic enteritis in pigs. They are believed to be carcinogenic and
mutagenic to humans and as a consequence were banned for the use in food
producing animals within the European Union under Regulation 2377/90. They are
also banned for use in the U.S.A and China [Xia et al., 2007]. The analysis of these
compounds is required under Council Directive 96/23/EC.
As a result of this ban, there is a need for rapid multi-residue analytical methods that
have the capability of including a wide range of these analytes in order to ensure
compliance with legislation. Previously the analysis of these compounds was carried
out in liver and muscle [Xia et al., 2007; Polzer et al., 2001] but studies on the
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stability and homogeneity of nitroimidazoles in incurred muscle [Polzer et al., 2004;
Polzer et al., 2005] show that there is not a homogenous distribution of analyte in
turkey muscle and also there is a rapid reduction in analyte concentration in muscle
stored for prolonged periods above 4 °C. In contrast it was discovered that for
plasma, retina and egg samples the analytes were stable during storage under the
same conditions which resulted in constant concentrations and allowed detection of
these compounds for longer periods after medication had been halted. Therefore,
plasma, retina and eggs have been recommended as target matrices for the residue
control of nitroimidazoles [Polzer et al., 2004; Polzer et al., 2005]. Current methods
that are used for the analysis of these compounds are limited to the analysis of at
most seven nitroimidazole compounds [Mottier et al., 2006, Sun et al. 2007], but the
majority analyse for fewer [Xia et al., 2006; Polzer et al., 2001; Fraselle et al., 2007
Wang, 2001; Capitan-Vallvey et al., 2002; Hurtaud-Pessel et al., 2000; Ho et al.,
2005; Ding et al., 2006; Mortier et al., 2003; Thompson et al., 2009]. These methods
use varied extraction protocols including the use of acetonitrile [Mottier et al., 2006]
or ethyl acetate [Xia et al., 2006; Sun et al. 2007] as extraction solvent. In some
cases the samples were extracted using a buffer of NaCl/KH2PO4 with protease and
adjusting the pH to 3 with 25% HCl [Fraselle et al., 2007; Polzer et al., 2001]. This
was performed as it was believed that nitroimidazole compounds may be protein
bound.
The majority of these current methods then employ a solid phase extraction step
(SPE) in order to clean up their extract. [Mottier et al., 2006; Xia et al., 2007; Xia et

al., 2006; Polzer et al., 2001; Polzer et al., 2004; Polzer et al., 2005; Fraselle et al.,
2007; Sun et al. 2007] and methods that do not employ SPE [Ding et al., 2006;
Mortier et al., 2003] were not used to analyse plasma. Various techniques have been
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used for the analysis of these compounds such as HPLC-UV [Sun et al. 2007] and
GC-MS/MS [Polzer et al., 2001; Ho et al., 2005]. The use of GC-MS/MS limits the
number of analytes that can be analysed due to problems arising from derivatisation,
due to the fact that HMMNI and RNZ form the same derivatisation products [Xia et

al., 2007]. Presently more methods are now being developed for this analysis by LCMS/MS which allow for a greater number of analytes being analysed [Mottier et al.,
2006; Xia et al., 2007; Xia et al., 2006; Capitan-Vallvey et al., 2002]. This
overcomes the problem of derivatisation and allows for quicker run times.
From examination of published literature no method was found that was capable of
analysing the ten nitroimidazoles listed in this paper. The sample preparation
described in this study is more efficient than previously published methods due to the
absence of a SPE step. In previous studies a deconjugation step was utilised by
addition of either a protease or an acid to deconjugate possible protein bound
residues. In this study it was found that this step was not necessary by investigation
of incurred samples of plasma received from the Community Reference Laboratory
(CRL) in Berlin. A recently published method also omits this deproteination step
[Thompson et al., 2009].
A rapid, sensitive and specific multi-residue method for the detection and
confirmation of a wide variety of nitroimidazoles in plasma has been developed and
validated in accordance with CD 2002/657/EC. A recommended level (RL) for
MNZ, DMZ and RNZ of 3 ng mL-1 has been proposed by the CRL hence this was
used in validating these three compounds. This RL was also applied to the remaining
seven compounds for which no RL has been proposed. During validation, all
compounds were analysed in a single chromatographic run at 1, 1.5 and 2 times the
RL (3 ng mL-1) with six replicates at each level. Selectivity, linearity, recovery,
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accuracy and precision were established and values for CCα and CCβ were
determined.

3.3

Experimental

3.3.1 Materials and reagents
All analytical standards of nitroimidazoles, including deuterated substances were
provided by the CRL (BVL, Berlin, Germany) except HMMNI, MNZ-OH, HMMNId3, MNZ-OH-d2, DMZ- d3 and RNZ -d3 (all from WITEGA Laboratorien Berlin,
Germany), RNZ (Sigma, St. Louis, MO, USA) and DMZ (Fluka, St. Louis, MO,
USA). Water LC-MS grade (Fluka, St. Louis, MO, USA). Methanol, Acetonitrile
and Hexane HPLC Grade (Reagecon, Clare, Ireland). Sodium Chloride was AnalaR
grade (VWR, Poole, England). Individual stock standards at 1mg mL-1 in ethanol
were prepared and are stored at 4ºC for 1 year. Individual intermediate standard
solutions (10 and 1µg mL-1) in methanol were prepared and working standard
solutions (mixture of (dueterated) nitroimidazoles) (200 and 500ng mL-1) were
prepared in methanol and are stored at 4ºC for 3 months.

3.3.2

LC-MS/MS Instrumentation

The LC-MS/MS system is a TSQ Quantum Ultra EMR coupled to a Finnigan
Surveyor LC system (Thermo Fisher, Waltham, MA, USA). The instrument is
controlled by Xcalibur software (Version 1.4). Separation was achieved using a (100
 2)mm, 3m particle size, Luna C18 column (Part No. 00D-4251-B0) protected by
a Security Guard guard cartridge system (202)mm, both supplied by Phenomenex
(Torrance, California, USA). The oven temperature was set at 40ºC. The
chromatographic separation performed on gradient mode using water acidified with
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0.1% acetic acid (mobile phase A) and acetonitrile acidified with 0.1% acetic acid
(mobile phase B), at a flow of 0.25mL min-1. The initial conditions (0-4min) were
95% A. Then the conditions changed to 5% A (4-7min) and these were maintained
until 9 min, the conditions returned to 95% A in 3min (9-12min), and were
maintained until the end of the run at 20min. The ionisation used was positive
electrospray ionisation (ESI) mode with a spray voltage of 4350V. The individual
MRMs with their respective collision energies are listed in Table 3-1.

3.3.3 Plasma samples
Bovine, porcine, ovine, avian and equine plasma was obtained from local abattoirs
and stored at –20 C in polypropylene centrifuge tubes (50mL). Samples of this
plasma were analysed and those found to contain no detectable residues of the
analytes of interest were used as negative controls. Chromatograms of blank plasma
are seen in Figure 3-3.

3.3.4 Sample extraction and clean-up
Bovine plasma (5mL) was pipetted into polypropylene centrifuge tubes (50mL).
These were fortified with mixed internal standard (50 µL of 200 ng mL-1) which
corresponded to 2 ng mL-1. Samples were fortified at 3, 4.5 and 6 ng mL-1 by adding
mix working standard solution (30, 45 and 60 L portions of 500 ng mL-1) and these
were vortexed (20secs). Acetonitrile (10mL) was added and vortexed. NaCl (2g) was
added to this slurry which was then centrifuged (4500 rpm for 10min). The top
organic layer from each sample was then transferred to polypropylene tubes (15mL)
and evaporated (60ºC) to 6mL under nitrogen. Hexane (5mL) was added and the
tubes were then vortexed (30secs). The hexane layers were discarded and the extracts
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were evaporated to dryness under the same conditions. The extracts were
reconstituted in Water: Acetonitrile (95:5, 200µL) and filtered through 0.2µm
syringe filters. An aliquot (20µL) was injected onto the LC column. Chromatogram
of a 2.5ng mL-1 fortified plasma sample is seen in Figure 3-4.

Table 3-1: Parent/Daughters fragmentations and corresponding collision
energies.
Nitroimidazole Parent/Daughter Collision Energies
Compound

Parent Ion

DMZ

142.2

MNZ

RNZ

IPZ

HMMNI

MNZ-OH

IPZ-OH

ORZ

TRZ

CRZ

Daughter Ions

Collision Energies

96.4

18

81.4

28

82.5

25

128.2

15

140.1

15

55.7

20

110.3

18

124.3

18

109.4

25

140.2

13

55.7

18

110.3

15

123.2

16

126.2

17

168.1

14

122.3

21

128.2

17

82.4

33

128.2

17

82.5

28

111.3

25

118.2

13

75.3

33

172.0

201.2

170.0

158.2

188.2

186.0

220.0

186.0

245.0
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Figure 3-3: Chromatograms of Blank Bovine Plasma (the arrow points out the expected
retention time of each compound).
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Figure 3-4: Chromatograms for the ten nitroimidazole compounds fortified at 2.5ug mL-1

3.3.5 Matrix-Matched Calibration
Bovine matrix matched calibration curves were prepared and used for quantification.
Control plasma was prepared as above (2.4). One control plasma sample was used
for each calibration standard level. Plasma samples (5mL) were pipetted into
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polypropylene tubes (50mL). Samples were fortified with mixed internal standard
(50 L of 200 ng mL-1) at a level corresponding to 2 ng mL-1. Samples were fortified
at 0, 2.5, 5, 7.5, 10 and 20ng mL-1 by adding mixed working standard solution (0, 25,
50, 75, 100 and 200 l aliquots of a 500 ng mL-1).
Six deuterated internal standards are used; d3-DMZ, d3-RNZ, d3-HMMNI, d2MNZ-OH, d3-IPZ and d3-IPZ-OH. For compounds with no deuterated form i.e.
MNZ, TRZ, ORZ and CRZ, d3-HMMNI is used as internal standard.

3.3.6 Method validation
For estimation of accuracy, blank bovine plasma samples were fortified with each
analyte at 3.0, 4.5 and 6.0ng mL-1. Six replicate test portions at each of the three
fortification levels (18) were analysed on three separate days over a period of two
weeks. To determine any matrix effects caused by biological variations arising from
plasma from different species (bovine, ovine, porcine, avian and equine), a fourth
day analysis was carried out. Two sets of ten plasma samples (two of each species)
were analysed as in section 2.4. The first set was fortified with only internal standard,
and the second set was fortified with both internal standard and with the analytes at a
concentration equivalent to 4.5ng mL-1. The estimation of precision, intra-assay and
inter-assay repeatability of the method were calculated along with CCand CC
Absolute recovery was determined by analysing five replica plasma samples fortified
at 3.0ng mL-1 prior to extraction and five replica plasma samples fortified at the
equivalent concentration after extraction.
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Results and Discussion

3.4.1 Preliminary experiments
The LC-MS/MS method was developed to provide confirmatory data for the analysis
of 10 nitroimidazoles in plasma. The MS/MS fragmentation conditions were
investigated and collision energies were optimised for each individual compound to
give best response. For a method to be deemed confirmatory under CD 2002/657/EC
it must yield 4 identification points. In this method a precursor ion (parent mass) and
two daughter ions (corresponding to strong and weak ion) are monitored for each
analyte (Table 3-1). This yields 4 identification points (1 for the parent ion and 1.5
for each daughter ion) hence it can be deemed a confirmatory method. When the
MS/MS fragmentation conditions for HMMNI were optimised it was seen that the
background noise was very high in its strong daughter ion. This was investigated
further and it was found that the use of the laboratory’s 18.2 MΩ water supply in the
mobile phase was producing the high background. This problem was overcome by
the use of LC-MS/MS grade water in the mobile phase.
From previous work carried out on these compounds it was seen that acetonitrile can
be used as a suitable extraction solvent [Mottier et al., 2006]. Various extraction
procedures were examined. Double extractions are common practice in sample
preparation but this in turn leads to an increased amount of solvent being used. Tests
were carried out to see if this double extraction was necessary in the case of this
procedure. Results were compared between a single and double extraction. These
showed that recoveries were not significantly improved with the use of a double
extraction therefore a single extraction of 10mL would suffice.
Past work carried out on nitroimidazoles showed that the addition of NaCl helped to
remove impurities [Mottier et al., 2006; Xia et al., 2006]. In order to investigate at
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which stage the NaCl should be added to yield the cleanest extract various
experiments were performed. It was found that the addition of NaCl (2g) directly
after addition of acetonitrile allowed for greater purification and produced a cleaner
sample for analysis.
SPE is widely used as a sample clean-up method. Cartridges of extrelute NT20
[Polzer et al., 2004], Oasis MCX [Xia et al., 2007], SCX [Sun et al., 2007] and HLB
[Capitan-Vallvey et al., 2002], have been used in methods for the analysis of
nitroimidazoles. With advances in LC-MSMS and its ability to perform Multi
Reaction Monitoring (MRM) for compounds, which greatly reduces the effect of
matrix interferences, the need for SPE is reduced. As a result it was found that
addition of a quick liquid-liquid wash step was sufficient to remove an adequate
amount of interferences and this in turn allows for quicker sample preparation times.
Hexane was used in previous work carried out on these compounds [Mottier et al.,
2006; Xia et al., 2007] to help remove impurities, therefore the use of hexane as a
liquid-liquid wash solvent was investigated in order to improve sample clean up.
Hexane with varying amounts of ethyl acetate (0%, 2%, 5% and 10%) was used as
the wash solvent. Ethyl acetate was added to help remove more polar impurities.
Results concluded that the addition of this in any percentage gave poorer recoveries
for some of the compounds due to the higher polarity of ethyl acetate. As a result
hexane was chosen for the wash solvent. Samples were filtered before injection to
remove any remaining impurities. Different types of syringe filters with varying pore
sizes and various packing including PVDF, PTFE and Nylon filters were tested.
Decreased analyte recovery was observed when using the PTFE and Nylon filters.
Samples were cleaner when 0.25µm sized filters were used compared with 0.45µm.
As a result 0.25µm PVDF syringe filters were chosen.
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3.4.2 Validation study
As part of the validation study, various experimental parameters were determined.
These included specificity, linearity, accuracy, absolute recovery, repeatability, CC,
CC and measurement of uncertainty. These parameters were determined in
accordance with guidelines described in CD 2002/657/EC. In order to further
demonstrate the applicability of the developed method analysis of incurred test
material was also performed.

Table 3-2: Validation results of % CV, Accuracy, Absolute Recovery, CCα, CCβ, Measure of
Uncertainty and Linearity.

CV

Accuracy

CCα

CCβ

MU

Linearity

%

%

Recovery % µg L-1

µg L-1

%

R2

Metronidazole

4.9

106.6

50.4

0.52

0.89

50.4

>0.990

MNZ-OH

6.3

105.8

61.8

0.53

0.91

24.0

>0.990

Dimetridazole

6.1

101.8

61.4

0.58

0.99

22.8

>0.990

Ronidazole

5.6

101.5

67.5

0.60

1.02

23.5

>0.990

HMMNI

4.5

101.4

68.5

0.57

0.98

31.4

>0.990

Ipronidazole

15.1

103.5

71.8

1.49

2.54

54.4

>0.990

IPZ-OH

5.5

101.2

72.7

0.55

0.94

23.8

>0.990

Ternidazole

5.8

106.5

71.1

0.57

0.97

36.8

>0.990

Ornidazole

9.3

108.0

66.9

1.11

1.89

51.9

>0.990

Carnidazole

13.2

108.8

60.5

1.52

2.60

67.8

>0.990

Analytes

Absolute

3.4.2.1. Specificity
The technique of LC-MS/MS itself offers a high degree of selectivity and specificity
due to its ability to operate in multi reaction monitoring mode (MRM), which greatly
reduces the effect of matrix interferences. On each of the four occasions when
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validation was performed no interfering peaks were observed at the retention time for
any of the transitions. This allowed for clear identification and quantification of all
analytes.

3.4.2.2. Linearity of the Response
Calibration curves were prepared by plotting the response factor (analyte peak
area/internal standard peak area) as a function of analyte concentration (0 to 20 ng
mL-1). The regression coefficients (r2) for all the calibration curves used in this study
were  0.990. This showed that these analytes have a good fit to linearity within this
range.

3.4.2.3. Absolute Recovery
Absolute recovery was calculated by determining concentration of samples fortified
before extraction and dividing by the concentration of samples fortified after
extraction and expressing this result as a percentage. Absolute recoveries were in the
range of 50.4-72.7% (Table 3-2). These values fall within acceptable ranges.

3.4.2.4. Accuracy
CD 2002/657 states that accuracy should be between 70-110%. The mean corrected
accuracy (n = 6) of the analytes were found by experiment to lie between 101% and
109 % for all analytes (Table 3-2) and therefore are acceptable.

3.4.2.5. Repeatability
Inter assay precision (CV %) should be as low as reasonably possible as the method
works in the ng mL-1 range. Values for CV % in range of 4.5-15.1% were achieved
for all compounds (Table 3-2). The main reason for the excellent precision
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demonstrated here can be attributed to the availability of six deuterated analogues of
the compounds being examined. Deuterated internal analogues were not available for
metronidazole, ternidazole, carnidazole, ornidazole. For these analytes d3-HMMNI
was used as the corresponding internal standard and corrected well for any losses or
matrix suppression.

3.4.2.6. CC and CC
CC is defined as the limit above which it can be concluded with an error probability
of , that a sample contains the analyte. For prohibited substances an value equal
to 1 % is applied. CC is the smallest content of the substance that may be detected,
identified and quantified in a sample, with a statistical certainty of 1-, where
 CC and CC were calculated using the calibration curve procedure
according to ISO 11843. After identification, the signal is plotted against the added
concentration. The corresponding concentration at the y-intercept plus 2.33 times the
standard deviation of the within-laboratory reproducibility of the intercept equals the
CC. CC values of for all 10 compounds are listed in Table 3-2 and are all below
1.52 ng mL-1. CC is the concentration corresponding to the signal at CC + 1.64
times the standard error of the intercept (i.e. the intercept + 3.97 times that standard
error of the intercept). CC values for all 10 compounds are listed in Table 3-2 and
are all below the RL of 3ng mL-1.

3.4.2.7. Measurement of Uncertainty
The measurement of uncertainty was estimated by taking into account the
within laboratory reproducibility over days 1, 2 and 3 as well as considering the
repeatability on day 4 due to matrix effects caused by different species. These two
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variability’s were combined and multiplied by a coverage factor of three to give
an overall figure for the MU. This approach of using the within laboratory
reproducibility as a good estimator of measurement of uncertainty is taken from the
SANCO/2004/2726rev4 document. It recommends using the within laboratory
reproducibility and using a coverage factor of 2.33 to estimate expanded uncertainty,
however as it was felt that not all the environmental and other factors that could
be varied over the course of the validation were examined, hence a coverage
factor of 2.33 may underestimate the true uncertainty of the method. So a value of 3
was chosen instead to give a more realistic value for the true uncertainty.
Values for MU are seen in Table 3-2 and lie between 20 and 70%. High MU values
are seen for MNZ, CNZ and ORZ as they have no deuterated analogue to use as an
internal standard. These values are increased further due to a high value for
reproducibility due to matrix as a result of a high biological variation between
species (day 4). A high value is also observed for IPZ especially in day 1 due to
insufficient data points across its short peak width. The dwell time for this compound
was altered and results improved on day 2 and 3.

3.4.2.8. Evaluation
In order to evaluate this method two incurred samples were analysed. The samples
were lyophilised plasma and were obtained from the CRL for nitroimidazoles in
Berlin. One contained high levels of nitroimidazoles and the other contained lower
levels. The results achieved from using the method are seen in Table 3-3 and when
compared with the set values all but one lie well within the measurement uncertainty
for each analyte. Exception is MNZ-OH in the V08G0247 sample where the result
achieved was above the value stated by the CRL. Taken into consideration if the
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CRL’s measurement uncertainty was placed on their result the ranges of both labs
would overlap.
Table 3-3: Results achieved using method, of two incurred plasma samples.
SAMPLE:

Compound

V08G0246
Actual Amt

Calculated Amt

(ng mL-1)

(ng mL-1)

RANGE
MU(%)

MU of Cal
Amt*

Upper

Lower

MNZ-OH

4.55

4.643

24.04

1.116

5.759

3.527

HMMNI

1.71

1.357

31.35

0.425

1.782

0.932

Metronidazole

1.48

1.198

50.42

0.604

1.802

0.594

Ronidazole

2.33

1.789

23.5

0.420

2.209

1.369

IPZ-OH

1.69

1.435

23.78

0.341

1.776

1.094

SAMPLE:

V08G0247
RANGE

Compound

Actual Amt

Calculated Amt

(ng mL-1)

(ng mL-1)

MU(%)

MU of
Cal

Upper

Lower

Amt*
MNZ-OH

2.02

2.707

24.04

0.651

3.358

2.056

HMMNI

0.66

0.787

31.35

0.247

1.034

0.540

Metronidazole

0.6

0.672

50.42

0.339

1.011

0.333

Ronidazole

0.94

1.109

23.5

0.261

1.370

0.848

IPZ-OH

0.66

0.551

23.78

0.131

0.682

0.420

* MU calculated on result achieved by method.

3.5

Conclusions

A multi-residue confirmatory method has been developed that simultaneously
identifies, confirms and quantifies ten nitroimidazole compounds in plasma by LCMS/MS. It can be considered as a rapid method, as the only clean-up step required is
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a hexane wash. The method also has a short chromatographic run time of only 20
minutes for each sample.
The method includes 10 nitroimidazole compounds including seven that are
suggested by the CRL in Berlin to be analysed. In addition other nitroimidazoles that
haven’t been analysed previously such as Ornidazole and Carnidazole are included.
The obtained data fulfils the requirements laid down in CD 2002/657/EC and allows
the calculation of all relevant performance characteristics. This study shows that the
developed method meets the required sensitivity of 3ng mL-1 which is the RL used
for these compounds. The CC and CC values determined for each analyte are
lower than this level. The method performs very well in terms of accuracy and
repeatability for each of the analytes due to the utilisation of six different deuterated
internal standards. The values achieved for % accuracy, CV % and MU all fall within
acceptable ranges. The applicability of the method for use on different types of
plasma was demonstrated by the satisfactory results obtained from the Day 4 analysis
of different species.
The reduced number of analytical steps within the method makes it very amenable
for high through-put regulatory monitoring of these compounds. The objective of the
work to develop a rapid confirmatory method capable of monitoring for these
residues in plasma at ng mL-1 levels and validate according to the requirements in
CD 2002/657/EC therefore has been achieved successfully.
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Abstract

A rapid confirmatory method has been developed and validated for the simultaneous
identification, confirmation and quantitation of eleven nitroimidazoles in eggs by
liquid chromatography tandem mass spectrometry (LC-MS/MS). The method is
validated in accordance with Commission Decision 2002/657/EC and is capable of
analysing Metronidazole (MNZ), Dimetridazole (DMZ), Ronidazole (RNZ),
Ipronidazole

(IPZ)

and

their

hydroxy

metabolites

MNZ-OH,

HMMNI

(Hydroxymethyl, Methyl Nitroimidazole), IPZ-OH. The method is also capable of
analysing Carnidazole (CRZ), Ornidazole (ORZ), Tinidazole (TNZ) and Ternidazole
(TRZ). MNZ, DMZ and RNZ have been assigned a Recommended Level (RL) of 3
µg kg-1 by the Community Reference Lab (CRL) in Berlin. The developed method
described in this study is easily able to detect all the nitroimidazole compounds
investigated at this level and below. Egg samples are extracted with acetonitrile, and
NaCl is added to help remove matrix contaminants. The acetonitrile extract
undergoes a liquid-liquid wash step with hexane; it is then evaporated and
reconstituted in mobile phase. The reconstituted samples are analysed by liquid
chromatography tandem mass spectrometry (LC-MS/MS). The decision limits (CC
range from 0.33-1.26 µg kg-1 and the detection capabilities (CC, range from 0.562.15 µg kg-1. The results of the inter-assay study, which was performed by fortifying
hen egg samples (n = 18) on three separate days, show the accuracy calculated for
the various analytes to range between 87.2-106.2%. The precision of the method,
expressed as %CV values for the inter-assay variation of each analyte at the three
levels of fortification (3, 4.5 and 6.0 µg kg-1), ranged between 3.7-11.3%. A Day 4
analysis was carried out to examine species variances in eggs from different birds
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such as duck and quail and investigating differences in various battery and free range
hen eggs.
Keywords: Nitroimidazoles; Method Validation; Liquid Chromatography- tandem
Mass Spectrometry; Egg.

4.2

Introduction

Nitroimidazoles are imidazole heterocycles with a nitrogen group incorporated in the
structure. Examples of these compounds are metronidazole (MNZ), dimetridazole
(DMZ), ronidazole (RNZ), ipronidazole (IPZ), carnidazole (CNZ), ornidazole
(ONZ), tinidazole (TNZ) and ternidazole (TRZ). These examples are known as 5nitroimidazoles as they contain a NO 2 group on the 5th position on its ring which can
be seen in figures 4-1.
Nitroimidazoles are extensively metabolised in avian, bovine and porcine species
[Mottier et al., 2006]. The main metabolites of DMZ, IPZ and MNZ result from the
oxidation of the side chain in the C-2 position of the imidazole ring to form hydroxy
metabolites. RNZ has a different degradation pathway but results in an identical
metabolite to that of DMZ [Mottier et al., 2006]. These metabolites are HMMNI,
MNZ-OH and IPZ-OH. Structures of these metabolites are shown in figure 4-1.
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Dimetridazole
(1, 2-dimethyl-5-nitroimidazole)
HMMNI
(2-hydroxymethyl-1methyl-5-nitroimidazole)

Ronidazole
(1-methyl-2-[(carbamoyloxy)
methyl]-5-nitroimidazole)

Metronidazole
(1-(2-hydroxyethyl)-2-methyl
-5-nitroimidazole)

Ipronidazole
(2-isopropyl-1-methyl-5nitroimidazole)

MNZ-OH
(1-(2-hydroxyethyl)-2hydroxymethyl-5-nitroimidazole)

IPZ-OH
(1-methyl-2-(2′-hydroxyisopropyl)5-nitroimidazole)
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Carnidazole
(1-(2-ethylcarbamothioic acid O-methyl ester)
-2-methyl-5-nitroimidazole)

Ternidazole
2-Methyl-5-nitroimidazole-1propanol; 3-(2-Methyl-5-

Nitroimidazoles in Eggs

Ornidazole
(1-(3-chloro-2-hydroxypropyl)2-methyl-5-nitroimidazole)

Tinidazole
1-(2-ethylsulfonylethyl)-2methyl-5-nitro-imidazole

N
O N
2

N

SO2
Figure 4-1: Chemical Structures of Nitroimidazole Compounds and Metabolites

These 5-nitroimidazoles are very effective for the prophylactic and therapeutic
treatments of diseases such as histominiasis and coocidiosis in poultry, genital
tricchoniasis in cattle and hemorrhagic enteritis in pigs. However these compounds
are now suspected to be carcinogenic and mutagenic to humans and as a consequence
were banned for the use in food producing animals within the European Union under
Regulation 2377/90. They are also banned for use in the U.S.A and China [Xia et al.,
2007]. The analysis of these compounds is required under Council Directive
96/23/EC.
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As the use of these substances are prohibited and food containing residues of these
compounds may be dangerous to the consumer, there is a need for rapid multi residue
analytical methods that have the capability of analysing a wide range of these
analytes in order to ensure compliance with legislation. Previously, analysis of these
compounds focused on liver and muscle [Xia et al., 2007; Polzer et al., 2001].
However studies on the stability and homogeneity of nitroimidazoles in incurred
poultry muscle [Polzer et al., 2004; Polzer et al., 2005] show that there is not a
homogenous distribution of the analyte(s) in turkey muscle and also there is a rapid
degradation in analyte concentration in muscle stored for prolonged periods above
4 °C. In contrast it was demonstrated that for egg, plasma and retina samples; the
analytes are stable during storage under the same conditions as the muscle samples
and as a result concentrations are stable allowing detection of these compounds for
longer periods after medication had ceased. Therefore, egg, plasma and retina have
been recommended as target matrices for the residue control of nitroimidazoles
[Polzer et al., 2004; Polzer et al., 2005]. Current methods used for the analysis of
nitroimidazoles in any matrix are limited to the analysis of at most seven
nitroimidazole compounds [Mottier et al., 2006; Sun et al., 2007], but the majority
analyse for fewer [Xia et al., 2006; Polzer et al., 2001; Fraselle et al., 2007 Wang,
2001; Capitan-Vallvey et al., 2002; Hurtaud-Pessel et al., 2000; Ho et al., 2005;
Ding et al., 2006; Mortier et al., 2003; Thompson et al., 2009]. These methods use,
varied extraction protocols including the use of acetonitrile [Mottier et al., 2006] or
ethyl acetate [Xia et al., 2006; Sun et al. 2007]. In some cases the samples are
extracted using a buffer of NaCl/KH2PO4 with protease and adjusting the pH to 3
with 25% HCl [Fraselle et al., 2007; Polzer et al., 2001]. This was performed as it
was believed that nitroimidazole compounds may be protein bound.
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The majority of these current methods then employ a solid phase extraction step
(SPE) in order to purify the extract [Mottier et al., 2006; Xia et al., 2007; Xia et al.,
2006; Polzer et al., 2001; Polzer et al., 2004; Polzer et al., 2005; Fraselle et al., 2007;
Sun et al. 2007] and of the methods that do not employ SPE [Ding et al., 2006; Xia

et al., 2006] only one was used to analyse eggs [Xia et al., 2006]. Various techniques
have been used for the determination of these compounds such as HPLC-UV [Sun et

al. 2007] and GC-MS/MS [Polzer et al., 2001; Ho et al., 2005]. The use of GCMS/MS limits the number of analytes that can be analysed due to problems arising
from derivatisation, such as the fact that HMMNI and RNZ form the same
derivatization products [Xia et al., 2007]. Presently more methods are being
developed for this analysis by LC-MS/MS which allow for a greater number of
analytes to be analysed [Mottier et al., 2006; Xia et al., 2007; Xia et al., 2006;
Capitan-Vallvey et al., 2002]. This overcomes the problem of derivatisation and
allows for quicker analysis times.
From the aforementioned papers it is clear that the analysis of egg as a target matrix
for nitroimidazole [Polzer et al., 2004; Polzer et al., 2005] has been overlooked.
From examining published literature, only three methods were found that were
capable of analyzing nitroimidazoles in eggs. [Mottier et al., 2006; Xia et al., 2006;
Mohamed et al., 2008]. These methods are limited to at most the analysis of seven
analytes. The method described by Xia et al. while rapid only analyses four
compounds while the methods by Mottier et al., 2006 and Mohamed et al., 2008
analyse seven compounds but they incorporate time consuming SPE clean-ups in
there methods.
From examination of published literature no method was found that was capable of
the thorough analysis of eleven nitroimidazoles listed in this paper. The sample
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preparation described in this study is more efficient than previously published
methods due to the absence of a SPE step. In previous studies a deconjugation step
was utilised by addition of either a protease or an acid to deconjugate possible
protein bound residues. Newer methods [Thompson et al., 2009] are now omitting
this step and in this paper an incurred sample is tested to reinforce this theory.
A rapid, sensitive and specific multi-residue method for the detection and
confirmation of a wide variety of nitroimidazoles in egg has been developed and
validated in accordance with Commission Decision 2002/657/EC. A recommended
level (RL) for MNZ, DMZ and RNZ of 3 µg kg-1 has been proposed by the CRL
hence this was used in validating these three compounds. This RL was also applied
to the remaining eight compounds for which no RL has been proposed. During
validation, all compounds were analysed in a single chromatographic run at 1, 1.5
and 2 times the RL (3 µg kg-1) with six replicates at each level over three separate
days. The validation parameters selectivity, linearity, recovery, accuracy, precision,
measurements of uncertainty as well as decision limits (CCα) capabilities (CCβ)
have been established.

4.3

Experimental

4.3.1 Materials and reagents
MNZ, IPZ, CNZ, TNZ, TRZ, ORZ, IPZ-OH were provided by the CRL (BVL,
Berlin, Germany). HMMNI, MNZ-OH, HMMNI-d3, MNZ-OH-d2, DMZ- d3 and
RNZ -d3 (all from WITEGA Laboratorien Berlin), RNZ (Sigma) and DMZ (Reidelde-Haen). Water is of LC-MS grade quality (Reidel-de-Haen). All other solvents
were of LC quality and purchased from Reagecon (Clare, Ireland). Sodium Chloride
was AnalaR grade and purchased from VWR (Poole, England). Individual stock
111

Chapter 4

Nitroimidazoles in Eggs

standards at 1mg mL-1 in ethanol were prepared and stored at 4ºC for 1 year.
Individual intermediate standard solutions (10 and 1 µg mL-1) in methanol were
prepared and working standard solutions (mixture of nitroimidazoles) (500 ng mL-1)
were prepared in methanol and stored at 4ºC for 3 months. Deuterated standards were
prepared similarly except mixed standard was 200 ng mL-1.

4.3.2 LC-MSMS Instrumentation
The LC-MS/MS system is a TSQ Quantum Ultra EMR coupled to a Finnigan
Surveyor LC system. The instrument is controlled by Xcalibur software (Version
1.4). Separation was achieved using a (100  2) mm, 3 m particle size, Luna C18
column (Part No. 00D-4251-B0) protected by a Security Guard guard cartridge
system (202) mm, both supplied by Phenomenex. The oven temperature was set at
40 ºC. The chromatographic separation performed on gradient mode using water
acidified with 0.1% acetic acid (mobile phase A) and acetonitrile acidified with 0.1%
acetic acid (mobile phase B), at a flow of 0.25 mL min-1. The initial conditions (0-4
min) were 95% A. Then the conditions changed to 5% A (4-7 min) and these were
maintained until 9 min, the conditions returned to 95% A in 3 min (9-12 min), and
were maintained until the end of the run at 20 min. The ionisation mode used was
positive electrospray ionisation (ESI) mode with a spray voltage of 4350 V. The
individual MRMs with there respective collision energies are listed in Table 4-1.
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Table 4-1: MS/MS parent daughter fragmentation and Collision energies.

Nitroimidazole Parent/Daughter Collision Energies
Parent

Daughters

Collision Energies

m/z

m/z

(eV)

96.4

18

81.4

28

82.5

25

128.2

15

140.1

15

55.7

20

124.3

18

109.4

25

140.2

13

55.7

18

123.2

16

126.2

17

168.1

14

122.3

21

128.2

17

82.4

33

128.2

17

82.5

28

118.2

13

75.3

33

121.2

18

202.0

15

Compound

DMZ

MNZ

RNZ

IPZ

HMMNI

MNZ-OH

IPZ-OH

ORZ

TRZ

CRZ

TNZ

142.2

172.0

201.2

170.0

158.2

188.2

186.0

220.0

186.0

245.0

248.0
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4.3.3 Egg samples
Egg was obtained from local shops, homogenised and stored at –20 C in
polypropylene centrifuge tubes (50 mL). Samples of theses egg were analysed and
those found to contain no detectable residues of the analytes of interest were used as
blank egg. Chromatograms of blank egg are seen in figure 4-2.

4.3.4 Sample extraction and clean-up
Egg (3 g) is weighed into a polypropylene centrifuge tubes (50 mL). These are
fortified with mixed internal standard (30 µL) which correspond to 2 µg kg-1.
Samples are fortified at levels corresponding to 3, 4.5 and 6 µg kg-1 by adding mix
working standard containing each analyte (18, 27 and 36 L) and these are vortexed
(20 s). To this acetonitrile (6 mL) is added and the tubes are vortexed. NaCl (1.2 g) is
added to this slurry which is then hand shaken and centrifuged (4350 x g for 10min).
The top organic layer is then transferred to a polypropylene tube (15 mL). Hexane
(3.5 mL) is added and this is vortexed (30 s). The hexane layer is then removed and
the extracts are evaporated to dryness at 60ºC under a nitrogen stream. They are then
reconstituted in 95:5 Water:ACN (200 µL). These are finally filtered through 0.2 µm
PVDF syringe filters. An aliquot (20 µL) is injected onto the LC column.
Chromatogram of a 2.5 µg kg-1 fortified egg sample is shown in figure 4-2.
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Figure 4-2: Chromatograms of all Nitroimidazole Compounds; (a) Fortified at 2.5µg kg-1 and
(b) corresponding blank egg samples.
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4.3.5 Matrix-Matched Calibration
Matrix matched calibration curves were prepared and used for quantification. Blank
egg previously tested and shown to contain no residues was prepared as above. One
blank egg sample was used for each calibration standard level.

Samples were

fortified at levels corresponding to 0, 2.5, 5, 7.5, 10 and 20µg kg-1 by adding mixed
working standard solution (0, 15, 30, 45, 60 and 120 l).
Calibration curves were prepared by plotting the response factor (peak area
analyte/internal standard peak area) as a function of analyte concentration (0 to 20 µg
kg-1). Six deuterated internal standards are used; d3-DMZ, d3-RNZ, d3-HMMNI, d2MNZ-OH, d3-IPZ and d3-IPZ-OH. For compounds with no deuterated form i.e.
MNZ, TRZ, TNZ, ORZ and CRZ, d3-HMMNI is used as internal standard.

4.3.6 Method validation
For estimation of accuracy, blank hen egg samples were fortified with each analyte at
3.0, 4.5 and 6.0 µg kg-1. Six replicate test portions, at each of the three fortification
levels, were analysed. Analysis of the 18 test portions was carried out on three
separate occasions. On a fourth occasion in order to determine any effects caused by
different birds and egg types, 10 different blank samples from various birds were
analysed, these samples consisted of five different sample types i.e. duck eggs, quail
eggs, battery hen eggs, free range hen eggs and eggs containing omega three fatty
acids and vitamin E. The samples were analysed in duplicate, the first were fortified
with only internal standard, and the second set was fortified with both internal
standard and with analytes at a concentration equivalent to 4.5 µg kg-1. For the
estimation of the precision of the method, intra and inter-assay repeatability was
calculated.
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Results and Discussion

4.4.1 Preliminary experiments:The method was developed from an existing method used in the laboratory for the
analysis of nitroimidazoles in plasma [Cronly et al., 2009 (a)] to provide
confirmatory data for the analysis of 11 nitroimidazoles in eggs. The MS/MS
fragmentation conditions were investigated and collision energies were optimised for
each individual compound to give best response. For a method to be deemed
confirmatory under Commission Decision 2002/657/EC it must yield 4 identification
points. In this method a precursor ion (parent mass) and two daughters
(corresponding to strong and weak ion) are monitored for each analyte (Table 4-1).
This yields 4 identification points (1 for the parent ion and 1.5 for each daughter ion)
hence it can be deemed a confirmatory method. In addition to this relative retention
times and ion ratios are tracked for each compound and ensured that they are within
acceptable ranges stated in EC 2002/657.
When the compound HMMNI was optimised it was seen that the background noise
was very high in its strong daughter ion when tuning its standard solution. This was
investigated further and it was found that the use of the laboratory’s 18.2 MΩ water
supply in the mobile phase was producing the high background. This problem was
overcome by the use of LC-MS grade water in the mobile phase.
From previous work carried out on these compounds it was seen that acetonitrile is
an effective extraction solvent [Mottier et al., 2006]. Various extraction procedures
were examined. Double extractions are common practice in sample preparation but
this in turn leads to an increased amount of solvent and time being used. Tests were
carried out to see if this double extraction was necessary. Results were compared
between a single and double extraction. Comparison of double and single extraction
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recoveries only showed an improvement of between 5-7%. This combined with the
fact that the lowest calibration level was easily distinguished above background noise
allowed for a single extraction step of 6ml to be utilised.
Past work carried out on these compounds showed that the addition of NaCl helped
to remove impurities. [Mottier et al., 2006; Xia et al., 2006]. The position at which
NaCl addition gave the cleanest sample was ascertained by investigating whether
addition with or after extraction solvent gave better results. The addition of NaCl (2
g) with extraction solvent allowed for greater impurities to be removed and produced
a cleaner sample for analysis.
SPE is widely used as a sample clean-up method. Cartridges of extrelute NT20
[Polzer et al., 2004], Oasis MCX [Xia et al., 2007], SCX [Sun et al. 2007] and HLB
[Capitan-Vallvey et al., 2002], have been used in methods for the analysis of
nitroimidazoles. Advances in LC-MSMS and its ability to operate in Multi Reaction
Monitoring greatly reduce the effect of matrix interferences hence the need for SPE
is reduced in some applications. As a result it was found that addition of a quick
liquid-liquid wash step was sufficient to remove an adequate amount of interferences
and this in turn allows for quicker sample-preparation times.
Hexane was employed as a wash solvent in prior work carried out on these
compounds [Mottier et al., 2006; Xia et al., 2007] therefore the use of hexane as a
liquid-liquid wash solvent was investigated. Hexane with varying amounts of ethyl
acetate (0%, 2%, 5% and 10%) was used as the wash solvent. Ethyl acetate was
added to help remove more polar impurities but on examination of samples purified
with hexane which contained various amounts of ethyl acetate it was that ethyl
acetate in any percentage gave poorer recoveries for some of the compounds due to
its higher polarity. As a result hexane with no additive was chosen for the wash
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solvent. Samples are filtered before injection to further remove impurities. Various
types and sizes of syringe filters were investigated including PVDF, PTFE and Nylon
filters, losses were noted for some of the analytes with both the PTFE and Nylon
filters. Filtering the samples through 0.25 µm PVDF syringe filters gave the best
results and these were chosen for the study.

4.4.2 Validation study
Validation of the method was carried out according to procedures described in
Commission Decision 2002/657/EC covering specificity, calibration curve linearity,
accuracy, absolute recovery, repeatability, decision limit (CC), detection capability
(CC) and measurement uncertainty. An evaluation of the method was also carried
out by running an incurred sample from FAPAS. Ruggedness is demonstrated on an
ongoing basis through the use of this method for the routine analysis of
nitroimidazoles in eggs as part of the National Residue Control Plan in Ireland.
Routine analysis has been carried out by various analysis and very similar results to
those in validation have been observed. Nitroimidazole standards are stable over
time. The peak areas of the analytes are monitored on an ongoing basis and the
results achieved are consistent for standards stored 4 ºC.
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Table 4-2: Results received from Validation; CV%, Accuracy, Absolute Recovery, CCα, CCβ,
Measurement of Uncertainty and Linearity.

Absolute
CV

Accuracy

%

%

Analytes

CCα

CCβ

MU

Linearity

µg kg-1

µg kg-1

%

R2

Recovery
%

Dimetridazole

4.2

98.0

69

0.43

0.73

28

>0.990

Metronidazole

3.8

106.2

58

0.38

0.64

19

>0.990

Ronidazole

5.6

104.5

72

0.59

1.01

34

>0.990

Ipronidazole

4.7

100.3

70

0.53

0.90

27

>0.990

HMMNI

4.3

99.2

74

0.45

0.78

18

>0.990

MNZ-OH

3.7

102.5

67

0.33

0.56

22

>0.990

IPZ-OH

4.4

100.4

77

0.43

0.73

26

>0.990

Ornidazole

7.8

92.4

77

0.79

1.34

50

>0.990

Ternidazole

4.5

99.6

67

0.41

0.71

19

>0.990

Carnidazole

11.3

87.2

76

1.26

2.15

61

>0.990

Tinidazole

5.1

97.2

72

0.45

0.77

24

>0.990

4.4.2.1. Specificity
The technique of LC-MS/MS itself offers a high degree of selectivity and specificity.
To establish the selectivity/specificity of the method, egg samples were fortified with
the eleven analytes and the internal standards and non-fortified samples were also
analysed. On each of Days 1, 2 and 3 egg samples were examined and on Day 4, 5
different types of egg samples were examined.
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4.4.2.2. Linearity of the Response
The linearity of the chromatographic response was tested with matrix matched curves
using 6 calibration points in the concentration range of 0 to 20µg kg-1. The
regression coefficients (r2) for all the calibration curves used in this study were 
0.990.

4.4.2.3. Absolute Recovery
Absolute recovery was determined by analysing five replica egg samples fortified at
4.5 µg kg-1 before extraction and five replica egg samples fortified at 4.5 µg kg-1 after
extraction and calculating the ratio as a % of one over the other. Results given in table
4-2 lie between 58-77%.

4.4.2.4. Accuracy
The accuracy of the method was determined using egg samples fortified at 3.0, 4.5
and 6.0 µg kg for each analyte. Mean corrected accuracy (n = 6) of the analytes,
determined in four separate assays shown in Table 4-2 was between 87.2% and
106.2% for the 11 analytes.

4.4.2.5. Repeatability
Quite low values for % CV (Table 4-2) were achieved for the majority of
compounds, the main reason for this can be attributed to the availability of six
deuterated analogues of the compounds being examined. For those compounds
without a deuterated analogue namely metronidazole, ternidazole, carnidazole,
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ornidazole and tinidazole; d3-HMMNI is used and corrects quite well for any losses
or matrix suppression of the other compounds.

4.4.2.6. CC and CC
The decision limit (CC) of the method was calculated according to the calibration
curve procedure using the intercept (value of the signal, y, where the concentration, x
is equal to zero) and 2.33 times the standard error of the intercept for a set of data
with 6 replicates at 3 levels (3, 4.5 and 6 µg kg-1). The detection capability (CC)
was calculated by adding 1.64 times the standard error to the CC. Blank egg tissue
was fortified at 1, 1.5 and 2 times the RL of 3µg kg-1 for each analyte; 3µg kg-1 for
each compound has been used for the method validation in this work as this is the RL
suggested by the Community Reference Laboratory (CRL) in Berlin for some of
these analytes. CC is the concentration corresponding to the intercept + 2.33 times
the standard error of the intercept. CC values of for all 11 compounds are listed in
Table 4-2 and are all below 1.52 µg kg-1. CC is the concentration corresponding to
the signal at CC + 1.64 times the standard error of the intercept (i.e. the intercept +
3.97 times that standard error of the intercept). CC values for all 11 compounds are
listed in Table 4-2 and are all below the RL of 3 µg kg-1.

4.4.2.7. Measurement Uncertainty
The measurement of uncertainty was estimated by taking into account the
within laboratory reproducibility over days 1, 2 and 3 as well as considering the
repeatability on day 4 due to matrix effects caused by different egg matrices These
two variabilities were combined and multiplied by a coverage factor of three to
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give an overall figure for the uncertainty of the measurement. This approach of
using the within laboratory reproducibility as a good estimator of measurement of
uncertainty is taken from the SANCO/2004/2726rev1 document (SANCO
2004/2726rev1 2004). It recommends using the within laboratory reproducibility and
using a coverage factor of 2.33 to estimate expanded uncertainty, however as it was
felt that not all the environmental and other factors that could be varied over the
course of the validation were examined, hence a coverage factor of 2.33 may
underestimate the true uncertainty of the method. So a value of 3 was chosen
instead to give a more realistic value for the true uncertainty, this approach
was acceptable to the ISO17025 (ISO/IEC 17025 2005) auditors as well. Values for
MU are seen in Table 4-2 and lie between 18 and 61%. High MU values are seen for
CNZ and ORZ as they have no deuterated analogue to use as an internal standard.
These values are increased further due to a high value for reproducibility due to
matrix as a result of a high biological variation between species (day 4 experiment).

4.4.2.8. Evaluation
Table 4-3: Results of FAPAS Proficiency Test
SAMPLE: FAPAS PT 02120
RANGE

Compound

Actual Amt
(µg kg-1)

Calculated Amt
(µg kg-1)

MU(%)

MU of
Cal Amt

Upper

Lower

ZScores

MNZ

3.5

2.942

19.45

0.572

3.514

2.370

0.7

MNZ-OH

2.67

3.085

22.23

0.686

3.771

2.399

-0.7

In order to evaluate this method an incurred sample received as part of the Food
Analysis Performance Assessment Scheme (FAPAS) was analysed. Figure 4-3
shows chromatograms with both the strong and weak ions for MNZ-OH and MNZ
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which were found to be present in these samples. These samples were tested using
the method described here and found to yield satisfactory results. Z-scores
achieved for both compounds were less than 1. As well as good z-scores when the
method measurement of uncertainty is applied, the assigned values fall within the
possible range of concentrations given by this method. Also the method found no
peaks of analytes that were not present in the sample. Results of this proficiency test
are seen in table 4-3.
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Figure 4-3: Chromatogram of FAPAS egg sample incurred with (1) MNZ-OH and (2) MNZ; (a)
Strong Ion (b) Weak Ion (c) Internal Standard; (1) d2-MNZ-OH and (2) d3-HMMNI
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Conclusions

The objective of this work was to develop a rapid confirmatory method capable of
identifying, confirming and quantifying eleven nitroimidazole compounds in egg at
µg kg-1 levels and to validate according to the requirements in Commission Decision
2002/657/EC and this was successfully completed.
The method can be considered as rapid, as it utilises only a hexane wash and omits
the use of the time consuming SPE step, it also utilises chromatography which
separates all analytes in a total run time of only 20 minutes. The method includes 11
nitroimidazole compounds including seven that are suggested by the CRL in Berlin
to be analysed as well as other nitroimidazoles that are rarely if at all analysed such
as tinidazole, ornidazole and carnidazole.
The obtained data fulfills the requirements laid down in Commission Decision
2002/657/EC and allows the calculation of all relevant performance characteristics.
This study shows that the developed method meets the required sensitivity of 3 µg
kg-1 which is the RL used for these compounds. The CC and CC values
determined for each analyte are lower than this level. The method performs very well
in terms of accuracy and repeatability for each of the analytes due to the utilisation of
six different deuterated internal standards. The values achieved for accuracy, %CV
and measurement of uncertainty all fall within acceptable ranges. The applicability of
the method for use on different types of eggs was demonstrated by the satisfactory
results obtained from the Day 4 analysis of different species.The reduced number of
analytical steps within the method makes it very amenable for high through-put
regulatory monitoring of these compounds.
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Abstract

A liquid chromatography tandem mass spectrometry method recently developed,
validated and accredited was used to screen for the presence of metronidazole,
ronidazole dimetridazole ipronidazole, ternidazole, tinidazole, ornidazole carnidazole
and three hydroxy metabolites hydroxy-metronidazole, HMMNI and hydroxyipronidazole in Irish retail egg samples . The method used had had decision limits
(CCin the range 0.33-1.26 µg kg-1 and detection capabilities (CC, ranging from
0.56-2.15 µg kg-1 for all analytes. The internal standard corrected recovery
calculated for the various analytes range between 87.2-106.2% while the coefficient
of variance expressed as %CV range between 3.7-11.3%. The method was applied to
160 samples of caged, free range and organic hen and duck eggs available on the
Irish Retail market as well as two incurred proficiency test egg samples. No
nitroimidazole residues were detected in the survey samples above CCα and the
results achieved for the two proficiency test samples were acceptable when compared
with the assigned values.
Keywords: Nitroimidazoles; eggs; retail survey; LC-MS/MS

5.2

Introduction

Nitroimidazoles (NMZs) are imidazole heterocycles with a nitrogen group
incorporated in the structure. Examples of these compounds are metronidazole
(MNZ), dimetridazole (DMZ), ronidazole (RNZ), ipronidazole (IPZ), carnidazole
(CNZ), ornidazole (ONZ), ternidazole (TRZ) and tinidazole (TNZ). These examples
are known as 5-nitroimidazoles as they contain a NO2 group on the 5 ring position.
The structures of these compounds can be seen in figure 5-1. 5-NMZs are active
against most obligate anaerobic bacteria and a variety of protozoa; as a result they
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are very effective in the prophylactic and therapeutic treatment of histominiasis and
coccidiosis in poultry [Bishop, 2005].

Dimetridazole
(1, 2-dimethyl-5-nitroimidazole)

HMMNI
(2-hydroxymethyl-1-methyl-5-nitroimidazole)

Ronidazole
(1-methyl-2-[(carbamoyloxy) methyl]-5nitroimidazole)

Metronidazole
(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole)

Ipronidazole
(2-isopropyl-1-methyl-5-nitroimidazole)

Carnidazole
(1-(2-ethylcarbamothioic acid
O-methyl ester)-2-methyl-5nitroimidazole)

Ornidazole
(1-(3-chloro-2hydroxypropyl)-2-methyl-5nitroimidazole)

MNZ-OH
(1-(2-hydroxyethyl)-2-hydroxymethyl-5-

nitroimidazole)

IPZ-OH
(1-methyl-2-(2′-hydroxyisopropyl)-5nitroimidazole)

Ternidazole
2-Methyl-5-nitroimidazole-1propanol; 3-(2-Methyl-5nitroimidazol-1-yl)propan-1-ol

Tinidazole
1-(2-ethylsulfonylethyl)-2methyl-5-nitro-imidazole

N
O 2N

N

SO2

Figure 5-1: Structures of eleven nitroimidazole residues that were analysed for as part of the
survey.
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Toxicological studies carried out on these compounds suggest that they are possibly
carcinogenic and mutagenic in humans. The European Agency for the Evaluation of
Veterinary Products (EMEA) have published summary reports on three
nitroimidazole

compounds;

metronidazole

[EMEA

Report,

Metronidazole],

dimetridazole [EMEA Report, Dimetridazole] and ronidazole [EMEA Report,
Ronidazole]. While the reports suggest the studies carried out on humans are
insufficient and inconclusive to prove or disprove carcinogenicity of these
compounds, results in animal studies are conclusive [IARC, 1987]. This in their
opinion is enough to consider these compounds as carcinogenic and in the interest of
human health they are prohibited for use in food producing animals.
Due to these possible health risks associated with their use, nitroimidazole
compounds previously used for treatment in animal husbandry, were prohibited
originally by there inclusion in Annex IV of Commission Regulation 2377/90 but
now by inclusion table 2 of Commision Regulation 37/2010. Compounds in this table
are ones for which no Maximum Residue Level (MRL) can be fixed and therefore
are prohibited for use in food producing animals. However because of concerns over
these compounds no other 5-NMZ such as IPZ and TRZ has been issued a license for
use in food producing animals and are therefore also prohibited.
NMZ compounds are rapidly metabolised in bovine, porcine and avian species. The
main metabolite of DMZ, IPZ and MNZ results from the oxidation of the side chain
in the C-2 position of the imidazole ring to form hydroxy metabolites [EMEA
Report, Metronidazole]. RNZ has a different degradation pathway but results in an
identical metabolite to that of DMZ. These metabolites are 2-hydroxymethyl-1methyl-5-nitroimidazole

(HMMNI),

hydroxy-metronidazole

(MNZ-OH)

and

hydroxy-ipronidazole (IPZ-OH). The structures of these compounds are seen in
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figure 5-1. As these compounds still contain the imidazole ring their carcinogenicity
cannot be overlooked. Also these metabolites can be an indication of potential
misuse of prohibited nitroimidazoles compounds and therefore should also be
examined. From studies carried out by Polzer et al., 2004 on the measurements of the
parent drug and the corresponding main hydroxy-metabolite in various incurred
materials it can be concluded that HMMNI should be chosen as target analyte to
prove a treatment with DMZ. The metabolite IPZ-OH is recommended to detect an
illegal medication with IPZ. To check for a treatment with RNZ or MNZ, the
measurement of the parent drug is to be preferred. The studies also go on to state that
the ratio of parent drug to metabolite was found to vary with the length of the
withdrawal time in the case of a treatment with DMZ and respective data on the
behaviour of the other nitroimidazoles are not available to date, it is recommended to
monitor both, the parent drug and the respective metabolite, whenever possible in
order to get more reliable results [Polzer et al., 2003].
The European Union Reference Laboratories (EURLs) published a Guidance
Document

in

2007

(CRL

Guidance

2007)

that

outlined

recommended

concentration/levels (RC/RL) that laboratories should aspire to measure for
prohibited substances with no legislative minimum required performance level
(MRPL). The document also specified which matrices should be sampled and also
what marker residue should be analysed (parent drug or metabolite). The information
given in this document in relation to nitroimidazoles can be seen in table 5-1.
Matrices that should be used for the analysis of nitroimidazoles are plasma, retina
and eggs (Polzer at al., 2003). A level of 3 μg kg-1 has been assigned as the RL for
NMZs and all methods used in the analysis of NMZ residues should be capable to
detect to at least this level.
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Table 5-1: EURL recommendations for nitroimidazoles adapted from CRL Guidance Document
2007.

Substances

Nitroimidazole:
Dimetridazole,
Ronidazole,
Metronidazole

hydroxy metabolites:
MNZ-OH,
HMMNI

Matrix

Recommended
Concentaration *

Poultry:
Plasma,
Serum,
Eggs
3ppb
Pigs (and others species):
Plasma,
Serum,
Muscle

* CCbeta for screening methods or CCalpha for confirmatory methods should be lower than the value
expressed in this column

Although these compounds have been prohibited for use in food producing animals
since the mid 1990s their analysis in eggs has not always been carried out. This was
the case in Ireland where their analysis in eggs was not carried out prior to 2007.
From examination of non compliant findings in Europe, reported in the European
Food Safety Authority (EFSA) annual report and on the Rapid Alert System for Food
and Feed (RASFF) the abuse of these prohibited compounds cannot be overlooked.
The 2009 report from EFSA states that there were 6 non compliant findings of
nitroimidazole residues in 2007 and 5 in 2008. All positive findings were in poultry
meat and egg products for metronidazole and ronidazole in two member states
[EFSA Report, 2009]. From examination of the RASFF reports two positive results
for poultry meat products also contained metronidazole and ronidazole. Hence taking
into consideration these non compliant findings and the lack of analysis carried out
on these compounds in eggs in Ireland prior to 2007, it was felt that an examination
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of eggs available in the Irish retail market for the presence of NMZ residues would
be beneficial. It would firstly help ensure that the ban on these compounds is being
observed and secondly it would give confidence to the consumer that the eggs that
reach the table are free from these harmful residues.
To the best of our knowledge, no data on the presence of NMZ residues in Irish Eggs
has previously been published. Therefore the aim of this study was to examine
occurrences of NMZ residues in eggs sold on the Irish retail market. The analysis of
160 egg samples for eleven NMZ compounds was carried out with an in house
validated and ISO 17025 accredited LC-MS/MS method (Cronly et al., 2009 (b)).

5.3

Materials and methods

5.3.1 Sample collection and preparation
Table 5-2: Information on samples taken as part of the survey

Hen Eggs

Duck Eggs

148

12

Leinster

36

3

Munster

62

5

Connaght

30

2

Ulster

20

2

Free Range

118

12

Organic

14

0

Caged

11

0

Barn

5

0

Total Numbers

Purchased in

Farming
Practices

This survey was carried out in conjunction with Ashtown Food Research Centre
(AFRC) and the collection of eggs was performed by them. Hen and duck eggs were
purchased from farmer markets, small shops, convenience stores and large chain
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supermarkets all over Ireland. To ensure representative samples 12 eggs were used
for each one. Whole egg samples were homogenised, transferred into polypropylene
tubes (50ml) and stored at -20ºC until transfer to our laboratory. These samples were
delivered by courier in a frozen state and stored at -20ºC until analysis. A table of
samples analysed and information related to them can be seen in table 5-2.

5.3.2 Chemicals and materials
CNZ, TNZ, TRZ, ORZ were provided by the EURL (BVL, Berlin, Germany). IPZOH, MNZ, IPZ, HMMNI, MNZ-OH, HMMNI-d3, MNZ-OH-d2, DMZ- d3 and
RNZ -d3 (all from WITEGA Laboratorien Berlin), RNZ and DMZ (Sigma, St. Louis,
MO). Water is of LC-MS grade quality (Fluka). All other solvents were of LC
quality and purchased from Reagecon (Clare, Ireland). Sodium Chloride was AnalaR
grade and purchased from VWR (Poole, England). Individual stock standards at 1mg
mL-1 in ethanol were prepared and stored at 4ºC for 1 year. Individual intermediate
standard solutions (10 and 1 µg mL-1) in methanol were prepared and working
standard solutions (mixture of nitroimidazoles) (300 ng mL-1) were prepared in
methanol and stored at 4ºC for 3 months. Deuterated standards were prepared
similarly except mixed standard was 300 ng mL-1.

5.3.3 Sample extraction
Extraction method is one taken from Cronly et al., 2009 (b). In brief; egg samples (3
g) are weighed into a polypropylene centrifuge tubes (50 mL). These are fortified
with mixed internal standard. A calibration curve is run with each batch by fortifying
blank egg at levels corresponding to 0, 2.5, 5, 7.5, 10 and 20 µg kg-1 by adding mix
working standard containing each analyte (0, 25, 50, 75, 100 and 200µL) and these
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are vortexed (20 s). To these samples acetonitrile (6 mL) is added and the tubes are
vortexed. NaCl (1.2 g) is added and shaken vigorously by hand before centrifuging
(4350 x g for 10min). The top organic layer is then transferred to a polypropylene
tube (15 mL). Hexane (3.5 mL) is added and this is vortexed (30 s). The hexane layer
is then removed and the extracts are evaporated to dryness at 50ºC under a nitrogen
stream. They are then reconstituted in 95:5 Water: ACN (200 µL). Before injection
the samples are filtered through 0.2 µm PVDF syringe filters. An aliquot (20 µL) is
injected onto the LC column. A chromatogram of a 2.5 µg kg-1 fortified egg sample
is presented in figure 5-2.

5.3.4 Liquid chromatography tandem mass spectrometry conditions
Two LC-MS/MS systems were used in the analysis of these samples, first was a TSQ
Quantum Ultra EMR coupled to a Finnigan Surveyor LC system and controlled by
Xcalibur software (Version 1.4) and the second one an AB Sciex Triple Quad 5500
couple to Schimadzu UFLC XR LC system which is controlled by Analyst Software
1.5. Separation was achieved using C18 column with an oven temperature was set at
40 ºC. The chromatographic separation performed on gradient mode using water
acidified with 0.1% acetic acid (mobile phase A) and acetonitrile acidified with 0.1%
acetic acid (mobile phase B). As the two LC are different one being HPLC and the
other UPLC the gradients and runs time are different. The gradients and mass
spectrometer parameters for the respective instruments can be seen in table 5-3. The
ionisation mode used was positive electrospray ionisation (ESI) mode and the
individual MRMs with there respective collision energies were optimised for both
instruments and are listed in table 5-4.
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Table 5-3: LC and MS/MS parameters for Instrument 1 (Thermo TSQ Quantum) and
Instrument 2 (AB Sciex 5500) used in analytical method.

Instrument 1
HPLC Gradient
Time (min)
0
4
7
9
12
20

%A
95
95
5
5
95
95

Instrument 2
UHPLC Gradient
Flow mL min-1
0.25
0.25
0.25
0.25
0.25
0.25

%B
5
5
95
95
5
5

TSQ Quantum Mass Spectrometer
Parameters

Time (min)
0
1.5
3
5
6
9

%A
95
95
5
5
95
95

%B
5
5
95
95
5
5

Flow mL min-1
0.55
0.55
0.55
0.55
0.55
0.55

AB Sciex 5500 Spectrometer Parameters

Ionisation Mode:

ESI (Positive
Mode)

Ionisation Mode:

ESI (Positive Mode)

Spray Voltage:

4350V

Spray Voltage:

4500V

Capiliary Temperature:

325ºC

Source Temperature:

650ºC

Source CID:

0

CAD Gas:

8

Collision Pressure:

1.5 Torr

Entrance Potential:

10V

Tube Lens Offset:

75

45psi

Quad MS/MS Bias:

-1

Sheath Gas Pressure:

65

Curtain Gas Pressure:
Ion Source Gas1
Pressure:
Ion Source Gas2
Pressure:

60psi

Auxilary Gas Pressure:

35

Resolution Q1:

unit

Ion Sweep Gas Pressure:

0

Resolution Q3:

unit

50psi
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Table 5-4: Information on precursor ion, product ion, collision energies and retention times for
each of the eleven nitroimidazole residues on both instruments.

Compound

Precursor
(M/z)

MNZ-OH

188

Product
(M/z)
123

HMMNI

MNZ

RNZ

DMZ

TRZ

TNZ

IPZ-OH

ORZ

CRZ

IPZ

Collision Energy (eV)
Instrument
Instrument
2
1
17

Retention Time (min)
Instrument
Instrument
2
1

16

126

23

17

110

20

18

158
140

17

13

82

33

25

128

19

15

140

17

15

55

29

20

96

21

18

172

201

142
81

31

28

128

19

17

186
82

37

28

121

23

18

82

47

15

168

19

14

122

27

21

128

23

17

248

186

220
82

39

33

118

21

13

75

43

33

124

25

18

109

33

25

245

170

1.34

3.23

1.77

4.38

2.11

5.02

2.38

5.81

3.05

7.35

3.69

8.6

3.97

11.71

4.09

12.12

4.11

12.19

4.27

12.57

4.32

12.67
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5.3.5 Validation studies
The validation studies of this method can be seen in Cronly et al. 2009(b). The
method was validated in accordance with Commission Decision 2002/657. The
validation results associated with this method can be seen in table 5-5. To ensure the
ongoing competency of the method proficiency test samples were analysed using the
method. The results achieved from this scheme must meet requirements set out by
both the organiser of the scheme in this case Food Analysis Performance Assessment
Scheme (FAPAS) as well as in house laboratory requirements for performance in
proficiency schemes.

Table 5-5: Validation results of %CV, accuracy, absolute recovery, CCα, CCβ, MU and
linearity.

Analytes

CV
%

Accuracy
%

Absolute
Recovery
%

CCα
µg kg-1

CCβ
µg kg-1

MU
%

Linearity
R2

Dimetridazole

4.2

98.0

69

0.43

0.73

28

>0.990

Metronidazole

3.8

106.2

58

0.38

0.64

19

>0.990

Ronidazole

5.6

104.5

72

0.59

1.01

34

>0.990

Ipronidazole

4.7

100.3

70

0.53

0.90

27

>0.990

HMMNI

4.3

99.2

74

0.45

0.78

18

>0.990

MNZ-OH

3.7

102.5

67

0.33

0.56

22

>0.990

IPZ-OH

4.4

100.4

77

0.43

0.73

26

>0.990

Ornidazole

7.8

92.4

77

0.79

1.34

50

>0.990

Ternidazole

4.5

99.6

67

0.41

0.71

19

>0.990

Carnidazole

11.3

87.2

76

1.26

2.15

61

>0.990

Tinidazole

5.1

97.2

72

0.45

0.77

24

>0.990
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Results and discussions

The LC–MS/MS method published in Cronly et al., 2009(b) was used to provide
confirmatory data for the analysis of 11 nitroimidazole compounds in hen and duck
eggs. The MS/MS fragmentation conditions were optimised in the method for each
individual compound to give best response. For a method to be deemed confirmatory
under Commission Decision 2002/657/EC it must yield 4 identification points. In this
method a precursor ion (parent mass) and two product ions (corresponding to strong
and weak ion) are monitored for each analyte (Table 5-4). This yields 4 identification
points (1 for the precursor ion and 1.5 for each product ion) hence it can be deemed a
confirmatory method. In addition to this relative retention times and ion ratios are
monitored for each compound and evaluated to ensure that they are within acceptable
ranges as stated in EC 2002/657. The developed extraction method assisted with the
reduction of matrix associated ion suppression but did not eliminate it completely;
this possible problem was overcome by the use matrix matched calibration curves
and deuterated internal standards. The method was fully validated in accordance with
Commission Decision 2002/657. The validation results associated with this method
can be seen in table 5. The method has also received ISO 17025 accreditation.
Table 2 lists the breakdown of samples analysed as part of this survey. The majority
incorporated in this survey were hen eggs as they are the most widely available on
the Irish market. The survey also analysed a number of duck egg samples. The
samples are broken into these two categories and information associated to province
of purchase and farming type is given. The samples were batched in numbers of ten
to fifteen each month and analysed using the accredited method. They were analysed
of the AB Sciex 5500 LC-MS/MS or Thermo Quantum LC-MS/MS. With each batch
a calibration curve was run and certain parameters were examined to ensure the
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extractions and instrumental analyses were successful. The 2.5 µg kg-1 matrix
extracted standard was run at the start and the Signal to Noise (S:N) for the weakest
transition for each analyte needed to be greater than 25. A chromatogram for each
compound at the lowest calibration level 2.5 µg kg-1 with associated S:N can be seen
in figure 5-2.

IP Z

DM Z

CRZ

RNZ

ORZ

M NZ

IP Z-O H

HM M NI

TN Z

M N Z-O H
TR Z

Figure 5-2: Chromatogram showing signal to noise of the eleven nitroimidazole residues in 2.5
µg kg-1 fortified blank egg sample relating to the lowest calibration.
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The calibration curve had to have a correlation coefficient of greater than 0.99 and an
intercept smaller than ± 0.3. Finally the internal standard in each sample had to have
a S:N greater than 25 to ensure that the extraction had worked for each sample.
Example of internal standards in samples with their associated S:N values can be
seen in figure 5-3. If these parameters were not met the sample would be repeated.

D 3-IP Z

D 3-IP Z-O H

D 3-D M Z

D 3-R N Z

D 3-H M M N I

D 3-M N Z-O H

Figure 5-3: Chromatogram showing the signal to noise of the six internal standards in a survey
sample.
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In addition to these batch suitability tests, the method was tested on an ongoing basis
by its use to analyse two proficiency test (PT) samples provided by FAPAS. These
were run in the same way as the survey samples and the results achieved were
compared to the assigned values. The chromatograms relating to the strong and weak
ions and internal standard for the positive PT samples can be seen in figure 5-4. The
results achieved gave very acceptable Z scores of less than +/- 2 and were well
within the measurement uncertainty MU of the method.
The samples analysed as part of the survey were collected all over the country over a
two year period in 2009 and 2010. The samples were sourced from different retail
outlets and markets from every province in Ireland to ensure that the egg samples
analysed were representative of eggs that are available to the Irish consumer. From
examination of the results of all 160 hen and duck egg samples no non compliant
findings were observed for any of the 11 nitroimidazole residues investigated.
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MNZ
Strong
Ion

MNZ
Strong
Ion

MNZ
Weak
Ion

MNZ
Weak
Ion

Int. Std.
D3-HMNNI

Int. Std.
D3-HMNNI

MNZ–OH
Strong
Ion

MNZ–OH
Weak
Ion

Int. Std.
D2-MNZ-OH

MNZ–OH
Strong
Ion

MNZ–OH
Weak
Ion

Int. Std.
D2-MNZ-OH

Figure 5-4: Chromatograms of strong and weak ions and internal standards relating to non
compliant results associated with FAPAS proficiency test samples
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Conclusions

The results indicate a zero incidence of illegal or accidental use of nitroimidazoles in
Irish poultry egg industry. The method used in the analysis of 160 hen and duck egg
samples was one published by Cronly et al., 2009(b) and was validated in accordance
with Commission Decision 2002/657/EC and has achieved ISO 17025 accreditation.
Each batch analysed had to meet certain requirements for acceptance and in the case
of all samples this was achieved. The method was further tested by its use in the
analysis of PT samples and results achieved demonstrated the method was capable of
the confirmation and quantitation of nitroimidazole residues in egg samples. Results
achieved had Z scores less 2 and were within MU of the method. Confirmatory
criteria of Ion ratios and RRT were within criteria set out in European legislation.
When taking into consideration non compliant findings in eggs in Europe and the
lack of analysis carried out on these compounds in eggs in Ireland prior to 2007, it
was felt that an evaluation of eggs available in the Irish retail market for the presence
of NMZ residues would be beneficial. Upon carrying out this survey which resulted
in complaint findings for all samples analysed it is felt that this demonstrates that the
ban on these compounds is being observed and secondly it gives confidence to the
consumer that the eggs that reach the table are free from these harmful residues.
Taking this into consideration it is felt that the monitoring of these compounds in
eggs which is being carried out as part of the national monitoring plan is sufficient to
ensure the continued enforcement of these prohibited compounds in eggs. In addition
to this the results achieved for this study will be added to other research which is
ongoing in AFRC in the hope of producing a dietary exposure assessment of food on
the Irish market.
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CHAPTER 6: RAPID MULTI-CLASS MULTIRESIDUE METHOD FOR THE CONFIRMATION OF
CHLORAMPHENICOL AND ELEVEN
NITROIMIDAZOLES IN MILK AND HONEY BY
LIQUID CHROMATOGRAPHY TANDEM MASS
SPECTROMETRY
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Abstract

A confirmatory method was developed to allow for the analysis of eleven
nitroimidazoles and also chloramphenicol in milk and honey samples. These
compounds are classified as A6 compounds in Annex IV of Council Regulation
2377/90 (European Commission 1990) and therefore prohibited for use in animal
husbandry. Milk samples were extracted by acetonitrile with the addition of NaCl;
honey samples were first dissolved in water before a similar extraction. Honey
extracts underwent a hexane wash to remove impurities. Both milk and honey
extracts were evaporated to dryness and reconstituted in initial mobile phase. These
were then injected onto a liquid chromatography-tandem mass spectrometry (LCMS/MS) system and analysed in less than 9min. The MS/MS was operated in
multiple reaction monitoring (MRM) mode with positive and negative electrospray
ionization. The method was validated in accordance with Commission Decision
2002/657/EC and is capable of analysing metronidazole, dimetridazole, ronidazole,
ipronidazole

and

there

hydroxy

metabolites

hydroxymetronidazole,

2-

hydroxymethyl-1-methyl-5-nitroimidazole, and hydroxyipronidazole. The method
can also analyse for carnidazole, ornidazole, ternidazole, tinidazole, and
chloramphenicol. A recommended level of 3 gL-1/gkg-1 for methods for
metronidazole, dimetridazole, and ronidazole has been recommended by the
Community Reference Laboratory (CRL) responsible for this substance group, and
this method can easily detect all nitroimidazoles at this level. A minimum required
performance level of 0.3 gL-1/gkg-1is in place for chloramphenicol which the
method can also easily detect. For nitroimidazoles, the decision limits (CCα) and
detection capabilities (CCβ) ranged from 0.41 to 1.55 gL-1 and from 0.70 to 2.64
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gL-1, respectively, in milk; and from 0.38 to 1.16 gkg-1 and from 0.66 to 1.98
gkg-1, respectively, in honey. For chloramphenicol, the values are 0.07 and 0.11
gL-1 in milk and 0.08 and 0.13 gkg-1 in honey. Validation criteria of accuracy,
precision, repeatability, and reproducibility along with measurement uncertainty
were calculated for all analytes in both matrices.
Keywords: Nitroimidazoles; chloramphenicol; milk; honey; lc-ms/ms; validation

6.2.

Introduction

6.2.1. Nitroimidzoles
5-Nitroimidazoles are primarily used for the prophylactic and therapeutic treatments
of diseases such as histominiasis and coocidiosis in poultry, hemorrhagic enteritis in
pigs and genital trichomoniasis in cattle. Recently, reports from China suggest that
the use of nitroimidazoles in beekeeping is being practiced [Zhou et al., 2007].
Nitroimidazoles may be used to prevent and control Nosema apis in hives. Nosema
Apis is a microsporidian pathogen that is commonly found in Apis mellifera
throughout the beekeeping world [Official Method (2003)].
Nitroimidazoles(NMZs) are believed to be carcinogenic and mutagenic to humans
and as a consequence are placed in the group A6 (prohibited) substances and their
use in food producing animals within the European Union is not permitted under
Regulation 2377/90. They are also prohibited for use in the U.S.A and China. The
analysis of these compounds is required under Council Directive 96/23/EC. The CRL
has also established a recommended level (RL) of 3 gL-1/gkg-1 for these
compounds. There is a need for rapid multi residue analytical methods that have the
capability to include a wide rage of these analytes in all matrices where abuse may be
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found. The structure of these 5-nitroimidazoles and their metabolites are seen in table
6-1.
The Community Reference Laboratory (CRL) in Berlin has carried out homogeneity
and stability studies on NMZs in various matrices [Polzer et al., 2004, Polzer et al.,
2005]. These studies showed that there is not a homogenous distribution of these
analytes in turkey muscle and they also observed a rapid degradation in analyte
concentration stored for prolonged periods above 4 °C. In contrast it was discovered
that for plasma, retina and egg samples; the analytes were stable during storage under
the same conditions which resulted in stable concentrations and allowed detection of
these compounds for longer periods after medication had been halted. Therefore, it is
advised that plasma, retina and eggs be used as target matrices for the residue control
of NMZs [Polzer et al., 2004, Polzer et al., 2005].
As a result of these published studies there has been an increase in the methods being
developed for the analysis of these compounds in matrices such as egg [Mottier et al.
2006, Mohammed et al., 2008, Xia et al., 2006, Daeseleire et al., 2000, Cronly et al.,
2009(b)] and plasma [Aerts et al., 1991, Fraselle et al., 2007, Thompson et al., 2009,
Cronly et al., 2009(a)]. The majority of methods published for the analysis of eggs
involve extraction with acetonitrile and the addition of NaCl. Purification
methodologies of these extracts varied. Solid Phase Extraction (SPE) such as
Hydrophilic Lypophilic Balance (HLB) catridges [Mottier et al., 2006] or Molecular
imprinted (MIPs) SPE cartridges [Mohamed et al., 2008] were used. In some
methods the samples were just filtered before injection and satisfactory results were
still achieved [Xia et al., 2006, Daeseleire et al., 2000, Cronly et al., 2009(a), (b)].
Methods for the analysis of these compounds in plasma are varied in their extraction
protocols. Extraction solutions such as aqueous buffer [Aerts et al., 1991],
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NaCl/Potassium phosphate buffer (Fraselle et al., 2007) and acetonitrile [Thompson

et al., 2009, Cronly et al., 2009 (b)] have been used in the extraction of NMZs from
plasma. SPE catridges of Extrelut [Aerts et al., 1991] and Chromabond kieselguhr
[Fraselle et al., 2007] have been used in the sample purification in this matrix.
Cronly et al., 2009 (a) omits the use of SPE and clean up is achieved by purifying
samples with the use of a hexane wash step and filtering before injection.
While suitable methods now exist for monitoring these analytes, no suitable methods
in matrices such as milk and honey exist for the comprehensive confirmatory
analysis of NMZs. The CRL for NMZs has suggested that honey be tested to
ascertain any possible misuse and if non-compliant results are found then this matrix
should be included in monitoring plans. They also state that countries with high milk
production should also analyse for these analytes in milk as their possible misuse in
this matrix cannot be discounted. From investigation of literature only two method
could be found that allows for the analysis of NMZs in honey. Zhou et al., 2007
published a method for the analysis of 5 NMZs in honey by HPLC-UV. Samples
were extracted with ethyl acetate and evaporated. The residue containing the NMZs
was dissolved in ethyl acetate–hexane and subjected to solid-phase extraction
cleanup by amino extraction columns. The eluent was evaporated, reconstituted and
injected onto the column. The second by Mol et al., 2008, was a multi-class
multiresidue method for the analysis of veterinary residues in honey. While the
method was confirmatory for eight nitroimidazole compounds it could only analyse
to 10 g kg-1 which is three times higher the RL for these compounds.
In relation to the analysis of nitroimidazoles in milk there are a limited number of
published methods available [Ortelli et al., 2009; Stolker et al., 2008, Thompson et

al., 2009]. These methods are all screening methods using either optical biosensor
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[Thompson et al., 2009] or time of flight mass spectrometers [Ortelli et al., 2009;
Stolker et al., 2008]. From investigation of literature there are no methods for the
confirmatory analysis of NMZs in milk at the levels desired.

6.2.2. Chloramphenicol
Chloramphenicol (CAP) is a broad spectrum bacteriostatic antibiotic that exerts its
effect by inhibiting bacterial protein synthesis. The structure of CAP is seen in table
6-1. Research carried out on CAP has shown that it has adverse toxicological affects
in human such as aplastic anaemia or grey-syndrome. Due to these health concerns it
has been classified as an A6 compound in annex IV of council regulation 2377/90
which means it is prohibited for use in food producing species. CAP has been issued
a minimum required performance limit (MRPL) of 0.3 ng mL-1 which means all
methods should be able to at least see to this level. As a result of this low level; CAP
is often analysed in single analyte methods [Rejtharova et al., 2009; Ronning et al.,
2006] although some multi amphenicol methods do exist [Zhang et al., 2008; Shen et

al., 2009]. In addition to this there are two other multiclass methods which include
the analysis of CAP [Lopez et al., 2008 and Sheridan et al., 2008.] These analyse for
CAP with compounds that are not prohibited for use such as sulfonamides and
tetracyclines.
A common trend in analysis of CAP in any matrix is the use of an SPE clean-up.
Common cartridge chemistries used in the analysis of CAP are Oasis HLB [Shen et

al., 2009], Mixed Cation Exchange (MCX) [Zhang et al., 2008] and the selective
technique of Molecular Imprinted Polymers (MIPs) [Rejtharova et al., 2009; Boyd et

al., 2007] An investigation into the methods used to analyse for CAP found that it is
often analysed singly in several matrices including milk and honey. Ronning et al.,
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2006 developed a method that anaylse for CAP residues in meat, seafood, egg,
honey, milk, plasma and urine with liquid chromatography–tandem mass
spectrometry. Samples were extracted with acetonitrile and chloroform was added to
remove water. Extracts were then evaporated to dryness, reconstituted and filtered
before injection. Rejtharova et al., 2009 described a method for the analysis of CAP
in urine, feed water, milk and honey samples by GC-MS-NCI using molecular
imprinted polymer clean-up.
On examining published literature it is quite clear that the confirmatory analysis of
NMZs in milk and honey has not been examined to date. No confirmatory methods
could be found for the analysis of these analytes in the matrices of honey and milk.
With growing concerns from China about the use of NMZs in honey the CRL having
recommended that this matrix be examined. The CRL have also recommended that
countries with high milk production should analyse for these compounds in milk.
Therefore there is a need for a comprehensive method to allow for the confirmatory
analysis of both these matrices. In addition to this, while the analysis of CAP in all
matrices is being performed it is often performed using single analyte methods which
contain time consuming SPE clean-up steps. From literature investigation no method
was found that was capable of analysing for CAP and the eleven NMZs listed in this
paper. The sample preparation described in this study is less time consuming than
previously published methods. The milk method has a sample size of 1ml which
allows for fast extraction times. The majority of methods for the analysis of CAP
incorporate the use of an SPE clean up. The method presented here omits this step
and still achieves satisfactory results.
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Table 6-1: Structures, Retention time (Rt), Precursor and Product ions and typical ion ratios for
all 12 analytes
Compound

Structure

Rt

MNZ-OH
1-(2-hydroxyethyl)-2hydroxymethyl-5-nitroimidazole

1.34

HMMNI
2-hydroxymethyl-1-methyl-5nitroimidazole

1.77

Metronidazole (MNZ)
1-(2-hydroxyethyl)-2-methyl-5nitroimidazole

2.11

Ronidazole (RNZ)
1-methyl-2-[(carbamoyloxy)
methyl]-5-nitroimidazole

2.38

Dimetridazole (DMZ)
1, 2-dimethyl-5-nitroimidazole

3.05

Ternidazole (TRZ)
2-Methyl-5-nitroimidazole-1propanol; 3-(2-Methyl-5nitroimidazol-1-yl)propan-1-ol

3.69

Precursor(
Typical
Product (M/z) Collision Energy
M/z)
Ion Ratio

O 2N

N

3.97
S O

4.09

Ornidazole (ORZ)
1-(3-chloro-2-hydroxypropyl)-2methyl-5-nitroimidazole

4.11

Carnidazole (CNZ)
1-(2-ethylcarbamothioic acid Omethyl ester)-2-methyl-5nitroimidazole

4.27

Chloramphenicol (CAP)
2,2-dichloro-N-[(1R,2R)-2hydroxy-1-(hydroxymethyl)-2-(4nitrophenyl)ethyl]acetamide

4.25

Ipronidazole (IPZ)
2-isopropyl-1-methyl-5nitroimidazole

4.32

126

23

110

20

140

17

82

33

128

19

140

17

55

29

96

21

81

31

128

19

82

37

121

23

82

47

168

19

122

27

128

23

82

39

118

21

75

43

257

-16

152

-12

124

25

109

33

0.71

0.73

172

0.70

201

0.33

142

0.30

0.46

186

248

2

IPZ-OH
1-methyl-2-(2′-hydroxyisopropyl)5-nitroimidazole

17

158

N

Tinidazole (TNZ)
1-(2-ethylsulfonylethyl)-2-methyl5-nitroimidazole

123
188

0.19

0.50

186

220

0.58

245

0.17

321

0.90

170

0.65
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Materials and Methods

6.3.1. Materials and Reagents
CAP and CAP-d5 were purchased from Sigma (St. Louis, MO) and Dr. Ehrenstorfer
GmbH(Germany) respectively. CNZ, TNZ, TRZ, ORZ were provided by the CRL
(BVL, Berlin, Germany). RNZ and DMZ were purchased from Sigma (St. Louis,
MO) and MNZ, IPZ, IPZ-OH, HMMNI, MNZ-OH, HMMNI-d3, MNZ-OH-d2,
DMZ-d3, RNZ-d3 were purchased from WITEGA Laboratorien (Berlin, Germany).
Water is of LC-MS grade (Fluka). All other solvents were of LC grade and
purchased from Reagecon (Clare, Ireland). Sodium chloride was AnalaR grade and
purchased from VWR (Poole, England). Individual stock standards of each analyte at
1mg ml-1 in ethanol were prepared and stored at 4˚C for 1 year. Individual
intermediate standard solutions (10,000 and 100 ng ml-1) in methanol were prepared.
Two working standards solutions (mixture of analytes) were prepared in methanol
containing all NMZs at levels of 300ng ml-1 and 100ng ml-1 respectively (for honey)
and CAP at levels of 30ng ml-1 and 10ng ml-1 respectively (for milk). Deuterated
standards were prepared similarly except the mixed standard contained 200ng ml-1
deuterated NMZs and 20ng ml-1 deuterated CAP.

6.3.2. LC-MS/MS Instrumentation
The LC-MS/MS system is an AB Sciex Triple Quad 5500 couple to Shimadzu UFLC
XR LC system. The instrument is controlled by Analyst Software 1.5 and operated in
positive and negative electrospray ionisation (ESI +/-).
Separation was achieved using a 100x2mm, 1.8 micron particle size Zorbax Eclipse
Plus C18 column supplied by Agilent Technologies (Santa Clara, CA). The column
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oven temperature was set at 45 ºC. The chromatographic separation was achieved
using gradient mode consisting of water acidified with 0.1% acetic acid (mobile
phase A) and acetonitrile acidified with 0.1% acetic acid at flow rate 0.5ml min-1.
The gradient is as follows; 95% A for the first 1.5 min. Then this changes to 5% A
from 1.5-3.0 min and maintained for 2.0 min. The conditions then return to the initial
95% A in 1.0 min (5-6min) and remain the same till the end of the run of 9.0 min. A
divert valve is utilised to help remove any matrix impurities from entering the
MS/MS. The LC flow is diverted for the first minute and the last three minutes of the
method. The ionisation mode used was positive electrospray ionisation for the NMZs
and negative electrospray ionisation for CAP. The MS/MS method was segmented in
order to obtain enough data points on each peak. The first three minutes is run in
positive mode and from then on it is run with positive and negative switching. A
source temperature of 650ºC with a spray voltage of 4500V was used to produce
parent to product ions. The individual precursor and products ions for each analyte
with their respective collision energies are listed in table 6-1.

6.3.3. Milk and Honey Samples
Milk and honey were obtained and stored at -20 ºC. Portions of these samples were
analysed and those found to contain no detectable residues of the analytes of interest
were used as blanks for the validation study. Chromatograms of blank milk and
honey samples can be seen in figure 6-1 and 6-2. For the day four validation studies
of variability due to matrix variances a wide range of milk and honey samples were
obtained. Milk samples comprised of high fat, low fat, organic milk and also milk
with added extra calcium, folic acid and vitamins A, B, D and E, a sample of goat's
milk was also examined. Honey samples comprised of the following types
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Kapetanios Pure Greek; Rowse Australian Eucalyptus; Capilano Australian Organic
Blended; Tropical Forest Ltd. Ethiopian Forest; Marks and Spencer’s New Zealand
Clover; Famille Michaud-Lavender Honey, Provence, France; New Zealand Manuka
Honey, Irish Honey ; Irish Honeycomb, Dublin; De Rit Blended Flower, Holland.

6.3.4. Methods
6.3.4.1. Milk Extraction
Milk (1mL) was pipetted into polypropylene centrifuge tubes (15mL). These were
fortified with mixed internal standard (30 µL) which corresponded to 6 ng mL-1 of
deuterated NMZs and 0.6 ng mL-1 deuterated CAP. Acetonitrile (2mL) was added
and vortexed. NaCl (0.5g) was added to this slurry which was shaken (30 secs) and
then centrifuged (4350 x g for 10min). The top organic layer from each sample was
then transferred to amber vials (5mL) and evaporated (50ºC) to dryness under a
stream of nitrogen. The extracts were reconstituted in Water: Acetonitrile (95:5,
200µL) and filtered through 0.2µm PVDF syringe filters. An aliquot (10µL) was
injected onto the LC column.

6.3.4.2. Honey Extraction
Honey (3 g) was weighed into polypropylene centrifuge tubes (50 mL). These were
then placed in an oven at 50 ºC for 30 min to soften. The samples were then fortified
with mixed internal standard (50 µL) which correspond to 2 µg kg-1 of deuterated
NMZs and 0.2 µg kg-1 deuterated CAP. Water (5ml) was then added to each sample
and these are then placed back in the oven for a further 10 min. The samples were
then thoroughly vortexed until the honey was fully dissolved in the water. To this
acetonitrile (10 mL) was added and the tubes were vortexed (20secs). NaCl (2 g) was
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added to this slurry which was then shaken (30secs) and centrifuged (4350 x g for
10min). The top organic layers were then transferred to polypropylene tubes (15 mL)
and evaporated (50ºC) to 6mL under nitrogen. Hexane (5 mL) was added and this
was vortexed (30secs). The hexane layer was then discarded and the extracts were
evaporated to dryness at 50ºC under a nitrogen stream. They were then reconstituted
in Water:ACN (200 µL of 95:5 and filtered through 0.2 µm PVDF syringe filters. An
aliquot (10 µL) was injected onto the LC column.

6.3.5. Matrix Matched Calibration Curves
Quantitation was carried out using matrix-matched calibration curves. Blank honey
and milk samples were used. These samples were fortified with mixed working
standard and submitted to the full extraction procedure of the method. A matrix
matched calibration curve is performed with every batch. Six samples are fortified
with internal standard and mixed working standard for a calibration range of 0 to 20
ng mL-1 (µg kg-1 Honey) for the NMZs and a range of 0-2 ng mL-1 (µg kg-1 Honey)
for CAP. Calibration curves were prepared by plotting the response factor (the ratio
of peak area analyte over peak area of internal standard) against analyte
concentration. Seven deuterated internal standards are used; d3- DMZ, d3-RNZ, d3HMMNI, d2-MNZ-OH, d3-IPZ, d3-IPZ-OH and d5-CAP. For those compounds with
no deuterated analogues; MNZ, TRZ, TNZ, ORZ and CRZ, d3-HMMNI is used as
an internal standard. For each analyte calibration curves were linear in the given
range with a correlation coefficient of at least 0.99.
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6.3.6. Method Validation
The LC–MS/MS method was validated according to 2002/657/EC guidelines. The
same validation protocol was used for both the honey and milk matrix. LC–MS/MS
identification criteria were verified throughout the validation study by monitoring
relative retention times, ion detection (signal-to-noise ratio (S/N)) and relative ion
intensities. LC-MS/MS identification criteria as set out in the legislation were
verified throughout the validation of the method.
Several method validation parameters were determined including linearity,
specificity, recovery, precision (repeatability and within-laboratory reproducibility)
and analytical limits (decision limit CC and detection capability CC). Specificity
was determined by analysing 10 different blank milk and honey samples sourced
from different suppliers. No interfering peaks were observed at the retention time for
any of the transitions. This allows for clear identification and quantification of all
analytes. To investigate the linearity of the method, matrix-matched calibration
curves were prepared and run with each of the validation batches to give 6 point
calibration curves ranging from 0 to 20g L-1 / g kg-1 for the NMZs and 0 to 2g L1

/ g kg-1 for CAP.

Since no certified reference materials were available for the analytes and matrices of
interest, the recovery from fortified negative samples was measured as an alternative
to trueness. The recovery and precision were determined through the analysis of
negative milk and honey samples fortified in six replicates at 1, 1.5 and 2 times the
RL and the MRPL of 3 and 0.3 g L-1 / g kg-1 for NMZs and CAP respectively. Six
replicate test portions at each of the three fortification levels (n = 18) were analysed
on three separate days over a period of two weeks. Samples were fortified with
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NMZs at 3, 4.5 and 6 g L-1 / g kg-1and with CAP at 0.3, 0.45 and 0.6 g L-1 / g
kg-1 by adding mix working standard solution (30, 45 and 60 µL) and analysed. To
determine any matrix effects caused by biological variations arising from various
milk and honey samples a fourth day analysis was carried out. For each matrix two
sets of ten different samples were analysed. The first set was fortified with only
internal standard, and the second set was fortified with both internal standard and
with the analytes at a concentration equivalent to 4.5g L-1 / g kg-1of NMZs and
0.45g L-1 / g kg-1 of CAP. From these four separate validation days an estimation
of recovery, precision (repeatability and within-laboratory reproducibility) and
analytical limits (decision limit CC, and detection capability CC) were
determined.

6.4.

Results and Discussion

6.4.1. Method Optimisation
The method was developed to provide confirmatory data for the analysis of CAP and
11 NMZs in milk and honey. The method was developed from an existing method
used in the lab to analyse for NMZs in plasma and eggs [Cronly et al., 2009(a), (b)].
The LC-MS/MS instrument used for this method was different than the one used
previously so fragmentation conditions were investigated and collision energies were
optimised for each individual compound to give best response. For a method to be
deemed confirmatory under Commission Decision 2002/657/EC it must yield 4
identification points. In this method a precursor ion (parent mass) and two product
ions (corresponding to quantifier and qualifier ion) are monitored for each analyte
(Table 6-1). This yields 4 identification points (1 for the precursor ion and 1.5 for
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each product ion) hence it can be deemed a confirmatory method. In addition to this
relative retention times and ion ratios are tracked for each compound and ensured
that they are within acceptable ranges stated in EC 2002/657. The LC gradient was
also optimised in order to have a quick run time but also have enough data points for
each peak. For a method to achieve reliable quantitation each analyte peak should
have at least 10-12 data points. As this method involved positive and negative
ionisation switching the MS/MS method had to be segmented. This along with
altering the LC gradient allowed for the analysis of all 12 analytes in a complete run
time of less than 9 minutes.
In developing the milk method; the sample size was reduced to as low as possible to
allow for a more efficient extraction method with reduced extraction costs as 1ml of
milk was extracted with 2ml of acetonitrile with the addition of 0.5g of NaCl. The
extract was then evaporated to dryness and reconstituted in initial mobile phase. The
samples were filtered and run on the LC-MS/MS. The instrument was sensitive
enough to see all the analytes at low concentrations with a sample size of only 1ml.
The matrix of honey is more complex and not much work had been carried out
previously on it. The majority of methods use a SPE clean-up and this was overcome
by adapting the previous methods used for aqueous based matrices (eggs and
plasma). The honey sample was first diluted in water before extraction with
acetonitrile and the addition of NaCl. Initial studies saw that the honey was quite
difficult to dissolve in the water so the honey was first softened in an oven before the
addition of water and this allowed the honey to dissolve fully. It was also seen that
when acetonitrile was added to this solution that two layers formed after shaking. It
was decided to take top organic layer and investigate if the analytes had been
extracted into this layer. It was clear upon evaporation of this layer that some honey
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had been taken into the layer and therefore could not be reconstituted. This did not
occur when NaCl (2g) was added to the mixture and shaken. The extract was hexane
washed and evaporated to dryness. The samples were reconstituted and filtered
before been run on the LC-MS/MS. This is a much less involved extraction than used
previously with these analytes in honey but results achieved were still satisfactory.

6.4.2. Validation
Validation is carried out in accordance with the procedures outlined in Commission
Decision 2002/657/EC covering specificity, calibration curve linearity, accuracy,
precision, decision limits (CCα), decision capability (CCβ) and measurement
uncertainty. Results are seen in table 6-2 for these criteria. The ruggedness of the
method is demonstrated on an ongoing basis through the use of it to analyse National
Residue Control Plan milk and honey samples in Ireland. The criteria of relative
retention times (RRT) and ion ratios were monitored for all analytes in the four
validations days. The values identified for these were all within European
requirements. The RRT tolerance of 2.5% was adhered to when standards were
compared to samples in the validation runs. Two transition ions were monitored for
each of the twelve analytes. The most intense was used for quantitation. All ion
ratios of samples were within tolerances as set out by European criteria when
compared with standards used during validation.
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Table 6-2: Validation Results for Milk and Honey; Coefficient of Variance (%CV), Accuracy,
Decision Limits (CCα) and Detection Capabilities (CCβ), Measurement Uncertainty (MU) and
Correlation Coefficients (R2).

Analytes

CV%

Accuracy CCα

CCβ

MU

%

g L-1 / g kg-1

g L-1 / g kg-1

%

R2 Value

Milk

Honey

Milk

Honey

Milk

Honey

Milk

Honey

Milk

Honey

MNZ-OH

4.5

4.1

92.0

103.8

0.43

0.39

0.73

0.67

27

25

>0.99

HMMNI

4.1

4.6

94.5

104.2

0.42

0.42

0.71

0.71

27

29

>0.99

MNZ

7.8

6.7

92.6

108.9

0.65

0.72

1.10

1.22

30

51

>0.99

RNZ

4.3

3.5

94.3

102.4

0.41

0.38

0.70

0.66

23

24

>0.99

DMZ

9.2

9.4

96.2

94.7

1.08

0.73

1.83

1.24

40

42

>0.99

TRZ

5.4

9.0

93.9

102.0

0.53

0.78

0.91

1.34

23

56

>0.99

TNZ

15.3

12.4

90.5

104.4

1.55

1.16

2.64

1.98

61

64

>0.99

IPZ-OH

4.8

6.2

94.2

100.8

0.46

0.64

0.78

1.10

20

39

>0.99

ORZ

11.4

11.3

90.8

100.7

1.08

1.00

1.85

1.71

69

81

>0.99

CRZ

10.8

10.7

91.7

101.0

1.23

0.95

2.09

1.62

40

90

>0.99

CAP

7.5

8.0

95.1

100.7

0.07

0.08

0.11

0.13

32

31

>0.99

IPZ

4.7

4.3

95

97.8

0.52

0.40

0.88

0.68

25

35

>0.99

162

Chapter 6

Analysis of Honey and Milk for NMZs and CAP

6.4.2.1. Specificity
The technique of LC-MS/MS itself offers a great deal of specificity and selectivity.
To establish the specificity and selectivity of the method blank milk and honey
samples and samples fortified with all 12 analytes were analysed over the 3
validation days. On the fourth day 10 different types of milk and honey samples were
also analysed. Blank samples showed no interfering peaks in the area of interest for
any of the analytes. Chromatograms of blank milk and honey and milk and honey
fortified at the RL and MRPL for each of the analytes are seen in figure 6-1 and 6-2.

6.4.2.2. Linearity
The linearity of the chromatographic response was tested with matrix matched
calibration curves using six calibration points in the range of 0-20 g L-1 / g kg-1
NMZs and 0-2.0 g L-1 / g kg-1for CAP. The regression coefficients for all the
analytes on each of the validation days in both matrices were greater than 0.99.

6.4.2.3. Accuracy/Trueness
The accuracy (trueness) of the method was determined by fortifying 6 replicate milk
and honey samples at 1, 1.5 and 2 times the analytes respective RL or MRPL on
three separate days. Mean corrected recovery (n=6) of the analytes, determined in the
three separate validation batches are shown in table 6-2 range between 90.8 and
108.9% for the twelve analytes in both matrices. No absolute recovery was
determined as the use of internal standards means that each sample is individually
corrected for.

163

Chapter 6
Compound

Analysis of Honey and Milk for NMZs and CAP
A

B

MNZ-OH

HMMNI

MNZ

RNZ

DMZ

CAP
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TRZ

TNZ

IPZ-OH

ORZ

CRZ

IPZ

Figure 6-1. Chromatogram of blank milk (A) and milk (1ml) fortified at 2.5g L-1 for NMZs and
0.25g L-1 for CAP (B).
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TRZ

TNZ

IPZ-OH

ORZ

CRZ

IPZ

Figure 6-2: Chromatogram of blank honey (A) and honey (3g) fortified at 2.5g kg-1 for NMZs
and 0.25 g kg-1for CAP (B)
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6.4.2.4. Precision
Satisfactory values for inter-assay precision expressed as %CV values for the within
lab reproducibility (table 6-2) were achieved for all analytes in both matrices.
According to Commission Decision 2002/657/EC this coefficient of variance for the
repeated analysis of fortified material under reproducible conditions shall not exceed
the level calculated by the Horwitz equation. For a concentration of 100 g L-1 / g
kg-1 this equation gives a value of 23%. However when concentrations go under this
value the equation gives unacceptably high results. Therefore its stated in
Commission Decision 2002/657/EC that %CV should be kept as low as possible.
Results achieved range from 3.5 to 15.3% for all analytes in both matrices. These
acceptable results can be attributed to the availability of 7 deuterated analogues to
use as internal standards. HMMNI-d3 was used as an internal standard and worked
well for compounds with no deuterated internal standards such as CNZ, ORZ, TRZ
and TNZ.

 CC and CC
CC is defined as the limit above which it can be concluded with an error probability
of , that a sample contains the analyte. For prohibited substances an value equal
to 1 % is applied. CC is the smallest content of the substance that may be detected,
identified and quantified in a sample, with a statistical certainty of 1-, where
CC and CC were calculated using the calibration curve procedure in
accordance with ISO 11843. After identification, the signal is plotted against the
added concentration. The corresponding concentration at the y-intercept plus 2.33
times the standard deviation of the within-laboratory reproducibility of the intercept
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equals the CC. CC values of for the 12 compounds in honey and milk are listed in
Table 6-2 and are all below 1.55 g L-1 / g kg-1for the NMZs and below 0.08 g L-1
/ g kg-1 for CAP. CC is the concentration corresponding to the signal at CC +
1.64 times the standard error of the intercept (i.e. the intercept + 3.97 times the
standard error of the intercept). CC values for all compounds in honey and milk are
listed in table 6-2 and are all below the RL of 3ng mL-1and MRPL of 0.3g kg-1 for
NMZs and CAP respectively.

6.4.2.6. Measurement Uncertainty
The measurement uncertainty (MU) was estimated by taking into account the
within laboratory reproducibility over days 1, 2 and 3 as well as considering the
repeatability on day 4 due to matrix effects caused by various honey and milk
samples. These two variability’s were combined and multiplied by a coverage
factor of three to give an overall figure for the MU. This approach of using the
within laboratory reproducibility as a good estimator of measurement of uncertainty
is taken from the SANCO/2004/2726rev4 document. It recommends using the within
laboratory reproducibility and using a coverage factor of 2.33 to estimate expanded
uncertainty, however it was felt that not all the environmental factors that could be
varied over the course of the validation were examined. Therefore a coverage
factor of 2.33 may underestimate the true uncertainty of the method and instead a
value of 3 was chosen to give a more realistic value for the true uncertainty.
Values for MU are seen in Table 6-2 and lie between 23 and 69% for all compounds
in milk and between 24 and 90% for all analytes in honey.
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Higher MUs are seen in milk for some compounds with no deuterated analogues to
use as internal standards which is expected. Honey results in general display higher
MUs. High MU estimates are again seen for some of the compounds with no
deuterated analogues to use as internal standards in particular ORZ (81%) and CRZ
(90%). Their MU estimates in honey are the highest due to large values for
reproducibility due to matrix as a result of a variation between matrices used in the
day 4 experiment and the lack of suitable internal standards.

6.5.

Conclusions

The objective of this work was to develop a rapid multi-class multi-residue
confirmatory method capable of identifying, confirming and quantifying eleven
NMZ compounds and CAP in milk and honey at µg L-1 and µg kg-1 levels and to
validate according to the requirements in Commission Decision 2002/657/EC. This
was successfully completed.
The method can be considered as rapid, as it utilises an efficient extraction protocol
without the use of SPE. It also utilises chromatography which separates all analytes
in a total run time of only 9 minutes. The method includes the confirmatory analysis
of CAP and 11 NMZs in milk and honey which has not been seen before.
The obtained data fulfils the requirements laid down in Commission Decision
2002/657/EC and allows the calculation of all relevant performance characteristics.
This study shows that the developed method meets the required sensitivities of 3 g
L-1 / g kg-1 for NMZs and 0.3g L-1 / g kg-1for CAP which are the RL and MRPL
used for these compounds. The CC and CC values determined for each analyte are
lower than this level. The method performs very well in terms of accuracy and
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repeatability for each of the analytes due to the utilisation of seven different
deuterated internal standards. The values achieved for accuracy, %CV and
measurement of uncertainty all fall within acceptable ranges. The applicability of the
method for use on various types of milk and honey samples was demonstrated by the
satisfactory results obtained from the Day 4 analysis of different species. The
reduced number of analytical steps within the method makes it very amenable for
high through-put regulatory monitoring of these compounds.
From examination of published literature, no method was found that was capable of
the sensitive confirmatory analysis of CAP and eleven NMZs in milk and honey.
Methods published on these matrices analysed at most seven analytes and in the case
of CAP often analysed as a single analyte method. The method developed in this
study allows for improvement on any existing method as it allows for the analysis of
an increased number of analytes in matrices that have been previously overlooked. It
also allows for reduced sample preparation times as SPE clean-up has been omitted.
In the case of the extraction protocol for milk time and solvent usage is greatly
reduced compared to other published methods as a result of reduced sample size of
1mL.
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7.1 Abstract
A confirmatory method has been developed to allow for the analysis of fourteen
prohibited medicinal additives in pig and poultry compound feed. These compounds
are prohibited for use as feed additives although some are still authorised for use in
medicated feed. Feed samples are extracted by acetonitrile with addition of sodium
sulphate. The extracts undergo a hexane wash to aid with sample purification. The
extracts are then evaporated to dryness and reconstituted in initial mobile phase. The
samples undergo an ultracentrifugation step prior to injection onto the LC-MS/MS
system and are analysed in a run time of 26 minutes. The LC-MS/MS system is run
in MRM mode with both positive and negative electrospray ionisation. The method
was validated over three days and is capable of quantitatively analysing for
metronidazole,

dimetridazole,

ronidazole,

ipronidazole,

chloramphenicol,

sulfadiazine, sulfamethazine, dinitolimide, ethopabate, carbadox and clopidol. The
method is also capable of qualitatively analysing for tylosin, virginiamycin and
avilamycin. A level of 100 µg kg-1 was used for validation purposes and the method
is capable of analysing to this level for all the compounds. Validation criteria of
trueness, precision, repeatability and reproducibility along with measurement
uncertainty are calculated for all analytes.

Keywords: Antibiotics; pig and poultry compound feed; lc-ms/ms; validation.
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7.2 Introduction
The use of many antibiotics, coccidiostats and antibacterial growth promoters as feed
additives

has

been

prohibited

in

Europe

since

2006

by

Commission

Recommendation 2005/925/EC. This recommendation lists medicinal substances that
should be monitored and the substances are divided into two groups; medicinal
substances authorised as feed additives for certain animal species or categories and
medicinal substances no longer authorised as feed additives. This paper focuses on
the analysis of the second group of medicinal substances specifically antibacterial
growth promoters (AGPs) which are no longer authorised as feed additives; this
group consists of various different types of compounds. Nitroimidazoles and
chloramphenicol are banned for use in food producing animals. Other AGPs which
include virginiamycin and tylosin are prohibited for use as feed additives. Finally
some compounds such as sulfonamides are only permitted for use in medicated feed.
The structures for all fourteen analytes are presented in Tables 7-1a and 7-1b.
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Table 7-1a. Molecular Structures, Retention time (Rt), Precursor and Product ions and typical
ion ratios for all 11 analytes
Compound
Ipronidazole (IPZ)
2-isopropyl-1-methyl-5nitroimidazole

Dimetridazole (DMZ)
1, 2-dimethyl-5-nitroimidazole

Metronidazole (MNZ)
1-(2-hydroxyethyl)-2-methyl-5nitroimidazole

Ronidazole (RNZ)
1-methyl-2-[(carbamoyloxy)
methyl]-5-nitroimidazole

Molecular Structure

Rt

Precursor
Ion (M/z)

9.90

170

2.83

1.95

2.21

Sulfadiazine (SDZ)
4-amino-N-pyrimidin- 2-ylbenzenesulfonamide

Sulfamethazine (SMZ)
2-(p-Aminobenzenesulfonamido)4,6-dimethylpyrimidine

Ethopabate (EPB)
methyl 4-(acetylamino)-2ethoxybenzoate

Clopidol (CLOP)
3,5-Dichloro-2,6-dimethyl-pyridin4-ol

13.46

2.39

4.29

14.16

2.00

Dinitolmide (DINIT)
2-Methyl-3,5-dinitrobenzamide

2.65

7.68

124

18

109

25

96

18

81

28

82

25

128

15

140

15

110

18

257

18

152

12

110

23

156

17

186

17

156

19

136

32

206

13

128

24

101

26

175

19

130

22

151

18

181

12

172

201

321

251

279

238

192

Carbadox (CAR)
methyl (2E)-2-[(1,4dioxidoquinoxalin-2-yl)
methylene]hydrazinecarboxylate

Collision
Energy

142

Chloramphenicol (CAP)
2,2-dichloro-N-[(1R,2R)-2hydroxy-1-(hydroxymethyl)-2-(4nitrophenyl)ethyl]acetamide

Product
Ions

263

224
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Table 7-1b: Molecular Structures, Retention time (Rt), Precursor and Product ions and collision
energies for all 3 analytes.

Compound

Tylosin (TYL)

Viginiamycin (VIR)

Avilamycin (AVIL)

Molecular Structure

Rt

14.03

16.12

14.89

Precursor
Ion (M/z)

Product
Ions (M/z)

Collision
Energy

772

29

174

37

355

20

508

15

373

45

391

48

917

526

791

Nitroimidazoles and chloramphenicol are classified as prohibited substances in table
2 of Commission Regulation 2010/37/EC and therefore prohibited for the use in
animal husbandry. As a result these should not be found in animal feeds. While there
are single class methods for the analysis of some of compounds [Vincent et al., 2008;
Galarini et al., 2009; Pecorelli et al., 2003; Barbosa et al., 2007; van Holthoon et al.,
2010] there are very few published methods for nitroimidazoles and chloramphenicol
in animal feed. Capitan-Vallvey et al., 2007 describes a method for the analysis of
nitroimidazoles in feed by LC-MS and Vinas et al., 2006 describes a method for
chloramphenicol in feed by LC-photo diode array detector.
The use of 5 AGPs including tylosin and virginiamycin were prohibited for this use
in Council Regulation 2821/98. As a result there are some published methods for the
176

Chapter 7

Prohibitted Medicinal Additives in Feed

analysis of these compounds. Van Poucke et al. described a method for the analysis
of tylosin and virginiamycin in feed by LC-MS/MS [Van Poucke et al., 2003 Van
Poucke et al., 2005] and Civitareale et al., 2004 describes a method for the analysis
of tylosin by LC-UV/DAD. Other medicinal additives listed in 2005/925/EC also
have LC methods for their analysis such as clopidol/nicarbazin [Dusi et al., 2000],
amprolium/ethopabate [Tan et al., 1996] and carbadox [Kesiunaite et al., 2008;
Hutchinson et al., 2005] while for compounds such as dinitrolimide no published
methods exist for their analysis. The majority of methods published for the list of
compounds specified in 2005/925/EC allow for the analysis of these compounds at
levels relating to therapeutic level or in the mg kg-1 range while only a few allow for
the analysis in the µg kg-1 range. Also, from examination of literature the majority
of methods are single or dual analyte methods while very few are capable of
analysing for a particular class of compounds.
From a review of the literature it would seem there is a lack of published methods
available that would help with the enforcement of Commission Recommendation
2005/925/EC. In addition to this, methods available are for single analytes/classes at
mg kg-1 range; often utilising large sample sizes which in turn need large amounts of
solvent for extraction which can prove expensive and time consuming. Reports from
the Screening and Identification Methods for official control of Banned Antibiotics
and Growth promoters in Feedingstuffs study (SIMBAG-FEED study) suggested that
methods be able to identify compounds to at least 5 times lower than the lowest
contents formerly described in the Directive 70/524/CEE. In many cases this was
around the 1ppm range [de Jong, 2005]. To aid compliance with Commission
Recommendation 2005/925/EC there is a need for an efficient sensitive multi-class
method to analyse for as many of the analytes listed in this recommendation as
177

Chapter 7

Prohibitted Medicinal Additives in Feed

possible. To this end; this paper describes the analysis of 14 of these prohibited
medicinal additives at 100 µg kg-1 levels in pig and poultry compound feed by LCMS/MS utilising a small sample size of 2 g and an efficient sample extraction
procedure.

7.3 Materials and Methods

7.3.1 Chemicals and Reagents
Dimetridazole (DMZ), ronidazole (RNZ), chloramphenicol (CAP), sulfadiazine
(SDZ), sulfamethazine (SMZ), dinitolimide (DINIT), ethopabate (ETB), carbadox
(CAR), clopidol (CLOP) and sulfaphenazole (SPZ) were purchased from Sigma (St.
Louis, MO, USA), metronidazole (MNZ), ipronidazole(IPZ), d3-IPZ, d3-DMZ, d3RNZ were purchased from WITEGA Laboratorien (Berlin, Germany), d5chloramphenicol were purchased from Dr Ehrenstorfer (Augsborg, Germany) and
tylosin, virginiamycin and avilamycin were received from RIKILT (Wageningen, The
Netherlands). Water was of LC-MS grade from Fluka (Germany). All other solvents
were of LC grade and purchased from Reagecon (Clare, Ireland). Anhydrous Sodium
sulphate was AnalaR grade and purchased from Acros (Geel, Belgium). Individual
stock standards of each analyte ranging between 0.25-1.00 mg ml-1 in ethanol were
prepared and stored at 4˚C. A working standard solution (mixture of analytes) (10 ug
mL-1) was prepared in acetonitrile and stored at 4º. Internal standards were prepared
similarly.

7.3.2 Instrumentation
The LC-MS/MS system was a TSQ Quantum Ultra EMR coupled to a Finnigan
Surveyor LC system. The instrument was controlled by Xcalibur software (Version
178

Chapter 7

Prohibitted Medicinal Additives in Feed

1.5). Separation was achieved using a (100  2)mm, 3m particle size, Luna C18
column (Part No. 00D-4251-B0) protected by a Security Guard guard cartridge
system (202)mm, both supplied by Phenomenex. The oven temperature was set at
40ºC. The chromatographic separation was performed in gradient mode using water
acidified with 0.2% acetic acid (mobile phase A) and acetonitrile acidified with 0.2%
acetic acid (mobile phase B), at a flow rate of 0.25mL min-1. The initial conditions
from 0-6min were 85% A. This was changed to 50% A over 2 minutes from 6-8min
and was maintained until 10 min. The conditions were changed again to 10% A over
2 minutes from 10-12 min and these were maintained until 15.20 min. Finally the
conditions returned to 85% A over 2.8 minutes from 15.20-18min and were
maintained until the end of the run at 26min. Electrospray ionisation (ESI) was used
in the MS with both positive and negative ionisation mode, with a spray voltage of
4350V and a cone temperature of 325 ºC. The individual precursor and products ions
for each analyte with their respective collision energies are listed in Tables 7-1a and
7-1b.

7.3.3 Pig and Poultry Compound Feed Samples
Different varieties of pig and poultry compound feed were sourced from various feed
mills. These were milled upon receipt to 1mm using a Retsch SM 100 mill and stored
in amber jars at 4ºC. Portions of these samples were analysed and those found to
contain no detectable residues of the analytes of interest except for residues of
sulfadiazine were used as blanks for the validation study. To ensure true robustness of
the method a high number of different feed samples were used in validation. These
included 18 different pig feeds and 18 different poultry feeds. Chromatograms of
blank feed can be seen in Figure 7-1b.
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7.3.4 Extraction
Feed (2 g) was weighed into polypropylene centrifuge tubes (50 mL). The sample
was fortified with mixed internal standard (50 µL) which corresponds to a
concentration of 250 µg kg-1 of internal standard in the feed material. To this
acetonitrile (12 mL) was added and the tubes were vortexed (20 secs). Anhydrous
sodium sulphate (3.5 g) was added to this slurry which was shaken (30 mins) and
centrifuged (5100rpm for 20 min). The organic layer was transferred to a clean
polypropylene tube (15 mL) and evaporated at 50ºC to 6 mL under nitrogen. Hexane
(5 mL) was added and the tubes contents were vortexed (30 secs) and centrifuged
(3750 rpm for 20 min). The hexane layer was discarded and the extracts were
evaporated to dryness at 50ºC under a nitrogen stream. The extract was reconstituted
in water: acetonitrile (85:15, 800 µL) and vortexed thoroughly for 45 secs. The
sample underwent an ultra-centrifugation step at 13750 rpm for 30 mins. This
centrifugation step separated the sample into two distinct layers. 200 µL of the clear
lower layer (containing the analytes) was transferred into an LC-MS vial. An aliquot
(20 µL) was injected onto the LC column.

7.3.5 Matrix Extracted Calibration Curves
Quantitation was carried out using matrix extracted calibration curves. Blank pig and
poultry feed samples were used. These samples were fortified with mixed working
standard and submitted to the full extraction procedure. Matrix extracted calibration
curves were performed with every batch. Six different feed samples are fortified with
internal standard and mixed working standard yielding a calibration range of 0 to
1000 µg kg-1 for all the 11 quantitation analytes. Calibration curves were prepared by
plotting the response factor (the ratio of peak area analyte over peak area of internal
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standard) against analyte concentration. Five internal standards were used; d3- DMZ,
d3-RNZ, d3-IPZ, d5-CAP and Sulfaphenazole. For those compounds for which no
suitable deuterated internal standard could be acquired; MNZ, CLOP, DIN, ETB and
CAR, d3-DMZ was used as an internal standard. For each analyte; calibration curves
were linear in the given range with a correlation coefficient of at least 0.98. In the
case of the 3 qualitative analytes, TYL, VIR and OLA no suitable internal standard
could be found. This resulted in poor linearity as matrix effects could not be corrected
for in a repeatable manner. For these analytes six different feed samples were
fortified; one at 0 µg kg-1 and five at the 100 µg kg-1. d3-DMZ was used as an internal
standard for these in order to compensate for any extraction errors.

7.3.6 Method Validation
LC–MS/MS identification criteria were verified throughout the validation study by
monitoring relative retention times and relative ion intensities. LC-MS/MS
identification criteria as set out in the Commission Decision 2002/657 were verified
throughout the validation of the method.
Several method validation parameters were determined including linearity,
specificity, trueness, precision (repeatability and within-laboratory reproducibility).
Specificity was determined by analysing a number of different blank animal feed
samples sourced from different mills. To investigate the linearity of the method,
matrix-extracted calibration curves were prepared and run with each of the validation
batches to give 6 point calibration curves in the range of 0 to 1000 g kg-1 for all
eleven quantitation analytes. To ensure linearity across the range of different feed
samples that could be encountered for these species a different type of feed
alternating between pig and poultry was used for each calibration point.
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Since no certified reference materials were available for the analytes and matrices of
interest, the trueness from fortified negative samples was measured as an alternative
to trueness. The trueness and precision of the method were determined through the
analysis of negative pig and poultry compound feed fortified in six replicates at 100
µg kg-1, 500 µg kg-1 and 1000 µg kg-1 with the eleven quantifiable analytes for a total
of 18 samples. This was repeated on three separate days. For the three qualititative
analytes all 18 samples were fortified at 100 µg kg-1. The type of feed was varied for
each of the six replicates in ordered to ensure that the method was fully fit for
purpose. From these three separate validation days an estimation of trueness,
precision (repeatability and within-laboratory reproducibility) and LC-MS/MS
confirmatory criteria were all evaluated.

7.4 Results and Discussion

7.4.1 LC-MS/MS Optimisation
The LC-MS/MS method was developed to provide confirmatory data for the analysis
of 14 antibiotics in pig and poultry compound feed. The MS/MS fragmentation
conditions were investigated and collision energies were optimised for each
individual compound to give best response. For a method to be deemed confirmatory
under Commission Decision 2002/657/EC it must yield 4 identification points. In
this method a precursor ion (parent mass) and two product ions (corresponding to
strong and weak ion) were monitored for each analyte (Tables 7-1a and 7-1b). This
yielded 4 identification points (1 for the precursor ion and 1.5 for each product ion)
hence it can be deemed a confirmatory method. In addition to this relative retention
times and ion ratios were monitored for each compound and evaluated to ensure that
they are within acceptable ranges as stated in CD 2002/657/EC. As this method
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involved positive and negative ionisation switching the MS/MS method had to be
segmented. The LC gradient was optimised in order to have as an efficient run time
as possible in order to allow successful segmentation of the MS/MS method. Only
when the positive and negative ionisation switching was isolated to one segment was
there enough data points for each peak. Lowering scan time and dwell time of the
instrument was not sufficient to achieve this. For a method to achieve reliable
quantitation each analyte peak should have at least 10-12 data points. The LC
gradient along with segmentation permitted for the analysis of all 14 analytes in a
complete run time of 26 minutes with each peak having a minimum of 12 data
points.

7.4.2 Sample Extraction Development
The development of the extraction method faced two major obstacles; one the need
to extract a wide variety of analytes with a single extraction and the other the need to
purify the sample sufficiently without losing the analytes in question. A variety of
extraction solutions including water, acetonitrile and methanol and various mixtures
of the three were tested. Immediately it was visibly evident that methanol and water
extracted far more matrix contaminants than acetonitrile and this resulted in lower
recoveries for the analytes using these extraction solvents. It was also observed that
acetonitrile consistently extracted the broad range of analytes therefore acetonitrile
was chosen as the extraction solvent. The next stage was to sufficiently clean up the
acetonitrile extract in order to determine down to the levels of interest. The use of
anhydrous sodium sulphate in sample clean up when extracting these analytes has
been previously seen. [Stubbings et al., 2009]. Hence the use of anhydrous sodium
sulphate was investigated followed by addition of a hexane wash step. This
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purification procedure sufficiently removed background interferences resulting in the
fact that a SPE clean-up step was not needed. The purification was completed when
the reconstituted extract underwent an ultracentrifugation step. This removed further
interferences and also allowed all analytes to be determined at levels in the µg kg-1
range.

7.4.3 Internal Standard Selection
While the extraction method allowed all analytes to be seen in the µg kg-1 range the
variability in sample recovery was noticeable from feed sample to feed sample. To
overcome this problem the sourcing of suitable internal standards was pursued. In
some cases deuterated analogues were available for the analytes such as d3-DMZ,
d3-IPZ, d3-RNZ and d5-CAP. These corrected well for all variabilities encountered
in extraction. Sulfaphenazole is a sulphonamide and it has been used as an internal
standard for sulfonamides in previous work [McDonald et al., 2009]. This was used
for SDZ and SMZ compounds and corrected sufficiently for them. Erythromycin was
tried for use with VIR, TYL and AVIL but did not correct consistently well for them.
As a last attempt the internal standards used for other compounds were used for the
remaining compounds without internal standards. It was observed that d3-DMZ
extracted consistently and as a result could be used as an internal standard for CLOP,
CAR, DIN and ETH. This allowed for eleven compounds to be analysed
quantitatively. For the remaining three compounds VIR, TYL and AVIL no suitable
internal standard could be identified. Therefore the method could only be used as a
qualitative extraction method for these compounds.
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7.4.4 Validation Approach Selection
As of yet no official EU validation protocol exists for the analysis of veterinary drugs
in animal feed. Therefore a validation protocol was designed in order to best show
that the method was fit for purpose. It was seen in development the variability due to
the matrix feed is significant. In order to prove that the method would extract all
analytes in a wide range of pig and poultry compound feed it was decided that feed
samples would be varied as much as possible. For each of the calibration curve
points a different feed would be used on each validation day to ensure linearity held
through for all feeds. Eighteen samples were analysed on each day of the three
validation days containing six different types of animal. A level of 100µg kg-1 was
chosen as a reporting level and this is significantly lower for the majority of the
analytes presented in this paper than observed in previous methods. SIMBAG study
suggested levels around 1000 µg kg-1 but it was felt that as these compounds are
banned they should not be present at any level. These compounds are prohibited for
use as feed additives and therefore these compounds should not be present at any
level and therefore the ALARA (as low as reasonably achievable) principle was
adopted. Work carried out prior to validation indicated that a level of 100µg kg-1
was achievable. This was chosen as it was felt that the method could be used to
determine this level on a routine basis for all analytes. For the three qualitative
analytes TYL, VIR, OLA it was decided that all eighteen samples on the three
different days would be fortified at the reporting level of 100 µg kg-1. The
measurement of uncertainty for each analyte would be calculated and added onto the
100 µg kg-1level and give us a value above which would result in a positive. For the
eleven quantitative analytes a different approach was taken. The eighteen samples on
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the three days would be made up of six replicates of 100, 500 and 1000g kg-1. This
was done in order to validate the method over the complete calibration range for
which positive results might be obtained. Specificity, trueness, precision
(repeatability and within-laboratory reproducibility); along with confirmatory criteria
laid out Commission Decision 2002/657 were determined during validation.

7.4.5 Specificity
The technique of LC-MS/MS itself offers a great deal of specificity and selectivity.
To establish the specificity and selectivity of the method 18 blank pig and poultry
compound feed samples and samples fortified with all 14 analytes were analysed
over the 3 validation days. All blank samples showed no interfering peaks in the area
of interest for any of the analytes except for sulfadiazine. This is as a result of low
levels of sulfadiazine found in the majority of feed samples available. Sulfadiazine is
still permitted to be used in medicated feed and this might possibly be the reason for
low levels been found in the feed. In order to correct for this, the feed samples were
analysed prior to validation and the response observed for SDZ was subtracted from
the results achieved during the validation procedure. Although this corrected the
results somewhat, the variability in the background sulfadiazine resulted in worse
validation results for this compound than the others. Chromatograms of blank feed
and feed fortified at 100 µg kg-1 for each of the fourteen analytes are seen in Figure
7-1a and 7-1b.
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Figure 7-1a: Chromatograms of Feed Fortified at a level equal to 100 g kg-1 for all 14
compounds.
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Figure 7-1b: Chromatograms of Blank Feed

7.4.6 Linearity of Response
The linearity of the chromatographic response was tested with matrix extracted
calibration curves using six calibration points in the range of 0-1000g kg-1 for all
eleven quantitative analytes on each of the validation days. The regression
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coefficients for all the analytes on each of the validation days in were greater than
0.98.
Table 7-2: Validation results for Accuracy, Repeatability, Reproducibility and Measurement
Uncertainty (MU) and Confirmatory data of typical ion ratios and relative retention
times(RRT) for all 14 analytes.
Cut-Off
Internal

Accuracy

Repeat

Reprod

MU

Typical

Typical

Standard

(%)

%RSD

%RSD

(%)

RRT

Ion Ratio

Level

Analyte

µg/kg
DMZ

DMZ-d3

98.9

4.5

8.9

27

1.0100

0.2344

100

RNZ

RNZ-d3

99.1

6.3

9.0

27

1.0053

0.0395

100

MNZ

DMZ-d3

102.5

5.8

9.3

28

0.6911

0.2964

100

IPZ

IPZ-d3

99.4

4.3

7.2

24

1.0164

0.8382

100

SDZ

SPZ

101.4

23.3

28.0

84

0.1666

0.4667

100

SMZ

SPZ

101.4

16.8

20.6

55

0.2987

0.2815

100

CAR

DMZ-d3

99.9

12.6

13.9

42

0.9466

0.1610

100

CAP

CAP-d5

101.2

11.4

12.0

36

1.0082

0.8108

100

CLOP

DMZ-d3

103.3

10.8

16.0

48

0.7125

0.3653

100

DINIT

DMZ-d3

96.3

7.7

14.8

44

2.7345

0.1880

100

ETB

DMZ-d3

99.4

9.1

16.3

49

5.0406

0.5094

100

TYL

DMZ-d3

95.6

16.8

21.8

69

5.0000

0.7275

169

VIR

DMZ-d3

100.0

22.7

22.9

65

5.7381

0.3777

165

AVIL

DMZ-d3

89.2

21.1

22.0

66

5.2961

0.4851

166
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7.4.7 Ion Ratios
Two transition ions were monitored for each of the fourteen analytes. The most
intense was used for quantitation. Ion ratios were calculated for all analytes. The ion
ratio is a ratio of ion responses. The ratios of weak ion responses/strong ion
responses are presented in Table 7-2. All ion ratios of samples were within tolerances
as set out by European criteria when compared with standards used during validation.
Control charts were used to ensure all ion ratios were acceptable. The example of
metronidazole is seen in Figure 7-2.

7.4.8 Relative Retention Times (RRT)
RRTs were calculated for all fourteen analytes in this method by calculating the ratio
of the retention time of the analyte over the retention time of its corresponding
internal standards. The RRTs tolerance for LC-MS/MS of 2.5% was adhered to when
standards were compared to samples in the validation runs. Control charts were again
used to ensure all ion ratios were acceptable. The example of metronidazole is seen
in Figure 7-3. The typical RRT for all the analytes are shown in Table 7-2.
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Metronidazole
Weak Ion
Peak Area
Ion Ratio

Strong Ion
Peak Area

Sample
Std 100 g kg
-1
Std 250 g kg
-1
Std 500 g kg
-1
Std 750 g kg
-1
Std 1000 g kg
Level 1 A
Level 1 B
Level 1 C
Level 1 D
Level 1 E
Level 1 F
Level 2 A
Level 2 B
Level 2 C
Level 2 D
Level 2 E
Level 2 F
Level 3 A
Level 3 B
Level 3 C
Level 3 D
Level 3 E
Level 3 F
-1

15194729
42333522
72310544
111573188
141124965
15930883
13779107
15060999
14015787
14936729
15109412
82300381
55668164
98201444
86217956
88044794
88971771
183983033
157024199
170214626
170597905
177451858
163816078

4752084
12107683
20962631
33615028
41197657
4802808
4100715
4687121
4045653
4494700
4330588
23812667
16886535
27970852
24778305
25699990
27257657
50847934
45227252
50069929
48706960
50805992
47947886

20%+

0.3127
0.2860
0.2899
0.3013
0.2919
0.3015
0.2976
0.3112
0.2886
0.3009
0.2866
0.2893
0.3033
0.2848
0.2874
0.2919
0.3064
0.2764
0.2880
0.2942
0.2855
0.2863
0.2927

20%-

0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556
0.3556

0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371
0.2371

Average Std Ion Ratio: 0.2964
Average + 20%
: 0.3556
Average – 20%
: 0.2371
Metronidazole

Ion Ratios Control Chart

20%+
20%-

0.3800
0.3600

Ion Ratios

0.3400
0.3200
0.3000
0.2800
0.2600
0.2400
0.2200
0.2000
Le v

Le v

Le v

Le v

Le v

Le v

Le v

Le v

Le v

Le v

Le v

Le v

Le v

Le v

Le v

Le v

Le v

F
el 3

E
el 3

D
el 3

C
el 3

B
el 3

F
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2
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Sample No.

Figure 7-2: Control Chart for Ion Ratio of Metronidazole
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Retention
Time

Sample
Std2
Std3
Std4
Std5
Std6

Metronidazole
Relative
Retention Time
Retention Time
of Internal
(RRT)
Standard

Std 100
Std 250
Std 500
Std 750
Std 1000
Level 1 A
Level 1 B
Level 1 C
Level 1 D
Level 1 E
Level 1 F
Level 2 A
Level 2 B
Level 2 C
Level 2 D
Level 2 E
Level 2 F
Level 3 A
Level 3 B
Level 3 C
Level 3 D
Level 3 E
Level 3 F

1.94
1.95
1.94
1.94
1.94
1.95
1.94
1.94
1.93
1.95
1.94
1.94
1.94
1.94
1.94
1.94
1.94
1.96
1.94
1.94
1.94
1.95
1.95

2.82
2.80
2.82
2.80
2.81
2.82
2.82
2.80
2.80
2.80
2.82
2.82
2.82
2.82
2.82
2.82
2.82
2.82
2.80
2.80
2.80
2.82
2.82

0.6879
0.6964
0.6879
0.6929
0.6904
0.6915
0.6879
0.6929
0.6893
0.6964
0.6879
0.6879
0.6879
0.6879
0.6879
0.6879
0.6879
0.6950
0.6929
0.6929
0.6929
0.6915
0.6915

2.5%+

2.5%-

0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084
0.7084

0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738
0.6738

Average RRT: 0.6911
Average + 2.5%: 0.7081
Average – 2.5%: 0.6738
Relative Retention Times Control Charts

Metronidazole
2.5%+
2.5%-

0.7200
0.7100

RRT

0.7000
0.6900
0.6800
0.6700
0.6600
0.6500
el 2

el 1

el 1

el 1

el 1

el 1
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Figure 7-3: RRT Control Chart for Metronidazole
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7.4.9 Trueness
The trueness of the method was determined by fortifying 18 replicate feed samples
on three separate days. For the eleven quantitative analytes six replicates were
fortified at 100, 500, 1000g kg-1 while the three qualitative analytes were all spiked
at 100g kg-1 for the 18 replicates. Mean corrected trueness (n=6) of the analytes,
determined in the three separate validation batches, are shown in Table 7-2 ranging
between 89.2 and 103.3 for the fourteen analytes in pig and poultry feed. No
recovery was determined as the use of internal standards means that each sample is
individually corrected for.

7.4.10 Precision (Repeatability and within-lab Reproducibility)
Repeatability (within-day) and within-laboratory reproducibility (different days and
operators) were determined by calculating relative standard deviations (RSD, %) for
the repeated measurements. Overall repeatability (RSD, %) and within-laboratory
reproducibility (RSD, %) ranged from 4.3 to 23.3% and from 7.2 to 28.0%,
respectively, for all analytes (Table 7-2).
The usefulness of suitable deuterated internal standards is demonstrated in the
acceptable results for repeatability and within-laboratory reproducibility obtained for
DMZ, RNZ, IPZ and CAP. Although deuterated analogues could not be obtained by
our laboratory for use as internal standards for over half of the analytes investigated,
acceptable repeatability and within-laboratory reproducibility is obtained by using
the d3-DMZ for MNZ, CLOP, DINIT, ETH, CAR and using sulfaphenazole for
SMZ. Less favorable is the situation for SDZ. Rather high RSD values were obtained
for both the repeatability and within-laboratory reproducibility of SDZ (between 20
and 28%), even when applying correction by means of an internal standard
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(sulfaphenazole). This is as a result of the variability for the feed sample due to the
low levels of SDZ present in the feed.

7.4.11 Measurement of Uncertainty
The measurement uncertainty (MU) was estimated by taking into account the within
laboratory reproducibility over days 1, 2 and 3. This value was multiplied by a
coverage factor of three to give an overall figure for the MU. This approach of
using the within laboratory reproducibility as a good estimator of measurement of
uncertainty is taken from the SANCO/2004/2726rev4 document. It recommends
using the within laboratory reproducibility and using a coverage factor of 2.33 to
estimate expanded uncertainty, however it was felt that not all the environmental
factors that could be varied over the course of the validation were

examined.

Therefore a coverage factor of 2.33 may underestimate the true uncertainty of the
method and instead a value of 3 was chosen to give a more realistic value for
the true uncertainty. Values for MU are seen in Table 7-2 and lie between 24 and
84% for all the analytes.
Higher MUs are seen in some compounds with no deuterated analogues for use as
internal standards which is expected. In particular the MU for SDZ (84%) is the
highest observed for any of the analytes investigated due to problems with low levels
of SDZ observed in the majority of feed used. This resulted in greater variability in
results achieved for SDZ and in turn increased its MU.

7.5 Conclusions
The objective of this work was to develop a rapid multi-class confirmatory method
capable of analysing for fourteen prohibited medicinal additives in pig and poultry
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compound feed at 100 g kg-1 and to validate in such a way as to best show the
method as fit for purpose. This was successfully completed to allow for the
quantification of 10 analytes and qualitative analysis of 4 analytes.
The method can be considered as rapid, as it utilises an efficient extraction protocol
without the use of large sample sizes, extraction volumes and SPE. It also utilises
chromatography which separates all analytes in a total run time of only 26 minutes.
The method permits the analysis of 14 medicinal additives in pig and poultry
compound feed which has not been seen in literature before.
The obtained confirmatory criteria of ion ratios and relative retention times fulfill the
requirements laid down in Commission Decision 2002/657/EC. The calculation of all
relevant performance characteristics was performed during validation. This study
shows that the developed method meets the desired sensitivity of 100 µg kg-1 for all
the compounds. The method performs satisfactorily in terms of trueness and
repeatability for each of the analytes investigated with the exception of sulfadiazine
due to the utilisation of five different internal standards. The values achieved for
trueness, %RSD and measurement of uncertainty all fall within acceptable ranges
except for sulfadiazine. The applicability of the method for use on various types of
pig and poultry compound feed was demonstrated by the satisfactory results obtained
from the validation. The validation data shows that the method allows for the
quantitation of 10 analytes and the qualitative analysis of 3 analytes. While
sulfadiazine was validated in order to be quantified the validation results achieved
were not acceptable. This is as a result of varying background sulfadiazine in the
feeds that were used in validation. That said, the reduced number of analytical steps
within the method makes it very amenable for high through-put regulatory
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monitoring of these compounds and enforcing Commission Recommendation
2005/925/EC.
The method developed in this study is an improvement on existing methods as it
allows for the analysis of an increased number of analytes in this matrix. It also
allows for reduced sample preparation times and solvent usage than other published
methods.
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8.1 Abstract
A confirmatory multi-residue method has been developed to allow for the detection,
confirmation and quantification of eleven coccidiostats in animal feed by liquid
chromatography-tandem mass spectrometry (LC-MS/MS). The method can be used
to determine halofuginone, robenidine, nicarbazin, diclazuril, decoquinate,
semduramicin, lasalocid, monensin, salinomycin, narasin, maduramicin at levels
relating to unavoidable carry over as stated in Regulation 2009/8/EC. Feed samples
are extracted with water and acetonitrile with the addition of anhydrous magnesium
sulphate and sodium chloride. The extract then undergoes a freezing out step before
being diluted and injected onto the LC-MS/MS system. The LC-MS/MS system is
run in MRM mode with both positive and negative electrospray ionisation and can
confirm all eleven analytes in a run time of 19 minutes. The sensitivity of the method
allows quantification and confirmation for all coccidiostats at a 0.5% carry over
level. The method was validated over three days in accordance with of European
legislation; Commission Decision 2002/657/EC. Validation criteria of accuracy,
precision, decision limit (CC, and detection capability (CCalong with
measurement uncertainty are calculated for all analytes. The method was then
successfully used to analyse a number of feed samples that contained various
coccidiostat substances.

Keywords: Coccidiostats; Regulation 2009/8/EC; LC-MS/MS; Animal Feed;
Validation.
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8.2 Introduction
The use of many antibiotics, coccidiostats and antibacterial growth promoters as feed
additives

has

been

prohibited

in

Europe

since

2006

by

Commission

Recommendation 2005/925/EC. This recommendation lists medicinal substances that
should be monitored and the substances are divided into two groups; medicinal
substances authorised as feed additives for certain animal species or categories and
medicinal substances no longer authorised as feed additives. Following this ban of
antibiotics such as tylosin, virginiamycin and spiramycin as feed additives no
antibiotics other than coccidiostats and histomonostats can be marketed and used as
feed additives within the European Union. Coccidiostats constitute the main choice
to fight against coccidiosis. Coccidiosis is a parasitic disease of the intestinal tract
caused by unicellular organisms. The disease is highly contagious and spreads from
one animal to another by contact with infected faeces. Coccidiosis is a major disease
in poultry as well as in many other hosts. [Matabudul et al., 1999]
During the production of feed containing coccidiostats as feed additives, unavoidable
carry-over of the coccidiostats from target to non target feed occur from the use of
the same production lines. This may lead to high concentrations of coccidiostats in
non-target feed; which could harm certain species and also accumulation of
coccidiostats may be a risk to human health. As a result of these concerns and in
order to avoid coccidiostat carry-over, Regulation 2005/183/EC sets specific
requirements for companies using coccidiostats in the production of feed, pertaining
particularly to facilities and equipment, production, storage and transport, to avoid
any cross-contamination. In addition to this EU legislation was published in the form
of Regulation 2009/8/EC and this established maximum limits for unavoidable carry
over of coccidiostats and histomonostats. Taking into account the application of good
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manufacturing practices, carry-over rates of approximately 1 and 3% of the
authorised maximum content should be considered for sensitive and less sensitive
non-target animal species, respectively. A carry-over rate of 1% should also be
considered for feed used during the period before slaughter, for other target species
feed to which no coccidiostats are added, and for non-target feed for ‘continuous
food producing animals’ (dairy cows or laying hens). The structures and the 1% and
3% carry over levels of all the coccidiostats covered by this legislation are seen in
table 8-1.
As a result of this legislation there is a need for reliable multi-residue methods to
help enforce it. From examination of literature it was observed that there is a limited
amount of methods available to carry out this work. There are number of methods for
the analysis of these substances in various biological matrices such as liver, muscle
and eggs [Dubois et al., 2004; Olejnik et al., 2009; Mortier et al., 2005(a)]. Methods
for the analysis of feed for some of these compounds are varied; from the analysis of
one analyte [de la Huebra et al., 2010; Mortier et al., 2005(b); Kot-Wasik et al.,
2005] up to the analysis of several [Vincent et al., 2008; Mortier et al., 2005(a)]. A
method by Vincent et al., 2008 allowed for the analysis of the six ionophore
coccidiostats by LC-MS/MS. Purification was by solid phase extraction and
quantification was by matrix matched standards or by standard addition. A method
published by Mortier et al., 2005(a) allowed for the analysis of four substances of
interest; HAL, ROB, DNC and DIC in feed by LC-MS/MS. Samples were extracted
with methanol and concentrated up before filtering through a 0.22m filter.
Quantification was performed with the use of internal standards and calibration
curves. To the laboratory’s knowledge only one method has been published in
literature to allow for the analysis of all eleven coccidiostats in feed. Delahaut et al.,
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2010 published a method for the analysis of eleven coccidiostats in feed by LCMS/MS. Samples were extracted with 10% Na2CO3 and double extraction
acetonitrile. No purification was performed and quantitation was performed by the
use of internal standards and quadratic regression model [Delahaut et al., 2010].
From previous work carried out on the analysis of feed in our laboratory it is clear
that feed is a very complex matrix [Cronly et al., 2010 (b)]. Each feed sample can
almost be unique at time therefore developing a method to allow for its analysis can
prove difficult. None of the methods available in literature could be applied
successfully to allow for the analysis of all eleven coccidiostats in the feed that is
encountered in our laboratory. As a consequence a method had to be optimised in our
laboratory that would allow for the extraction of all eleven analytes but would also
overcome the issue of feed variability that would be encountered on a routine basis.
To this end; this paper describes the analysis of eleven coccidiostats in pig and
poultry feed at unavoidable carry-over levels described in Regulation 2009/8/EC by
LC-MS/MS utilising an efficient extraction protocol.

8.3 Materials and Methods

8.3.1 Chemicals and Reagents
Robenidine (ROB), nicarbazin (NIC), diclazuril (DIC), decoquinate (DEC), lasalocid
(LAS), monensin (MON), salinomycin (SAL), narasin (NAR), maduramicin (MAD),
nigericin (NIG), d8-Robenidine (d8-ROB), d8-4,4'-dinitrocarbanilide (d8-DNC) and
d5-decoquinate (d5-DEC) were all purchased from Sigma (St. Louis, MO, USA).
Halofuginone (HAL) was purchased WITEGA Laboratorien (Berlin, Germany) , bisdiclazuril (bis-DIC) from Janssen (Beerse, Belgium) and semduramicin (SEM) from
Phibro (Pittsburgh, PA, USA). Water is of LC-MS grade from Fluka (Berlin,
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Germany). All other solvents are of LC grade and purchased from Reagecon (Clare,
Ireland). Anhydrous magnesium sulphate is AnalaR grade and purchased from Sigma
(St. Louis, MO, USA). Individual stock standards of each analyte ranging between
0.50-1.00 mg ml-1 were prepared in methanol for all compounds except for
halofuginone (water) and nicarbazin (dimethylsulfoxide) and stored at 4˚C. Working
standard solution (mixture of analytes) was prepared in acetonitrile by diluting stock
standard into a range that equated to the carryover levels in 2.5g of feed and stored at
4ºC for. Internal standards were prepared similarly.

8.3.2 Instrumentation
The LC-MS/MS system is a TSQ Quantum Ultra EMR coupled to a Finnigan
Surveyor LC system. The instrument is controlled by Xcalibur software (Version
1.5). Separation was achieved using a (100 x 3)mm, 3.5m particle size, Symmetry
C8 column protected by a Security Guard guard cartridge system (20 x 2)mm,
supplied by Waters and Phenomenex respectively. The oven temperature was set at
40ºC. The chromatographic separation was performed in gradient mode using water
acidified with 0.1% formic acid (mobile phase A) and acetonitrile acidified with 0.1%
formic acid (mobile phase B), at a flow rate of 0.6mL min-1. The initial conditions
(from 0-1min) were 100% A. Then the conditions were changed to 2% A over 4
minutes from 1-5min and this were maintained until 11.50 min. Finally the conditions
returned to 85% A over 0.5 minutes from 11.5-12min, and were maintained until the
end of the run at 19min. Electrospray ionisation (ESI) was used in the MS with both
positive and negative ionisation utilised with a spray voltage of 4500V and a cone
temperature of 350 ºC. The individual precursor and products ions for each analyte
with their respective collision energies are listed in Table 8-1.
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Table 8-1: Molecular Structures, 1% and 3% Carry-over, Electrospray Ionisation (ESI)
Retention time(Rt), Precursor and Product ions for all 11 analytes.
Compound

Halofuginone

Robenidine

Nicarbazin

Diclazuril

Decoquinate

Semduramicin

Lasalocid

Salinomycin

Monensin

Narasin

Maduramicin

Structure

1% Carry
Over
(mg/kg)

3% Carry
Over
(mg/kg)

Rt

ESI

Precursor
(M/z)

0.030

0.090

5.48

positive

416

0.700

0.500

0.001

0.400

0.250

1.250

0.700

1.250

0.700

0.050

2.100

1.500

0.003

1.200

0.750

3.750

2.100

3.750

2.100

0.150

6.02

7.30

7.56

8.21

9.08

9.38

9.69

9.76

10.08

10.30

positive

negative

Product
(M/z)

Collision
Energy

100.4*

21

120.0

29

138.0

31

155.0*

18

107.2

38

136.9*

18

405

333.9

20

407

335.9*

22

203.9*

42

372.1

29

833.3*

39

851.3

41

377.2*

32

577.2

32

431.0*

50

531.4

45

461.5

55

675.3*

41

431.4*

50

531.4

45

719.5

65

877.7*

35

333.9

301

negative

positive

positive

positive

positive

positive

positive

positive

418

895.4

613.3

773.5

693.4

787.4

935.9
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8.3.3 Pig and Poultry Compound Feed Samples
A variety of pig and poultry compound feed samples were sourced from various feed
mills. These were milled upon receipt to 1mm using a Retsch SM 100 mill and stored
in amber jars at 4ºC. Portions of these samples were analysed and those found to
contain no detectable residues of the analytes of interest were used as blanks for the
validation study. To ensure robustness of the method a high number of different feed
samples were used in validation. These included 12 different pig feeds and 12
different poultry feeds. Chromatograms of blank feed can be seen in Figure 8-1a.

8.3.4 Extraction
Feed (2.5 g) was weighed into polypropylene centrifuge tubes (50 mL). The sample
was fortified with mixed internal standard (25 µL). To this deionised water (12 mL)
was added and the tubes were shaken (15 min). To this acetonitrile (25mL) was
added and the tubes were shaken (15min). Anhydrous MgSO4 (4.0 g) and NaCl (2g)
was added to this slurry which was then shaken (15 min) and centrifuged (5100rpm
for 20 min). The organic layer was then transferred to a clean polypropylene tube (50
mL) and placed in a -80 ºC freezer for 15mins to allow for freezing out of matrix
components. The samples were then removed from the freezer. 10mL of the extract
is then transferred to a clean polypropylene tube (15mL) and centrifuged at 4500rpm
for 10min. The extract is then run twice. The first was a straight extract and the
second was the extract diluted 15 times in mobile phase B. An aliquot (20 µL) of
each is injected onto the LC-MS/MS.
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8.3.5 Matrix Extracted Calibration Curves
Quantitation was carried out using matrix extracted calibration curves. Blank pig and
poultry feed samples were used. These samples were fortified with mixed working
standard and submitted to the full extraction procedure. A matrix extracted
calibration curve was performed with every batch. Feed samples were fortified with
internal standard and mixed working standard yielding a calibration range relating 0
to 4% carryover of each of the eleven analytes. Calibration curves were prepared by
plotting the response factor (the ratio of peak area analyte over peak area of internal
standard) against analyte concentration for the four compounds with internal
standard. Four internal standards were used; d8- DNC, d8-ROB, d5-DEC and bisDIC. For compounds for which no suitable internal standard could be acquired; HAL
and the six ionophore coccidiostats SEM, LAS, SAL, MON, NAR and MAD;
calibration curves were prepared by plotting the peak area of the analyte against
analyte concentration.

8.3.6 Method Validation
The LC–MS/MS method was validated according to Commission Decision
2002/657/EC guidelines. LC–MS/MS identification criteria were verified throughout the validation study by monitoring relative retention times, ion recognition
(signal-to-noise ratio (S/N)) and relative ion intensities. LC-MS/MS identification
criteria as set out in the legislation were verified throughout the validation of the
method.
Several method validation parameters were determined including linearity,
specificity, recovery, precision and analytical limits (decision limit CC, and
detection capability CC). Specificity was determined by analysing 28 different
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blank pig and poultry samples sourced from different mills. To investigate the
linearity of the method, matrix-matched calibration curves were prepared and run
with each of the validation batches to give 6 point calibration curves ranging from 0
to 4% carryover for each of the analytes.
Since no certified reference materials were available for all the analytes and matrices
of interest, the recovery from fortified blank samples was measured as an alternative
to trueness. The accuracy and precision were determined through the analysis of wide
variety of blank pig and poultry feed samples fortified in seven replicates relating to
0.5%, 1% and 3% carryover of each of the analytes. Seven replicate test portions at
each of the three fortification levels (n = 21) were analysed on three separate days
over a period of two weeks. Samples were fortified by adding mix working standard
solution (12.5, 25 and 75 µL) and analysed. From these three separate validation days
the estimation of recovery, precision and analytical limits (decision limit CC, and
detection capability CC) were determined along with the methods measurement
uncertainty.

8.4 Results and Discussion

8.4.1 LC-MS/MS Optimisation
The LC-MS/MS method was developed to provide confirmatory data for the analysis
of 11 coccidiostats in pig and poultry compound feed. The MS/MS fragmentation
conditions were investigated and collision energies were optimised for each
individual compound to give best response. For a method to be deemed confirmatory
under Commission Decision 2002/657/EC it must yield 4 identification points. In
this method a precursor ion (parent mass) and two product ions (corresponding to
strong and weak ion) are monitored for each analyte (Table 8-1). This yields 4
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identification points (1 for the parent ion and 1.5 for each daughter ion) hence it can
be deemed a confirmatory method. In addition to this relative retention times and ion
ratios are monitored for each compound and evaluated to ensure that they are within
acceptable ranges as stated in EC 2002/657.
Previous work carried out on coccidiostats in various matrices used a range of
different columns and gradients. A popular choice with many methods is C18 with
acidified water and acetonitrile gradient [Mortier et al., 2005 (a); Dubois et al., 2004;
Delahaut et al., 2010]. Other methods used phenylhexyl [Olejnik et al., 2009] and C8
[Dubreil-Chéneau et al., 2009] columns with three mobile phases. During the
development of this method it was found that a combination of C8 column with a
mobile phase of water and acetonitrile acidified with 0.1% formic acid gave the best
retention, peak shape and separation for all compounds in an acceptable run time. As
this method involved positive and negative ionisation switching, the MS/MS method
had to be segmented. The LC gradient was optimised in order to have the negative
ionisation in one segment. Only when the positive and negative ionisations were
isolated to separate segments was there enough data points for each peak. For a
method to achieve reliable quantitation each analyte peak should have at least 12 -15
data points. The LC Gradient along with segmentation allowed for the analysis of all
11 analytes in a complete run time of 19 minutes with each peak having a minimum
of at least 12 data points.

8.4.2 Extraction Optimisation
The aim of the development work was to develop a quick efficient extraction
protocol for the analysis of eleven coccidiostats in a wide variety of feed. From
investigation of literature it was found that acetonitrile is commonly used as an
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extraction solvent for these compounds in various matrices [Olejnik et al., 2009;
Dubois et al., 2004; Delahaut et al., 2005]. From initial tests it was clear that
although acetonitrile extracted all the analytes of interest it also extracted a lot of
matrix interferences as feed is a very complex matrix. Previous research carried out
in our lab has demonstrated difficulties with this matrix [Cronly et al., 2010 (b)].
Feed is not a standardised formula and is a lot more variable than other biological
matrices such as plasma and milk. Even one batch of feed to the next can vary and
therefore each feed can be considered a unique sample.
Taking this into consideration there is a need for a suitable sample clean up
procedure. A number of procedures were investigated; the extraction of analytes by
water and acetonitrile with addition of NaCl [Cronly et al., 2009 (a)], extraction by
acetonitrile with the addition of anhydrous sodium sulphate [Cronly et al., 2010(b)]
and the extraction by water and acetonitrile with addition of NaCl and magnesium
sulphate [Walorczyk, 2008] in order to reduce the amount of interferences extracted
from the matrix. While all these helped to improve the recovery of the analytes and
the ion suppression in the LC-MS/MS the addition of NaCl and magnesium sulphate
with an extraction of water and acetonitrile gave the best results.
To help improve the method further the addition of a dispersive SPE step was added.
This improved the method repeatability but on investigation of literature it was found
that this step could be replaced by a freezing out step which can remove many of the
same matrix components as the dispersive SPE [Walorczyk, 2008; Mastovska et al.,
2010]. This step was performed by placing the extract into a -80ºC freezer for fifteen
minutes. Upon removal from the freezer a visible amount of particles had fallen to
the bottom of the extract. The addition of this step improved repeatability in different
feeds.
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The next step in the development was the selection of suitable internal standards.
From investigation of literature it was observed that some deuterated internal
standards were available [Dubreil-Chéneau et al., 2009]. Deuterated standards
available were ROB-d8, DNC-d8 and DEC-d5. Other internal standards used were
bis-DIC for diclazuril and nigericin for the ionophore coccidiostats [Mortier et al.,
2005; Vincent et al., 2008]. These were obtained and used as internal standards for
the various analytes. It was seen that while the deuterated standards and bis-DIC
corrected satisfactorily for their respective analogues, nigericin did not correct the
ionophore coccidiostats adequately. It was observed that in calibration curves of the
six ionophore coccidiostats the curve started levelling off near the top. Recent work
published [Delahaut et al., 2010] suggested the use of quadratic instead of linear
calibration curves. While in single feeds this gave coefficient of determination (R2)
values of 0.99, the use of this curve for calculating fortified samples gave very
variable results in various different types of feed. Therefore in order to use this
approach the selection of feed for matrix matched curves had to be very similar to the
feed being analysed. As feed can vary greatly it was felt that this approach would not
be fit for purpose in our laboratory where a wide range of feed samples would be
received for analysis.
In order to overcome this problem it was decided that diluting the extract would
allow for less matrix interference while still having enough analyte signal. Various
dilutions were tested and it was found that a 1 in 15 dilution gave linear curves in a
single feed with R2 of 0.99 using nigericin as an internal standard for the ionophore
coccidiostats. When this was used for calculating the levels in fortified feed samples
it was seen that while in some feeds, results were satisfactory, there were cases in
which the results were not acceptable in relation to accuracy. Upon further
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investigation it was seen that this was due to the unsuitability of nigericin as an
internal standard for these compounds in feed. Results showed that when peak areas
for the analyte increased, the results for nigericin decreased and vice versa. This
resulted in larger errors in the results for these feeds. It was seen that repeatability
and accuracy were greatly improved when no internal standard was used for these
compounds. The only drawback to this was that each extract would have to be run
twice, once as a straight extract and once diluted 15 times. This was as a result of the
levels and low responses for DIC and HAL in the diluted samples.
In order to ensure that this procedure would hold true in the wide variety of feed
samples likely to be encountered in the laboratory on a routine basis a validation
procedure was developed in accordance with Commission Decision 2002/657. In
each validation a single feed would be used for the six point matrix extracted
calibration curve and seven different feeds would be used for the replicates at the
three validation levels. This would allow the validation to fully cover the various
feeds likely to be encountered.

8.4.3 Validation
Validation was carried out in accordance with the procedures outlined in
Commission Decision 2002/657/EC covering specificity, calibration curve linearity,
accuracy, precision, decision limits (CCα), decision capability (CCβ) and
measurement uncertainty. Results are seen in table 8-2 for these criteria. The criteria
of relative retention times and ion ratios were monitored for all analytes in the three
validations days. The values identified for these were all within European
requirements.
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Table 8-2: Validation results for accuracy, precision (%CV), decision limit (CC) detection
capability (CC)and measurement uncertainty (MU) and confirmatory data of typical ion
ratios and relative retention times (RRT) for all 11 analytes.
Internal

Accuracy

CV

Standard

(%)

(%)

1% 

3%

1%

HAL

None

88.8

8.8

0.029

0.092

ROB

ROB-d8

95.0

6.1

0.786

DNC

DNC-d8

97.3

4.4

DIC

bis-DIC

96.3

DEC

DEC-d5

SEM

Typical

Typical

MU

3%

RRT

Ion Ratio

(%)

0.033

0.109

0.912

0.334

25

2.370

0.871

2.639

1.000

0.863

19

0.532

1.669

0.564

1.837

1.000

0.069

12

8.0

0.011

0.035

0.013

0.040

0.990

0.849

17

95.0

7.0

0.439

1.333

0.478

1.466

1.000

0.589

15

None

99.9

7.6

0.294

0.863

0.338

0.976

1.511

0.129

21

LAS

None

98.1

8.6

1.570

4.524

1.890

5.298

1.561

0.455

31

SAL

None

92.3

9.1

0.821

2.418

0.942

2.737

1.612

0.548

22

MON

None

96.6

6.3

1.388

4.178

1.527

4.606

1.624

0.354

21

NAR

None

101.7

7.0

0.775

2.380

0.850

2.660

1.677

0.463

19

MAD

None

104.5

8.4

0.057

0.168

0.064

0.187

1.714

0.037

24

CC (mg/kg)

CC (mg/kg)

Analyte

8.4.3.1 Specificity
The technique of LC-MS/MS itself offers a great deal of specificity and selectivity.
To establish the specificity and selectivity of the method 24 blank pig and poultry
compound feed samples and samples fortified with all 11 analytes were analysed
over the 3 validation days. All blank samples showed no interfering peaks in the area
of interest for any of the analytes. Chromatograms of blank feed and feed fortified at
0.5% carryover of each analyte are seen in Figure 8-1a and 8-1b.
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Figure 8-1a: Chromatogram of feed fortified at 0.5% Carry-Over
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Figure 8-1b: Chromatogram of blank feed
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8.4.3.2 Linearity of Response
The linearity of the chromatographic response was tested with matrix extracted
calibration curves using six calibration points in the range of 0-4% carryover for all
eleven analytes on each of the validation days. For each analyte; calibration curves
were linear in the given range with a coefficient of determination (R2) of at least 0.99
for all compounds except for LAS and MAD which were at least 0.98.

8.4.3.3 Ion Ratios
Two transition ions were monitored for each of the fourteen analytes. The most
intense was used for quantitation. Ion ratios were calculated for all analytes by
calculating the ratio of the strong ion over the weak ion. All ion ratios of samples
were within tolerances as set out by European criteria when compared with standards
used during validation. Control charts were used to ensure all ion ratios were
acceptable. The typical ion ratios for all the analytes are shown in Table 8-2.

8.4.3.4 Relative Retention Times (RRT)
RRTs were calculated for all analytes in this method by calculating the ratio of the
retention time of the analyte over the retention time of its corresponding internal
standards. For the seven compounds that do not use an internal standard, ROB-d8
was used for their RRT calculations. The RRT tolerance for LC-MS/MS of 2.5% was
adhered to when standards were compared to samples in the validation runs. Control
charts were again used to ensure all ratios were acceptable. The typical RRT for all
the analytes are shown in Table 8-2.
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8.4.3.5 Accuracy/Trueness
The accuracy (trueness) of the method was determined by fortifying 21 replicate feed
samples on three separate days. For the eleven coccidiostat analytes seven replicates
were fortified at 0.5%, 1% and 3% carryover. Mean corrected accuracy (n=7) of the
analytes, determined in the three separate validation batches are shown in Table 8-2
range between 88.8% and 104.5% for the eleven analytes in pig and poultry feed.
These are within acceptable limits set out in European legislation.

8.4.3.6 Precision
Satisfactory values for inter-assay precision expressed as %CV values for the within
lab reproducibility (table 8-2) were achieved for all analytes. According to
Commission Decision 2002/657/EC this coefficient of variance for the repeated
analysis of fortified material under reproducible conditions shall not exceed the level
calculated by the Horwitz equation. For a concentration of 1 mg kg

-1

this equation

gives a value of 16%. Results achieved range from 4.4 to 9.1% for all analytes and
this is less the desired 16%. These acceptable results can be attributed to the
availability of 4 suitable internal standards. For compounds without suitable internal
standards the optimisation of the extraction protocol can be attributed to the
acceptable values.

8.4.3.7 CC and CC
In the case of substances with an established permitted limit, the decision limit (CCα)
means the limit at and above which it can be concluded with an error probability of α
that a sample is non-compliant and the detection capability (CCis the
concentration at which the method is able to detect permitted limit concentrations
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with a statistical certainty of 1 – β. CC and CC values were determined in
accordance with sections 3.1.2.5 and 3.1.2.6 of commission decision 2002/657/EC
by fortifying seven samples at the 1% and 3% allowed carry over levels on three
different days (n=21) and calculating standard deviations. The concentrations at the
1% and 3% plus 1.64 times the calculated standard deviation was used to yield CC,
CCwas determined by addition of another factor of 1.64 times the standard
deviation. Values of CC and CC for each of the eleven analytes for the 1% and
3% carryover are shown in Table 8-2.

8.4.3.8 Measurement Uncertainty
The measurement uncertainty (MU) was estimated by taking into account the within
laboratory reproducibility over days 1, 2 and 3. This value was multiplied by a
coverage factor of two to give an overall figure for the MU. This approach of
using the within laboratory reproducibility as a good estimator of measurement of
uncertainty is taken from the SANCO/2004/2726rev4 document. It recommends
using the within laboratory reproducibility and using a coverage factor of 1.64 to
estimate expanded uncertainty for permitted substances, however it was felt that not
all the environmental factors that could be varied over the course of the validation
were examined. Therefore a coverage factor of 1.64 may underestimate the true
uncertainty of the method and instead a value of 2 was chosen to give a more
realistic value for the expanded uncertainty. Values for MU are seen in Table 8-2
and lie between 12 and 31% for all the analytes.
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8.4.3.9 Method Evaluation

Figure 8-2: Chromatogram containing strong and weak ions of non compliant samples

In order to evaluate this method non compliant feed samples that were received from
Rikilt (Netherlands) at levels relating to carry over issues were analysed. Figure 8-2
shows chromatograms with both the strong and weak ions for robenidine,
salinomycin and monensin which were found to be present in these samples. These
samples were tested using the method described here and found to yield satisfactory
results. When the methods measurement uncertainty is applied, the assigned values
fall within the possible range of concentrations given by this method. Also the
method found no peaks of analytes that were not present in the sample. Results of all
non compliant samples tested are seen in table 8-3.
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Table 8-3: Results of non compliant sample received from Rikilt

RESULTS
Feed

Calculated

Result + MU

Result -MU

Actual

Sample No.

Compound

MU (%)

(mg kg -1)

(mg kg -1)

(mg kg -1)

(mg kg -1)

12

ROB

19

3.24

3.86

2.62

2.9

7

SAL

22

2.24

2.73

1.75

2.3

14

MON

21

1.61

1.95

1.27

1.3

8.5 Conclusions
The objective of this work was to develop a rapid confirmatory method capable of
identifying, confirming and quantifying eleven coccidiostats at levels relating to
unavoidable carry-over in a variety of feed samples that the laboratory might
encounter on a routine basis and to validate in accordance with the requirements set
out in Commission Decision 2002/657/EC. This was successfully completed.
The method can be considered as rapid, as it utilises an efficient extraction protocol
without the use of large sample sizes, extraction volumes and SPE. It also utilises
chromatography which separates all analytes in a total run time of 19 minutes. The
method includes the analysis of 11 coccidiostats in a wide variety pig and poultry
compound feed.
The obtained confirmatory criteria of ion ratios and relative retention times fulfill the
requirements laid down in Commission Decision 2002/657/EC. The calculation of all
relevant performance characteristics was performed during validation. This study
shows that the developed method meets the desired sensitivity of 0.5% carry-over for
all the compounds. The method performs satisfactorily in terms of accuracy and
precision (%CV) for each of the analytes investigated and all fall within acceptable
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ranges. The analytical limits in terms of decision limit (CC, and detection
capability (CCof the method were calculatedfor all eleven coccidiostats.Therefore
applicability of the method for use on various types of pig and poultry compound
feed was demonstrated by the satisfactory results obtained from the validation. The
validation data shows that the method allows for the quantitation of 11 analytes. The
method was further evaluated by using it to analyse for these compounds in non
compliant samples. The reduced number of analytical steps within the method makes
it very amenable for high through-put regulatory monitoring of these compounds and
enforcing Commission Directive 2009/8/EC.

219

Chapter 9

Conclusions and Future Work

CHAPTER 9: CONCLUSIONS AND FUTURE WORK

220

Chapter 9

Conclusions and Future Work

9.1 Conclusions
The main areas on which this research focused was the development of analytical
methodologies for the detection of nitroimidazole residues in various biological
matrices. These included plasma, eggs, milk and honey [Cronly et al., 2009(a);
2009(b); 2010(a)]. By using generic extraction protocols the work also demonstrated
that different classes of drugs could be analysed together such as chloramphenicol
and nitroimidazoles. The developed method was then used to carry out a survey for
the presence of nitroimidazole residues in Irish retail egg samples [Cronly et al.,
2011(a)]. The second area of research focused on the analysis of medicinal additives
in animal feed. New legislation has been introduced in this area by the EU which
prohibits the use of wide number of these compounds [Commission Recommendation
2005/925/EC]. As a result there is a requirement for multi-class methods that can
analyse for a wide variety of these additives in feed. The remaining authorised
additives are only permitted for use in target species. Levels for allowed unavoidable
carryover of these additives in non target feed were set by the EU [Commission
Directive 2009/8/EC] and hence a need existed for an analytical method capable of
measuring all these substances at these carry over levels. Therefore as part of this
research two methods were developed for the analysis of animal feed, firstly for the
presence of 14 prohibited medicinal additives [Cronly et al., 2010(b)] and secondly
for the coccidiostats at levels relating to unavoidable carry over [Cronly et al.,
2011(a)]. The conclusions resulting from these two areas of research are discussed
fully in the following two sections.
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methodologies

for
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of

nitroimidazoles

and

chloramphenicol residues in biological matrices
When initiated the main focus of this research was on the development of multiresidue analytical methods for the analysis of nitroimidazole residues in plasma and
eggs by LC-MS/MS. There were a number of reasons for this;


Nitroimidazole compounds are believed to be carcinogenic and mutagenic to
humans.



They are prohibited for use in food producing animals by their inclusion in Table
2 of Council Directive 37/2010/EC.



Matrices of plasma and egg are recommended as target matrices for these
compounds by the EURL.



Finally their monitoring as part of the national residue control plan in Ireland
was limited to the analysis of two residues in one matrix.



LC-MS/MS offered a selective and sensitive confirmatory technique that could
overcome problems associated with derivatisation of these analytes for analysis
by GC-MS/MS.

From examination of literature it was apparent that there was a shift from traditional
labour intensive extraction and purification techniques such as SPE to more efficient
generic extraction protocols which resulted in significant economic and time
benefits.
The approach to method development taken as part of this research was to try to
incorporate as many nitroimidazole analytes as possible and develop a rapid and
efficient method. Initially a method published by Xia et al., 2006 for the analysis of
nitroimidazoles in muscle and eggs was used as the basis for the developed
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extraction protocol. Xia et al., 2006 method was limited to the analysis of four NMZ
residues so needed to be adapted to incorporate increased number of analytes. This
paper described the use of a fast LLE using acetonitrile. The miscible aqueous and
organic phases were separated by the addition of salt. The salt used was NaCl and
this resulted in the phases separating into two layers. The NMZ residues were
extracted into the acetonitrile phase which resulted in a cleaner extract.
Using this protocol as a basis for method development; methods were developed for
the analysis of NMZ residues in plasma and eggs. This was achieved by making the
following adaptations to the original method;


The samples were extracted with a single extraction rather than a double
extraction.



The samples were purified by the addition of a hexane wash step which removed
any further non polar impurities



Two centrifuge steps were incorporated, one to ensure complete phase
separation and another to remove any particulates prior to evaporation.



The sample was evaporated to dryness and reconstituted in a small volume to
increase sensitivity.



Finally after testing numerous filters, samples were filtered through 0.25 µm
PVDF filters which resulted in a clean extract for injection.

These adaptations allowed for rapid, multi-residue, confirmatory methods to be
developed that simultaneously identifies, confirms and quantifies ten NMZ residues
in plasma [Cronly et al., 2009(a)] and eleven NMZ residues in eggs [Cronly et al.,
2009(b)] by LC-MS/MS.
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The developed methods were an improvement on existing methodologies and the
benefits of the analytical methods are as follows;


An increased number of analytes are incorporated both in plasma and egg than
previously published in the literature. The method is capable of analysing for the
seven NMZ residues that are recommended for analysis by the EURL as well as
other nitroimidazoles that haven’t been analysed previously such as ornidazole
and carnidazole



The method can be considered as rapid, as it utilises an efficient extraction
protocol with purification by hexane wash and filtering.



The method is validated and the obtained data fulfils the requirements laid down
in CD 2002/657/EC and allows the calculation of accuracy, repeatability,
reproducibility and MU. These parameters fall within acceptable ranges for each
analytes.



The required sensitivity of the method is demonstrated by the values for CC
and CCThese values are lower than the RL for NMZ residues of 3 µg kg-1/ng
mL-1.



The developed methods were capable of analysing for plasma and eggs from a
variety of species. These include bovine, avian, porcine, ovine and equine
plasma and caged, free range and organic hen eggs along with duck and quail
eggs.



Finally both methods performed satisfactorily in evaluation tests carried out on
incurred plasma and egg samples where results achieved were within MUs when
compared to assigned values.
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Upon completion of validation of the developed method for the analysis of
nitroimidazoles in eggs, a survey of retail egg samples commenced [Cronly et al.,
2011(b)]. The two main reasons for undertaking this survey were that non compliant
findings of NMZ residues in eggs had been recorded in Europe [EFSA Report, 2009]
and also there was no analysis carried out on these compounds in eggs in Ireland prior
to 2007. Therefore it was felt that an evaluation of eggs available in the Irish retail
market for the presence of NMZ residues would be beneficial. The survey was carried
out throughout the course of the research with retail samples taken every month over
two years. Upon completion of this survey; 160 hen and duck egg samples were
analysed and no non-compliant samples were identified. It is felt that this
demonstrates that the ban on these compounds is being observed and it gives
confidence to the consumer that the eggs that reach the table are free from these
harmful residues. It is felt that the continued monitoring of these compounds in eggs
which is being carried out as part of the national monitoring plan is sufficient to
ensure the continued enforcement of these prohibited compounds in eggs.
Carrying on from the development of the methods for plasma and eggs other matrices
were examined. In order to ensure continued consumer protection the EURLs are, on
an ongoing basis, suggesting that a wider variety of residues and matrices be
examined. Two such matrices suggested by the EURL for nitroimidazoles were milk
and honey. Honey bees and dairy cows were originally not target species for
nitroimidazole drugs but abuse in them now cannot be overlooked. The EURL
suggest that countries with high milk production should test for NMZ residues in this
matrix. Reports from China about the potential use of nitroimidazoles in beekeeping
suggest that honey should also be investigated [Zhou et al., 2007]. Examination of
literature found that there was a lack of methods for these matrices with regards to the
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analysis of nitoimidazoles with only one confirmatory method for the analysis of
NMZ residues in milk and none in honey. Therefore it was felt that the previously
developed method could be adapted to include the analysis of milk and honey.
Due to the generic nature of the extraction procedure it was envisaged that it may be
possible to include other classes of compounds. From examination of literature and
legislation it was felt that it would be beneficial to include chloramphenicol. The
main reasons for this were that it is also listed in Table 2 of Commission 37/2010/EC
(prohibited substances), it is commonly analysed in single analyte labour intensive
methods which are time consuming and target matrices for this compound include
milk and honey. Therefore it was decided to adapt the method for the analysis of 11
NMZ residues and CAP in milk and honey by LC-MS/MS.
The main benefits of this method over existing published methods are as follows;


The method includes the confirmatory analysis of CAP and 11 NMZs in milk
and honey which has not been seen before.



The method can be considered as rapid, as it utilises an efficient extraction
protocol without the use of SPE and utilises rapid chromatography with a total
run time of only 9 minutes.



Methods previously published on these matrices analysed at most seven NMZ
analytes and in the case of CAP it was often analysed as a single analyte method.



This study shows that as the developed method uses a newer sensitive
instrument that even with reduced sample sizes required sensitivities of 3 g L-1 /
g kg-1 for NMZs and 0.3g L-1 / g kg-1for CAP which are the RL and MRPL
used for these compounds are easily achieved.

226

Chapter 9


Conclusions and Future Work

The method performs very well in terms of accuracy and repeatability for each
of the analytes due to the utilisation of seven different deuterated internal
standards.



In the case of the extraction protocol for milk; time and solvent usage is greatly
reduced compared to other published methods as a result of reduced sample size
of 1mL.

This concluded the research on the analysis of nitroimidazole residues in biological
matrices. The main aim of this research was to help improve the surveillance
capabilities of The State Laboratory with regards to the analysis of nitroimidazoles.
To this end, a number of novel, rapid, confirmatory, multi residue methods using
liquid chromatography tandem mass spectrometry in a variety of biological matrices
were successfully developed. Other aims including determining the potential misuse
of nitroimidazole compounds in eggs in the Irish poultry industry by the analysis of
retail survey samples and the implementation of these methods in the National
Reference Laboratory designated for nitroimidazoles in Ireland were also
successfully completed.

9.1.2 Analytical methodologies for the detection of medicinal additives in animal
feed.
The second phase of the research was concerned with the development of multi-class
analytical methods for the analysis of medicinal additives in animal feed. This
included methods for the analysis of 14 prohibited medicinal additives and the
analysis of 11 coccidiostats at levels relating to unavoidable carryover. The reasons
for researching this area are;
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Contaminated feed has the potential to result in possibly harmful levels of
residues in any animal fed such feed.



Recent legislation; Commission Recommendation 2005/925/EC; has prohibited
all previously used feed additives except for one class of compounds
coccidiostats and histomonostats.



Further legislation, Commission Directive 2009/8/EC established maximum
limits for unavoidable carry over of coccidiostats and histomonostats into
sensitive and less sensitive non target species.



Previously used single analyte HPLC methods used for the analysis of additives
at medicated level are not sensitive or selective enough to enforce levels set out
in the new legislation.



No multi-class multi-residue analytical methods were available for analysis of
these compounds and prior to this legislation, LC-MS/MS was not utilised in this
area.

It was felt that the best analytical tool for analysing these various feed additives and
enforcing new legislation was LC-MS/MS. However the use of LC-MS/MS in
medicinal additive analysis in animal feed is not routinely used and therefore this
research focused on the development and implementation of LC-MS/MS methods for
this purpose. Upon carrying out literature review it was decided that two methods
would be developed; one for the analysis of as many prohibited medicinal feed
additives as possible and one for the analysis of all allowed coccidiostat additives at
levels set out in legislation.
The first of these methods was developed to allow for the analysis of 14 prohibited
medicinal additives in pig and poultry compound feed. The method was one of the
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first multi-class feed additive methods to be published and it had significant benefits
over previously published articles. These included;


It is a rapid multi-class confirmatory method that allowed for the quantitative
analysis of 10 analytes and qualitative analysis of 4 analytes in pig and poultry
compound feed which had not been seen in literature before.



The method was capable of analysing all these compounds to a level of at least
100 µg kg-1.



The method developed in this study is an improvement on existing methods as it
allows for the analysis of an increased number of analytes in this matrix with
reduced sample preparation times and solvent usage.



The applicability of the method for use on the various different types of pig and
poultry compound feed was demonstrated by the satisfactory results obtained
from the validation.



The values achieved for accuracy, repeatability, reproducibility and MU all fall
within acceptable ranges.



The obtained confirmatory criteria of ion ratios and relative retention times for
all analytes fulfil the requirements laid down in Commission Decision
2002/657/EC.

The development of this method had great economical benefits as well as improved
analytical capabilities for monitoring laboratories. Previous methods were often
single analyte methods that needed large samples sizes and large volumes of
extraction solvents for analysis. As well as this a number of analytes such as
dinitolimide did not have methods for their analysis. This method allowed for all
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samples to be analysed for 14 analytes in a single run with less sample and solvent
required.
The final LC-MS/MS method to be developed as part of this research was a method
for the analysis of all eleven authorised coccidiostat feed additives at levels related to
unavoidable carry over in non target feed. Methods routinely used in monitoring
laboratories and many of the published methods in lliterature could only analyse for a
select number of these compounds. The allowed levels in non target feed for these
compounds ranged from the 5 mg kg-1 down to 10 µg kg-1 and some existing methods
had difficulty reaching the required sensitivity. The method developed as part of this
research could identify, confirm and quantify eleven coccidiostats at levels relating to
unavoidable carry-over in a variety of feed samples that the laboratory might
encounter on a routine basis and was validated in accordance with the requirements
set out in Commission Decision 2002/657/EC. The benefits of this method are as
follows;


The method can be considered as rapid, as it utilises an efficient extraction
protocol without the use of large sample sizes, extraction volumes or SPE. It also
utilises chromatography which allows for the analysis of all analytes in a total
run time of 19 minutes.



This study shows that the developed method meets the desired sensitivity of
0.5% carry-over of the medicated level for all the compounds.



The method performs satisfactorily in terms of accuracy and precision (%CV)
for each of the analytes investigated and all fall within acceptable ranges. Levels
for CCand CC were calculated for all compounds.
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The method was further evaluated by using it to analyse for these compounds in
non compliant samples. Results achieved were within MU for all analytes when
compared to the assigned values.



The reduced number of analytical steps within the method makes it very
amenable to high throughput regulatory monitoring of these compounds and as a
result enforcing Commission Directive 2009/8/EC.

The primary aim of this research; meeting the requirements of new EU legislation
with regard to medicinal feed additives was achieved by developing two new liquid
chromatography tandem mass spectrometry methods for the analysis of prohibited
medicinal feed additives in pig and poultry feed and eleven coccidiostats at
unavoidable carry over levels in animal feed. Both methods used efficient extraction
protocols with reduced usage of extraction solvents and decrease in sample
preparation time which will result in economical benefits for monitoring laboratories.
This work will contribute greatly to the research that is ongoing in this area as it has
shown improvements on many existing methods published in literature.

9.2 Future Work

9.2.1 Generic extractions for multi-class methods.
This research has demonstrated that in some cases the use of highly selective and
sensitive mass spectrometry techniques reduces the need for complex extraction
protocols utilising labour intensive purification steps. Leading on from this research it
is envisaged that future work in this area will be focused on the use of generic
extraction protocols for the analysis of multiple residues from multiple classes of
compounds in multiple matrices in a single method. An example of this is the
extraction method utilised in this study for nitroimidazoles. This was used for the
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analysis of nitroimidazoles and chloramphenicol in milk and honey. From
examination of literature similar extraction protocols with acetonitrile and phase
separation with NaCl has been used for the analysis of non steroidal anti
inflammatory drugs (NSAIDs) and corticosteroids in milk [Malone et al., 2009;
Malone et al., 2010]. Taken this into consideration this extraction procedure has the
capabilities of analysing for at least four classes of veterinary residues that routinely
monitored for as part of a European wide monitoring program.
Although there has been some work in the development of generic extraction methods
for the analysis of veterinary residues in biological matrices it is still somewhat in it’s
infancy. However the use of such extraction protocols has, for some time now, been
utilised in the analysis of pesticides. The most commonly used extraction method
utilised in this area is known as QuEChERS which stands for Quick, Easy, Cheap,
Effective, Rugged, and Safe. There is a wide range of these type of methods used in
pesticide residue analysis but they have the same core elements involved in their
extraction with some minor adaptations for specific analytes. Anastassiadiades et al.,
2003 and Lehotay et al., 2005 were some of the first to publish methods utilising this
type of generic method in pesticide analysis. Samples are extracted with acidified
acetonitrile. LLE is induced by addition of MgSO4 and NaCl to remove water. The
sample then undergoes purification with what is known as dispersive solid phase
extraction (d-SPE) by the addition of primary secondary amine (PSA), C18 sorbents
and MgSO4. The extract is centrifuged before injection and initially allowed for the
analysis of 80 different pesticides in a single extraction but has been further
developed to allow up to 229 pesticides to be incorporated [Lehotay et al., 2005].
There are a number of benefits to this type of approach in pesticide analysis which
might be beneficial in veterinary residue analysis [Lehotay et al., 2005]. These are;
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High recoveries (>85%) are achieved for a wide range of polarity and volatility.



Very accurate results are achieved because an IS is used to correct for
commodity to commodity water content differences and volume fluctuations.



High sample through-put of 10-20 preweighed samples in 30-40min.



A single person can perform the extraction without much training or technical
skill.



Despite ease of method the procedure is still quite rugged.

This type of generic extraction if adapted for the analysis of veterinary residues could
greatly improve the analytical capabilities of monitoring laboratories. To date there
has been only one published method for the analysis of veterinary residues attempting
to use QuEChERS protocol. Stubbings et al., 2009 published results of their research
for the analysis of 11 different classes of verteinary residues in animal tissue. The
published method was capable of screening for near 50 different residues but was
limited by there use of LC-MS/MS system. They needed to run samples several times
in order to achieve a complete screen.
This is where problems with the use of LC-MS/MS in this type of multi-class multianalyte work arise. This analytical instrument while it gives unequivocal confirmation
it can only analyse for a finite amount of analytes. The number of analytes it can
analyse for is governed by a number of factors such as scanning speed, dwell time,
need for pos/neg switching as well as column separation in order to allow for
segmentation of the MS/MS program. Therefore while a large number of analytes
could be determined using this instrument it might be a limiting factor. With the
advent of UHPLC-MS/MS more analytes can be incorporated due to increased
separation of analyte in shorter run times. However it is felt that future work in this
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area will lead to use of these type of generic extraction procedures in combination
with liquid chromatography coupled to high resolution mass spectrometry (LCHRMS). The benefits of this instrument technique are discussed fully in the next
section.

9.2.2 Screening for veterinary residues by High Resolution Mass Spectrometry
(HRMS).
Many analytical methods currently employed in monitoring laboratories throughout
Europe for the analysis of veterinary residues are performed using LC-MS/MS. The
major drawback of this technique is that it only offers targeted analysis i.e. only
compounds that the instrument is tuned may be detected. However, with the advent of
HRMS combined with recent advances in extraction procedures, the possibility exists
to monitor for potentially 100’s of harmful substances in one assay. Hence there will
be increased confidence that the food that reaches the consumer will be free from
harmful residues. From examination of published literature it has become apparent
that the capabilities of HRMS may be applied to the area of veterinary residue
analysis and offers many exciting opportunities [Kaufmann et al., 2011; Peters et al.,
2009]. The relatively few articles published to date in this area have shown the
impressive capabilities and possibilities of this technique.
To date this instrument is not considered a confirmatory instrument but never the less
its screening capability is vast and when applied to veterinary residues analysis has
the ability to improve analytical capability immensely. It is felt that future work in
this area will look at the possible combination of generic extraction procedures and
HRMS for the analysis of large numbers of residues in a single run. Two common
instruments that work on the basis of HRMS are Orbitrap and Time of Flight
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instruments. These instruments work on the basis of accurate mass calculations with
high resolution that allow for molecular weight determination to 4 decimal places.
This allows for compounds to be distinguished from each other. These instruments
can provide full scan targeted/untargeted screening and this approach offers a
number of advantages:


Using these instruments in untargeted full scan with a generic extraction
protocol allows samples of edible matrices (milk, eggs, meat etc.) containing
possibly dangerous levels of veterinary residues to be identified that may be
otherwise declared compliant.



It also allows for the re-interrogation of the data at a future date to examine for
the presence of possible residues which laboratories may not have been aware
of at the time of analysis.



The chemical formula of unknown residues can be determined which may allow
for identification of previously unknown compounds that are potentially being
abused.

It is anticipated that with decreasing cost of these instruments over time they will be
introduced more for performing targeted and untargeted screening assays of
veterinary residues in monitoring laboratories. It is believed the combination of this
powerful screening tool with generic extraction protocols such as QuEChERS will
lead to an improved monitoring program throughout EU member states for veterinary
residues.
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9.2.3 Development of a “risk based” approach to the monitoring of veterinary
residues.
The overall goal for this research was to improve the veterinary residue surveillance
capabilities of monitoring laboratories by the development of novel, efficient multiresidue analytical methods. As previously stated the use of veterinary drugs is
becoming a critical component of food production which has resulted in an increased
demand for veterinary residue surveillance systems. The current approach adopted
throughout the EU member states involves the analysis of a percentage of animals
slaughtered in the previous year as directed by Council Directive 96/23/EC. An
example of this approach is given below for bovine species taken from the legislation;
“The minimum number of animals to be controlled each year for all kinds of residues
and substances must at least equal 0.4 % of bovine animals slaughtered the previous
year, with the following breakdown:
Group A: 0.25 % divided as follows:
- one half of the samples are to be taken from live animals on the holding;
- one half of the samples are to be taken at the slaughterhouse.
Each sub-group in Group A must be checked each year using a minimum of 5 % of
the total number of samples to be collected for Group A. The balance must be
allocated according to the experience and background information of the Member
State.
Group B: 0.15 %
30 % of the samples must be checked for Group B 1 substances.
30 % of the samples must be checked for Group B 2 substances.
10 % of the samples must be checked for Group B 3 substances.
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The balance must be allocated according to the situation of the Member State species
for each class of compound every year.”
Key concerns over this type of approach are the economic viability of such
surveillance programmes when the prevalence of a residue approaches zero.
As human and financial resources available to support government monitoring of
veterinary residues are becoming more limited in many countries world-wide a search
to find a more efficient monitoring protocol is being considered. Hence the concept of
“risk based” monitoring programs has become an area of interest in veterinary residue
analysis. The main tenet of this approach focuses on the analysis of compounds in
particular species that pose a higher risk to human health. It is felt, issues that present
higher risks merit higher priority for residue surveillance resources as investments
will yield higher benefit-cost ratios.
As part of this research a survey of retail egg samples available on the Irish market
for the presence of nitroimidazole residues was performed. The results of this found
no noncompliant results in 160 samples. Therefore the assumption could be made that
the risk posed by nitroimidazole residues in eggs is relatively small. However more
factors need to be taken into consideration when developing risk based assessments.
This is where problems have arisen in implementing a risk based approach to residue
analysis. It is difficult to clarify the meaning of risk. Factors such as toxicity of
residues, overall occurrence of residues, species in which residues typically occur, the
intake of residues into humans from food and the deterioration of residues after
traditional cooking processes need to be taken into consideration when developing
risk based monitoring programs.
As a result of this, a lot of future work should go into assessing the risk associated
with these factors. Further toxicological studies should be carried out to assess the
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risk of residues to humans. Surveys like the one carried out in this research for
nitroimidazole residues in eggs, in addition to current monitoring plans, should be
carried out throughout Europe in a wide range of matrices to assess the occurrences of
different residues and the species they typically occur in. This information along with
values of Average Daily Intake (ADI) of certain foods for humans should be used in
determining the risk associated with certain residues. This associated risk will then be
used to determine what residues in what species should be given higher priority when
drafting residue plans.

9.2.4 Future work on contaminants in animal feed
Following an investigation into the Irish Dioxin crisis resulting from contaminated
feed fed to pigs in 2008 it was noted that there is too much emphasis placed on the
analysis of the quality of feed rather than on the monitoring for the presence of
undesirable substances in the feed. Therefore it was suggested that more samples
should be taken for the analysis of undesirables in animal feed. Hence as part of this
research, methods for the analysis of medicinal feed additives were developed. These
included detecting medicinal substances in feed that are no longer authorized as feed
additives as listed in Annex II of Commission Recommendation 2005/925/EC and
monitoring of unavoidable carryover of coccidiostats in non-targeted feed as per
Commission Directive 2009/8/EC.
Future work in this area will continue and should focus on the development of multianalyte methods for the analysis of contaminants in animal feed such as mycotoxins
and dioxins. Another area that should possibly be examined is the setting of
unavoidable carryover levels for medicines such as sulfadiazine and chlortetracycline
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in non medicated feed similar to what is set in legislation for cocciodisats in non
target feed. This work would be beneficial for a number of reasons;


Analytical methods for analysis of mycotoxins in animal feed: Fungal growths
and moulds on crops and animal feed can produce various mycotoxins. These
mycotoxins can pose a threat to animal health, consumer safety and food
processing activities if they occur at unacceptable limits. There are a number of
different parent classes of mycotoxins such as fusarium, aspergillus and
penicillium mycotoxins all with numerous sub components. Commission
Regulation (EC) No. 1881/2006 sets out maximum levels for contaminants in
foodstuffs. Levels are set for a number of mycotoxins including aflatoxins,
ochratoxin and deoxynivalenol. With the advent of newer, more selective and
sensitive analytical techniques emphasis should be place on the development
confirmatory multi analytes method for the analysis of a wide range of these
analytes in animal feedingstuffs in order to ensure these harmful contaminants
are below permitted levels.



Analytical methods for analysis of dioxins in animal feed: The general term
"dioxin" collectively refers to a class of structurally and chemically related
compounds known as halogenated aromatic hydrocarbons. They include polychlorinated

dibenzo-p-dioxins

(PCDD

or

Dioxin's),

polychlorinated

dibenzofurans (PCDF or Furans) and the "dioxin-like" Biphenyls (PCBs).
Dioxins and planar PCBs are carcinogenic and may have adverse effects on
reproduction. Dioxins and planar PCBs are fat soluble chemicals and exposure
of humans to these contaminants is largely from fat-containing foods of animal
origin. Many of the dioxin scares and crises are the result of animals fed dioxin
contaminated feed. This was the case in France in 1998 where dioxin239
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contaminated citrus pulp from Brazil was used in feed for dairy animals and
resulted in contaminated milk, and also in Belgium in 1999 where gross
contamination of waste edible oil with machine oil, resulted in contaminated
animal feed and contaminated food products such as poultry, eggs, red meat and
milk. More recently, there have also been two dioxin crises in Ireland (2008)
and Germany (2011). In Ireland, animal feed was contaminated with dioxins as
a result of an improper fuel being used in a direct drying burner system used to
dry animal feed which resulted in dioxin contaminated pork products on the
international market. Also in Germany the substitution of dioxin-contaminated
industrial fats for vegetable fats in animal feed resulted in the contamination in
possibly a 1000 pig and poultry farms. As a result of these contaminations and
the potential major health risks associated with these compounds increased
focus should be put on the analysis of these compounds in animal feed and the
development of multi-class method for their analysis.


Setting of unavoidable carryover levels of medicines in non medicated feed:
During this research, work was carried out on the analysis of medicinal
additives no longer authorised as feed additives. While some of these
compounds such as nitroimidazoles are no longer licensed for use in animals
some are still permitted to be used as medicines. Examples of these compounds
are sulfadiazine, tylosin and chlortetracycline are still used in medicated feed.
Part of the validation process involved sourcing blank feed material for use as
negative controls. However this proved quite challenging as it became apparent
that low levels of these medicines were present in a number of non medicated
feed samples possibly due to their carryover in feed mills. Currently the EU has
a zero tolerance policy to the presence of these substances in non medicated
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feed. However this is not practical and a similar approach of setting maximum
unavoidable carryover levels as used with coccidiostats in non target feed
should be considered.
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